The CDK-resistant pRB-E2F1 complex recruits chromatin-organizing proteins to repetitive DNA sequences by Ishak, Charles A
Western University 
Scholarship@Western 
Electronic Thesis and Dissertation Repository 
4-28-2017 12:00 AM 
The CDK-resistant pRB-E2F1 complex recruits chromatin-
organizing proteins to repetitive DNA sequences 
Charles A. Ishak 
The University of Western Ontario 
Supervisor 
Dr. Fred Dick 
The University of Western Ontario 
Graduate Program in Biochemistry 
A thesis submitted in partial fulfillment of the requirements for the degree in Doctor of 
Philosophy 
© Charles A. Ishak 2017 
Follow this and additional works at: https://ir.lib.uwo.ca/etd 
 Part of the Molecular Biology Commons, Molecular Genetics Commons, and the Neoplasms 
Commons 
Recommended Citation 
Ishak, Charles A., "The CDK-resistant pRB-E2F1 complex recruits chromatin-organizing proteins to 
repetitive DNA sequences" (2017). Electronic Thesis and Dissertation Repository. 4532. 
https://ir.lib.uwo.ca/etd/4532 
This Dissertation/Thesis is brought to you for free and open access by Scholarship@Western. It has been accepted 
for inclusion in Electronic Thesis and Dissertation Repository by an authorized administrator of 
Scholarship@Western. For more information, please contact wlswadmin@uwo.ca. 
i 
 
Abstract 
This thesis investigates mechanistic links between genome integrity and the 
recruitment of chromatin organizing proteins to repetitive DNA sequences mediated by the 
retinoblastoma tumor suppressor protein (pRB). I demonstrate that a CDK-resistant 
interaction between the pRB C-terminus and the E2F1 coiled-coil marked box (CM) domain 
establishes a scaffold that facilitates recruitment of multiple chromatin-organizing proteins to 
repetitive sequences across the genome throughout the cell cycle. Specifically, pRB recruits 
the enhancer-of-zeste-homologue 2 (EZH2) histone methyltransferase to establish repressive 
facultative heterochromatin at repetitive sequences, and the Condensin II complex to ensure 
proper DNA replication and mitotic progression. To disrupt the CDK-resistant pRB-E2F1 
interaction in vivo, a gene-targeted mutant mouse strain bearing a germline F832A 
substitution (Rb1
S
) is generated. Viable homozygous mutants permit exploration of CDK-
resistant pRB-E2F1 functions in cell culture and in vivo. Rb1
S/S
 MEFs and adult splenocytes 
exhibit pronounced misregulation of endogenous retroviruses (ERVs), long interspersed 
nuclear elements (LINEs) and major satellites (MaSats). Misexpression is associated with 
reduced co-occupancy of pRB and EZH2, along with reduced H3K27me3 at repetitive 
genomic regions but not developmental H3K27me3 targets. Furthermore, Rb1
S/S
 MEFs 
exhibit increased γH2AX, aneuploidy, ppRPA32, and chromosome segregation errors. 
γH2AX accumulates specifically at major satellites that exhibit reduced co-occupancy of 
pRB and Condensin II. Collectively, the consequences of perturbed EZH2 and Condensin II 
recruitment contribute to a state of genomic instability in Rb1
S/S
 cells that likely underlie the 
onset of spontaneous lymphomas that arise from the spleen or mesenteric lymph nodes of 
aged homozygous mutant mice. Finally, I explore whether the pRB-E2F1 scaffold provides 
an opportunity for therapeutic exploitation, and whether these properties directly alter tumor 
phenotypes in combination with p53 inactivation. Overall, this work suggests that chromatin-
organization mediated through the CDK-resistant pRB-E2F1 complex underscores a 
previously unknown facet of pRB-mediated tumor suppression.  
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Chapter 1  
1 Introduction 
Recent advancements in sequencing capabilities have illuminated the sheer 
magnitude of repetitive sequences within the human genome. Nearly half of the 
mammalian genome is comprised of repetitive sequences, while single copy protein-
coding sequences account for only 1-2% of total sequence content (Lander et al., 2001). 
Current models of the molecular genetics that underlie disease and development are 
predominantly based upon extensive characterizations of protein-coding sequences and 
the interactions of their protein products. In contrast, the contributions of repetitive 
sequences remain poorly understood and largely unaccounted for within these models.  
This omission is especially surprising upon consideration that investigations of 
repetitive elements have yielded seminal concepts within the field of eukaryotic genetics, 
many of which earned Nobel Prizes. For example, Barbara McClintock’s discovery of 
maize colour patterns driven by ‘controlling elements’ that could transpose to different 
chromosomal regions demonstrated that transposable elements existed and could regulate 
overt phenotypes of the individual (McClintock, 1950). A mechanism of transposition 
would emerge following the discovery that serologic tests against viral Gag proteins of 
the avian leukosis virus (ALV) could produce a positive signal in uninfected individuals 
(Dougherty and Di Stefano, 1966; Dougherty et al., 1967). The presence of viral-encoded 
proteins in the genome of uninfected individuals suggested that RNA viruses must 
integrate as DNA proviruses into the host germline. The discovery of reverse 
transcriptase by David Baltimore and Howard Temin provided a mechanism to explain 
  
2 
how RNA tumor viruses could ‘endogenize’ within the host (Baltimore, 1970; Temin and 
Mizutani, 1970). It also provided an explanation for the presence of the src viral 
oncogene (v-src) of the Rous Sarcoma Virus (RSV) within the genomes of uninfected 
chickens. Reactivation of endogenized RSV facilitated acquisition of src from the 
infected host (Stehelin et al., 1976). Thus, the concepts of mobile endogenous 
retroviruses that could regulate host phenotypes emerged. 
Characterization of endogenous retroviruses revealed multiple repeating instances 
of their sequences within various eukaryotic genomes. Numerous classes and structural 
features of these repeating sequences were uncovered (Figure 1.1) (Weiss, 2006). Due to 
the mutagenic potential of mobilization, and homology of endogenous retroviruses to 
RNA tumor viruses, early investigations focused on potential links between repetitive 
sequence activity and genome instability (Mager and Stoye, 2015).  
 This thesis explores potential links between genome integrity and the recruitment 
of chromatin organizing proteins to repetitive DNA sequences. Propagation strategy 
underlies two possible genomic distribution patterns used to classify repetitive elements: 
tandem or interspersed (Wicker et al., 2007). Understanding the structural features and 
propagation strategies of tandem and interspersed repeats is fundamental to 
understanding how host responses to repetitive sequences create vulnerabilities that may 
underlie genome instability. Following this review, a survey of structure-function 
characteristics suggests that the retinoblastoma tumor suppressor protein may provide a 
link between genome instability and chromatin organization at repetitive sequences. The 
data chapters that follow present the results from experimental exploration of this 
hypothesis.  
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Figure 1.1: Classification of repetitive elements. 
Repetitive elements are generally classified based upon genomic arrangement, expansion 
mechanism, and structural components. Only select families are listed for each repetitive 
element class. 
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1.1 Tandem repetitive elements  
Tandem repetitive elements are characterized by sequential adjacent ‘head-to-tail’ 
recurrences of a particular sequence that most often accumulate at either end of a 
chromosome arm. Tandem repeats are further sub-classified based on the length of a 
single element that repeats sequentially (Gemayel et al., 2010). Tandem repeats have long 
been hypothesized to expand through strand slippage replication, in which either the 
template or nascent DNA strand denatures during replication and re-anneals such that one 
of the strands is ‘looped out’ and then re-anneals to another part of the repeat on the other 
stand. If the template strand is looped out, contraction occurs on the nascent strand, while 
looping out of the nascent strand results in expansion of the repeat (Levinson and 
Gutman, 1987; Tachida and Iizuka, 1992).  
The visible accessory bands formed from density gradient centrifugation of 
genomic DNA were coined as ‘satellite’ DNA (Meselson et al., 1957). These bands were 
discovered to be comprised of the tandem DNA repeats that are primarily found at or 
near chromosome centromeres (Figure 1.2) (Walker, 1971). A satellite element that 
ranges from 1-10 nucleotides is classified as a microsatellite, also known as a simple 
sequence repeat, while elements that range from 10-60 nucleotides are minisatellites. 
Elements greater than this threshold are referred to as ‘satellites’ until 135bp in length, 
beyond which they are classified as megasatellites. Human centromeres and 
pericentromeres are both comprised of 171 bp α-satellites. In contrast, mouse  
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Figure 1.2: Structural features underlie expansion strategies of repetitive elements. 
Structural features reveal whether repetitive elements encode machinery required for 
autonomous transposition. Full-length endogenous retroviruses (ERVs) are flanked by 
long terminal repeats and encode machinery required for autonomous retrotransposition. 
The two open reading frames (ORFs) of long interspersed nuclear elements (LINEs) 
encode machinery required for autonomous retrotransposition, and transposition of short 
interspersed nuclear elements (SINEs). In contrast to retrotransposons, DNA transposons 
are flanked by terminal inverted repeats (TIRs) and encode a transposase that facilitates 
transposition that is inherently non duplicative. Tandem repetitive elements may be 
comprised of as few as a single repeating subunit arranged in tandem as a result of 
replication errors. Relative RNA polymerase and polyadenylation sites are shown. 
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centromeres are comprised of 123-bp minor satellites, while their pericentromeres are 
comprised of 234-bp major satellites (Gemayel et al., 2010).  
Satellite expansion occurs through replication machinery errors characterized as 
strand-slippage. However, recent evidence demonstrates that mammalian centromeric and 
pericentromeric repeats can also expand through an RNA intermediate that is reverse 
transcribed prior to re-integration into the host genome (Bersani et al., 2015). This 
provides a putative explanation for the identification of tandem repeat units found 
interspersed in isolation. 
While satellites constitute their own class of tandem repeats, certain satellites are 
segregated within the ‘variable number of tandem repeat’ (VNTR) class. This includes 
microsatellites that are also called short tandem repeats or simple sequence repeats. 
Opposite to the centromere are another family of VNTRs.  Vertebrate telomeric 
chromosome ends are comprised of tandem ‘TTAGG’ sequences that repeat from a few 
to over 100 kb depending on organism and age (Figure 1.2). These repeats extend into 
subtelomeric regions as well that encode G-rich transcripts known as telomere repeat-
containing RNA (TERRA) that range from 0.1-10kb (Ye et al., 2014).  
1.2 Interspersed repetitive elements 
In contrast to tandem repetitive elements, interspersed repetitive elements are 
predominantly dispersed throughout the intergenic regions of the genome. Structural 
features and expansion strategies define classification systems of interspersed repeats. 
Unlike tandem repeats that expand primarily through replication errors, interspersed 
repeats expand through variations of transposition. For this reason, interspersed repeats  
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are alternatively referred to as transposable elements (Kazazian, 2004). Intact 
transposable elements encode machinery required to transpose and propagate 
autonomously throughout the host genome, and facilitate non-automomous mobilization 
of partial elements. Mechanisms of propagation distinguish transposable element type 
and class (Jurka et al., 2007).  
1.2.1 Type I transposable elements 
Type I transposable elements undergo reverse-transcription during duplicative 
retrotransposition and are thus commonly referred to as retrotransposons (Boeke et al., 
1985; Garfinkel et al., 1985; Kazazian and Moran, 1998). These elements are commonly 
flanked by target site duplications as a result of staggered nicks at the integration site that 
are ‘filled in’ upon repair. Sub-classifications of Type I elements are based on the 
presence or absence of long terminal repeat (LTR) elements (Figure 1.1) (Mager and 
Stoye, 2015). Non-LTR retrotransposons account for approximately 30-35% of the 
mammalian genome, and are further distinguished by the absence of an encoded envelope 
protein (Treangen and Salzberg, 2012). 
The most abundant and active non-LTR retrotransposons are long interspersed 
nuclear elements (LINEs) that comprise ~21% of the human genome and were first 
characterized in human haemophilia (Dombroski et al., 1991; Kazazian et al., 1988; 
Rogan et al., 1987; Treangen and Salzberg, 2012). LINEs are believed to originate from 
host RNAs that were retrotransposed by active retrotransposons. The majority of the 1.5 
million LINEs within the human genome are thought to reside as inactive fragments that 
often lack the promoter element due to 5' end truncations, however, approximately 80-
100 full-length LINEs are thought to remain active (Beck et al., 2011). Full-length LINEs 
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possess a 5'UTR composed of tandem repeats with an internal RNA pol II promoter, 
followed by two open reading frames that encode machinery sufficient for autonomous 
retrotransposition, and finally a 3'UTR (Figure 1.2). ORF1 encodes an RNA-binding 
protein, while ORF2 encodes an endonuclease and reverse transcriptase (Kazazian and 
Moran, 1998). Structural variations of these modular domains distinguish phylogeny of 
LINE families into groups that are subdivided into clades. LINE ORF products are used 
to execute the mechanism of LINE retrotransposition called target-primed reverse 
transcription (TPRT) (Levin and Moran, 2011).  
Short-interspersed nuclear elements (SINEs) represent the second most abundant 
group of non-LTR retrotransposons. SINEs comprise ~13% of the mammalian genome, 
and are derived from small functional RNAs transcribed by RNA pol III such as transfer 
RNAs (tRNAs) or 7S or 5S ribosomal RNAs (rRNAs) (Treangen and Salzberg, 2012). 
Thus due to their origins, SINEs contain 5' internal RNA pol III promoters. The 3' ends 
contain poly(A) tails that can be recognized by LINE ORF products (Figure 1.2). SINEs 
utilize machinery encoded by LINEs to achieve non-autonomous retrotransposition. 
SINEs also contribute to SVA retrotransposons that can contain LTR sequences (Slotkin 
and Martienssen, 2007).  
LTR-containing retrotransposons, more commonly referred to as endogenous 
retroviruses (ERVs), comprise approximately 8% of the human genome and 10% of the 
mouse genome (Treangen and Salzberg, 2012). These elements derive from ancient 
exogenous retroviruses that infected germ cells or progenitors of germ cells and lost the 
potential for extracellular mobility and infection following host integration. Replication-
competent full-length ERVs contain 300-1000 bp LTRs flanking open reading frames 
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that collectively range from 6-9kb and encode Gag, Pol, and Env proteins to facilitate 
autonomous retrotransposition. More specifically, the Pol protein possesses a reverse 
transcriptase, endonuclease, and aspartyl protease domains (Figure 1.2). Gag encodes a 
‘group-specific’ retroviral antigen, while env encodes an envelope protein (Göke and Ng, 
2016). In addition, these elements contain an internal RNA polymerase II promoter 
sequence in the 5'LTR, an RNA polyadenylation sequence in the 3'LTR, signals for 
splicing, packaging, a tRNA primer-binding site, and a polypurine tract. Today, ERVs are 
more commonly found missing some ORFs, or missing all ORFs. Approximately 90% 
simply exist as solo LTRs. Phylogenetic analysis of the conserved regions of the pol gene 
dictates classification of ERVs into one of three classes that are further stratified into 
families (Thompson et al., 2016).  
Beyond LINEs, SINEs, and ERVs, NGS-based exploration continues to uncover 
retrotransposons that do not meet all criteria for existing Type I transposable element 
categories. For example, Penelope retrotransposons possess a single ORF that encodes a 
protein with reverse transcriptase and endonuclease activity, are flanked by LTR-like 
inverted terminal repeats, but lack LTRs. However, phylogenetic analysis of the Penelope 
reverse transcriptase groups it closer to telomerases than reverse-transcriptases of other 
non-LTR retrotransposons. Thus, structural and phylogenetic divergence underlies 
classification of Penelope as a separate class of retrotransposons (Jurka et al., 2007). 
Likewise analysis of reverse-transcriptase domains suggests Dictyostelium intermediate 
repeat sequence (DIRS) retrotransposons derive from the ancestor of an LTR 
retrotransposon currently in the mammalian genome. However the endonuclease domain 
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most resembles analogous domains found in DNA transposon-like elements found in 
species of fungi and other ciliates (Wicker et al., 2007).  
1.2.2 Type II transposable elements 
Type II transposable elements, also known as DNA transposons, are most distinct 
from Type I counterparts based upon their mechanism of mobilization throughout the 
host genome. DNA transposons encode a transposase that recognizes flanking 10-400 bp 
long terminal inverted repeats (Figure 1.2). Upon recognition, the transposase excises the 
DNA element, and nicks a new target site to integrate the element into new 'acceptor' site. 
At no point is an RNA intermediate generated. The gap left at the original 'donor' site is 
repaired. Colloquially, this approach is referred to as ‘cut-and-paste’ transposition, and is 
distinct from the ‘copy-and-paste’ transposition approaches of Type I elements (Munoz-
Lopez and García-Pérez, 2010). Differences in transposase homology primarily 
distinguish DNA transposase superfamilies. In addition to a transposase, some DNA 
transposon superfamilies also encode for DNA-binding proteins. Multiple instances of 
the same DNA transposon suggests that duplication of DNA transposons must occur 
despite the fact that DNA ‘cut-and-paste’ mobilization is not inherently duplicative. One 
model by which this can occur is transposition during replication. If a template element 
has been replicated and then transposes to a region that is yet to be replicated, the result is 
duplication of the element (Jurka et al., 2007).  
1.3 Host responses to repetitive elements 
1.3.1 Host exaptation of genomic parasites  
The potential mutagenic consequences of indiscriminate repetitive element 
mobilization threaten host genome stability. Therefore the host adopts strategies that 
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reduce mobilization potential of these elements. Over evolutionary time, this results in 
the accumulation of relatively dormant repetitive sequences that eventually fragment to 
varying degrees. Host genomes co-opt portions of these fragments to serve as novel genes 
or transcriptional regulatory elements. This co-option is referred to as exaptation (Cowley 
and Oakey, 2013). Utility for host exaptation may underlie the long-term success of 
particular elements in host colonization. Such repeat-derived genes and regulatory 
elements are commonly utilized in a cell type-specific and temporal manner. Review of 
how repetitive elements have become intricate components of host regulatory networks 
illuminates the vulnerabilities associated with this dependence. 
Repetitive element ORF sequences can be exapted as exons, or even full length 
genes. Up to 100 mammalian genes are believed to have evolved from repetitive 
elements. Over 50 protein-coding genes derive from the LTR retrotransposon gag 
protein, more than half of which reside on the X-chromosome (Thompson et al., 2016). 
Host dependence on such genes is most evident in the evolution of regulatory networks. 
For example in placental development, the human syncytin-1 and syncytin-2 proteins 
required for placental trophoblast formation derive from HERV ENV genes. Knock out 
of the mouse homologues syncytin-A and syncytin-B disrupts placental formation and 
impedes trophoblast fusion (Blaise et al., 2003).  
Exaptation of repetitive elements is more frequently employed towards 
maximizing transcriptional regulatory control for existing host genes. Intact ERV LTRs 
are particularly favourable for exaptation since recombination between the 5' and 3' LTRs 
removes the internal ERV ORFs but preserves a residual ‘solo’ LTR for the host genome 
to utilize. These LTRs contain promoters, enhancers, transcription factor binding sites, 
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and can provide polyadenylation sites for host mRNA. Evolutionary exaptation of such 
elements now confers tissue-specific control over entire regulatory networks that are 
active within the mammalian placenta, the developing embryo, germ cells, and erythroid 
cells (Chuong et al., 2017). 
Screening the 5' ends of host mRNA for evidence of LTR sequence identifies 
ERV LTRs that serve as functional host promoters. As promoters, ERV LTRs contribute 
functional binding sites for an expanding list of transcription factors that include p53, 
CTCF, ERα, c-Myc, and the pluripotency transcription factors NANOG, OCT4, and 
SOX2. Overall, 30% of all mammalian transcriptional start sites intersect with 
retrotransposons. The ability to direct pluripotency transcription factors in embryonic 
stem cells (ESCs) illustrates the prevalent exaptation of ERV LTRs by the host genome 
as tissue and cell type-specific promoters (Thompson et al., 2016).  
ChIP-seq profiling has identified numerous repetitive sequences that bear the 
epigenetic marks associated with enhancer elements, such as H3K4me3, H3K27Ac, 
H3K9Ac. DNase-seq demonstrates that accessibility of these repetitive element-derived 
enhancers varies in a cell-type specific and tissue specific manner. ChIP-seq also reveals 
that these enhancers are extensively bound by pluripotency transcription factors in ESCs, 
germ cells, the placenta, and tissues that participate in sexual reproduction (Göke and Ng, 
2016). While prediction of enhancer function is largely based upon gene proximity and 
epigenetic mark enrichment, direct loss-of-function approaches continue to confirm 
enhancer activity of these elements (Chuong et al., 2016).  
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1.3.2 Host epigenetic silencing of repetitive elements  
Prior to repetitive sequence exaptation, the host modulates accessibility of 
repetitive sequences through alterations to the structural organization of DNA to render 
these elements dormant (Groh and Schotta, 2017). In the nucleus of a eukaryotic cell, the 
entire genome is wrapped around histone proteins in a compact arrangement referred to 
as chromatin. This arrangement consists of a repeating nucleosome core that possesses 
approximately 147 base pairs of DNA wrapped around a core histone protein octamer 
comprised of two H3-H4 dimers bound to two H2A-H2B dimers. The nucleosome base 
possesses an H1 ‘linker’ histone involved in higher order compaction. Adjacent 
nucleosomes are connected by 10 - 80 bp of free ‘linker’ DNA (Venkatesh and 
Workman, 2015). Nucleosome compaction broadly distinguishes two general states of 
DNA accessibility. De-condensed chromatin establishes a ‘relaxed’ state referred to as 
‘euchromatin’ in which nucleosome-wrapped DNA is most accessible. In contrast, the 
most compact form of chromatin, referred to as ‘heterochromatin’, characterizes the least 
accessible state (Figure 1.3) (Mozzetta et al., 2015).  
Modulation of structure to regulate accessibility is achieved through a series of 
chemical modifications that do not alter DNA sequence. These modifications target the 
association between DNA and histones. Histones contain positively charged residues in 
their protruding tails that interact with the negatively charged double-stranded DNA 
backbone to facilitate an electrostatic interaction that maintains wrapped DNA around the 
nucleosome (Mozzetta et al., 2015). Covalent modifications imposed on histone tails or 
DNA alter the strength of the interaction with the double-stranded DNA backbone, 
leading to altered states of DNA accessibility. Through a combination of different  
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Figure 1.3: DNA and histone modifications underlie chromatin accessibility. 
Relative DNA accessibility per chromatin state is indicated along with typically 
associated epigenetic modifications. Representative nucleosomes depict arrangements of 
modifications associated with constitutive or facultative heterochromatin.  
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modifications, repression can be achieved through establishment of ‘constitutive’ 
heterochromatin, or the more readily reversible and dynamic ‘facultative’ 
heterochromatin.  
1.3.2.1 Constitutive heterochromatin through lysine methylation 
Constitutive heterochromatin is characterized by a combination of epigenetic 
marks to both histone tails and DNA, and enrichment of the heterochromatin protein 
HP1. The most prevalent of these modifications consist of histone methylation (Saksouk 
et al., 2015). Histone methylation occurs primarily on the side-chains of lysines and 
arginines of histone H3 and histone H4. Methylation does not alter the charge of the 
histone, and can occur in successive magnitude as mono-, di-, or tri- methylation. When 
certain residues are methylated they hold DNA together strongly and restrict access to 
various enzymes. Since histone methylation can either compact or loosen chromatin, an 
empirically derived ‘histone code’ has emerged to classify the effects of differential 
methylation (Mozzetta et al., 2015).  
Constitutive heterochromatin is most concentrated over centromeric and telomeric 
tandem repeats. In mice, pericentric heterochromatin can be readily visualized as DAPI-
dense foci (Peters et al., 2003). H3K9me3 enrichment defines the fundamental H3 lysine 
methylation mark that distinguishes constitutive heterochromatin from facultative 
heterochromatin (Figure 1.3). In mammals, H3K9 residues are methylated by the 
suppressor of variegation 3-9 homolog (SUV39h) and SET domain bifurcated (SETDB1) 
histone methyltransferases (HMTs) (Martens et al., 2005). Dependence of either HMT 
depends on chromosome region, developmental context, and cell type. At pericentric 
heterochromatin, SUV39h HMTs are the dominant HMTs. Individual knockout of either 
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Suv39h1 or Suv39h2 does not perturb viability and causes minimal changes to global 
H3K9me3 levels. In contrast, Suv39h1/2 double knock out mice are viable at sub-
mendelian ratios, and succumb to B-cell lymphomas with ~30% penetrance. Suv39h1/2 
double-knockout MEFs and ESCs exhibit pronounced reductions of H3K9me3 at 
pericentric major satellites and telomeric repeats (Table 1.1) (Lehnertz et al., 2003; Peters 
et al., 2001; Peters et al., 2003).  
Unlike SUV39h HMTs, the role of SETDB1 at tandem repeats remains poorly 
understood. While ChIP-seq suggests that SETDB1 accumulates at pericentric repeats, 
other techniques fail to detect this accumulation (Dejardin and Kingston, 2009). Loss of 
SETDB1 diminishes H3K9me3 at pericentric repeats, indicating some degree of non-
redundancy with SUV39h HMTs at these regions (Bulut-Karslioglu et al., 2012; Matsui 
et al., 2010). SETDB1 also targets interspersed repetitive elements. In mESCs, early 
embryos, and during gametogenesis, SETDB1 trimethylates H3K9 at repeats that include 
LINEs, and ERV classes I and II (Table 1.1) (Karimi et al., 2011; Liu et al., 2014; Matsui 
et al., 2010; Sharif et al., 2016). Following nucleation at interspersed repeats, H3K9me3 
spreads across the retrotransposon gene body to extend into neighbouring genes, a 
phenomenon referred to as position effect variegation (Allis and Jenuwein, 2016).  
Constitutive heterochromatin is also characterized by methylation of H4 lysine 20 
(Figure 1.3) (Schotta et al., 2004). The SUV4-20H1 and 2 HMTs catalyze H4K20me2/3 
deposition at centrometric, pericentric, and telomeric repeats (Jørgensen et al., 2013). 
Since recruitment is dependent on HP1 which itself recognizes H3K9me3, this is thought 
to be a downstream event relative to H3K9me3 (Schotta et al., 2004). Surprisingly, 
germline deletion of either Suv4-20h1 or Suv4-20h2 is not embryonic lethal  
  
17 
 
 
 
 
Table 1.1: Epigenetic alterations at repetitive elements in methyltransferase 
knockout models. 
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in mice, and Suv4-20h-double knockout mice are born at sub-mendelian ratios. Suv4-
20h1
-/- 
 MEFs exhibit modestly reduced H3K20me2 at pericentric repeats, while Suv4-
20h1
-/- 
reduces H3K20me3 at pericentric repeats (Table 1.1). Ablation of both HMTs 
results in monomethylation at H4K20 residues normally di- or tri-methylated (Schotta et 
al., 2008). 
1.3.2.2 Constitutive heterochromatin through hypoacetylation 
Another epigenetic feature of constitutive heterochromatin is the absence of 
modifications that neutralize electrostatic interactions between DNA and histones 
(Jeppesen and Turner, 1993). Histone acetylation and phosphorylation both neutralize the 
positive charge of histone tails to diminish affinity for proximal negatively charged DNA 
strands (Brehove et al., 2015; Saksouk et al., 2015). This leads to a less compact 
chromatin structure that facilitates DNA accessibility. Examples of phosphorylation 
marks that achieve this include phosphorylation of H2A.X at serine 129 during DNA 
damage (Brehove et al., 2015). However, for the context of constitutive heterochromatin, 
regulation of histone acetylation is more pertinent.  
Acetylation marks on histone tail lysines are commonly enriched at enhancer 
elements and gene promoters to facilitate access for transcription factors (Figure 1.3). 
Histone acetyl transferases (HATs) catalyze the transfer of acetyl groups from acetyl-
coenzyme A (acetyl CoA) to positively charged lysines on histone tails such as H3K9, 
H3K18, and H3K27 (Verdin and Ott, 2015). Conversely, histone de-acetylases (HDACs) 
catalyze the removal of acetyl groups from histone tails to re-compact chromatin 
(Taunton et al., 1996). Thus constitutive heterochromatin is also characterized by 
hypoacetylated histones due to HDAC activity. Accordingly, disruption of HDAC 
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activity using HDAC inhibitors can suffice to de-repress repetitive elements silenced by 
constitutive heterochromatin (Garcia-Perez et al., 2010).    
1.3.2.3 Constitutive heterochromatin through DNA methylation 
DNA methylation describes the addition of a methyl (CH3) group predominantly 
to carbon 5 of a cytosine residue adjacent to a guanosine that forms the repetitive unit of 
CpG dinucleotides. The addition of the methyl group reduces DNA accessibility to 
proteins that bind chromatin (Jones, 2012). This reduced accessibility contributes to the 
suppressive properties of constitutive heterochromatin used to silence repetitive DNA 
sequences (Smith and Meissner, 2013). DNA methyltransferases (DNMTs) methylate 
target cytosines. In mammalian cells, DNMT3A and DNMT3B catalyze de 
novo methylation, while DNMT1 is required for the maintenance of DNA methylation in 
particular during genome replication when passive demethylation can occur (Okano et 
al., 1999) (Li et al., 1992). The recently discovered DNMT3C also imparts de novo DNA 
methylation, however its activity is exclusive to male germ cells (Barau et al., 2016). The 
DNMT3 homologue DNMT3L lacks catalytic activity but enhances DNA binding and 
activity of the de novo DNMTs (Hata et al., 2002).  
DNA methylation is enriched at centomeric and subtelomeric tandem repeats in 
addition to interspersed repetitive sequences. Surprisingly, individual ablation of de novo 
DNMTs results in minimal CpG methylation reductions at repetitive sequences. Dnmt3a
-
/-
 mice are viable up to four weeks of age, while Dnmt3b
-/-
 mice are embryonic lethal at 
E9.5 (Okano et al., 1999). Examination of E9.5 ESCs from either model reveals that 
notable CpG methylation reductions are limited to minor satellites in Dnmt3b
-/-
 cells 
(Table 1.1) (Okano et al., 1999). Likewise, disruption of DNMT3C activity has limited 
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effects on methylation of repetitive sequences. The Dnmt3c
IAP
 allele disrupts expression 
of the full length Dnmt3c transcript due to an IAP insertion that results in exclusion of the 
last exon. This exclusion diminishes CpG methylation at a select number of ERV-K and 
L1 members only in the testes of day 20 homozygous mutant animals (Table 1.1) (Barau 
et al., 2016).  
Analogous to Dnmt3c inactivation, deletion of Dnmt3l in murine models does not 
induce embryonic lethality (Hata et al., 2002). Dnmt3l
-/-
 cells exhibit loss of de novo 
cytosine methylation at specific IAP LTRs and certain LINE1s but not centromeric or 
pericentric satellites (Table 1.1) (Bourc'his and Bestor, 2004; Hata et al., 2002). Dnmt1
-/-
 
mice are embryonic lethal at E9, and exhibit reductions of CpG methylation at IAP and 
centromeric satellites in ESCs (Table 1.1) (Colum et al., 1998; Li et al., 1992). A 
germline Dnmt1 hypomorphic murine model exhibits reductions of CpG methylation at 
IAPs in MEFs, with novel MMTV integrations detectable in a subset of the resulting T-
cell lymphomas in adult mice (Gaudet et al., 2003; Howard et al., 2008).  
1.3.2.4 Facultative heterochromatin dynamics at repetitive 
sequences 
In contrast to constitutive heterochromatin, facultative heterochromatin 
establishes a more readily reversible form of chromatin compaction (Trojer and Reinberg, 
2007). Facultative heterochromatin is distinguished by H3 methylation at K27 by the 
enhancer-of-zeste homologue (EZH) HMTs, EZH1 and EZH2 (Figure 1.3). Each HMT 
belongs to multi-subunit complexes referred to as Polycomb Group (PcG) complexes that 
were originally identified and characterized in D.melanogaster (Abel et al., 1996; Hobert 
et al., 1996; Jones and Gelbart, 1990, 1993). H3K27me2/H3K27me3 is largely 
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established by polycomb repressive complex 2 (PRC2) that contain suppressor of zeste 
12 homologue (SUZ12), embryonic ectoderm development (EED), and either 
retinoblastoma-associated protein 46 (RBAP46) or retinoblastoma-associated protein 48 
(RBAP48) (O'Carroll et al., 2001; Su et al., 2003; van der Vlag and Otte, 1999). Distinct 
PRC2 complexes contain either EZH1 or EZH2, however EZH2-containing PRC2 
complexes are most prevalent in mammalian cells. PRC2 establishes facultative 
heterochromatin in concert with polycomb repressor complex 1 (PRC1) that deposits 
H2AK119Ub1 (Figure 1.3) (Hauri et al., 2016; Margueron et al., 2008). In contrast to 
constitutive heterochromatin, the contribution of facultative heterochromatin-based repeat 
silencing remains poorly understood in mammalian ESCs, and relatively uninvestigated 
in somatic cells (Casa and Gabellini, 2012; Leeb et al., 2010). Expression patterns of 
repetitive elements in germline knockouts for effectors of constitutive heterochromatin 
provide some indication of possible roles of facultative heterochromatin and polycomb 
contributions towards repetitive element silencing. 
Redundancy of repetitive sequence silencing has been most characterized within 
the context of embryogenesis, during which successive rounds of DNA methylation and 
demethylation occur. Despite reductions of DNA methylation, silencing of repetitive 
elements is maintained through modification of histone tails (Leung and Lorincz, 2012; 
Rowe and Trono, 2011). This phenomenon is recapitulated in Dnmt1, Dnmt3a, and 
Dnmt3b triple-knockout ESCs that exhibit proper silencing of repetitive elements (Karimi 
et al., 2011). In these cells, pronounced reductions in CpG methylation and H3K9me2/3 
precede compensatory recruitment of PRC2 and H3K27me3 deposition at pericentric 
repeats (Saksouk et al., 2014). In contrast to germline knockouts that may be confounded 
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by long-term adaptation, acute loss of DNA methylation can be modeled through the 
‘2i+VitC’ treatment in which GSK2β and Mek1/2 inhibitors are used to ensure passive 
demethylation, while vitamin C stimulates TET enzymes that engage in active 
demethylation (Walter et al., 2016). In ESCs treated with 2i+VitC, H3K9me2 levels 
decrease, H3K9me3 levels remain constant, but H3K27me3 increases to maintain 
repetitive element silencing (Walter et al., 2016).  
The sensitivity of H3K9me2/3 deposition to CpG methylation loss in Dnmt triple-
knockout ESCs suggests that facultative heterochromatinization may compensate for loss 
of H3K9me3 alone (Déjardin, 2015). Indeed, in SUV39h1/2-deficient ESCs, PRC2 and 
H3K27me3 are recruited to repetitive sequences (Cooper et al., 2014). Pronounced 
misregulation of repetitive elements is only achieved upon 2i+VitC treatment of 
SUV39h1/2-deficient ESCs in combination with Eed knockout to disrupt PRC2 function 
(Walter et al., 2016). Likewise, depletion of all three HP1 isoforms in ESCs does not 
result in strong de-repression of repetitive elements (Maksakova et al., 2011). Even in 
MEFs, SETDB1 ablation results in minimal ERV de-repression, indicating presence of 
compensatory silencing in more differentiated cells (Maksakova et al., 2011). This 
suggests that facultative heterochromatin provides a sensitive and dynamic compensatory 
response to maintain repetitive element silencing upon disruption of constitutive 
heterochromatin marks. Its contributions towards silencing in normal somatic cells 
remain unknown.  
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1.4 Genome instability is associated with repetitive 
element activation 
Despite redundancy and compensatory potential of epigenetic silencing 
mechanisms, associations between repetitive element misregulation and genomic 
instability are well established (Belancio et al., 2010; Dombroski et al., 1991; Ionov et al., 
1993; Kazazian et al., 1988; Miki et al., 1992; Strand et al., 1993). Consequences of this 
misregulation are directly related to host strategies of repetitive element exaptation and 
silencing. For instance, alleviation of epigenetic silencing permits cis- or trans- regulatory 
activation by repetitive elements of adjacent genes (Lau et al., 2014). This has been 
observed for the MaLR THE solo LTR that activates the normally silenced CSF1R in 
Hodgkin lymphoma (Lamprecht et al., 2010). Furthermore, re-integration of tandem or 
interspersed repeats can drive mutagenesis by ablating expression, causing hypomorphic 
expression, or conferring oncogenic gain-of-function by providing alternate splice sites 
within gene bodies. This has been observed most frequently with mobile centromeric 
satellite repeats or LINE elements in human colorectal tumors (Bersani et al., 2015; 
Doucet-O'Hare et al., 2015; Miki et al., 1992; Rodic et al., 2015; Shukla et al., 2013). In 
addition, the meiotic and mitotic defects that accompany repetitive element misregulation 
suggest a yet unidentified connection between repeat-derived organization of 
chromosome structure and chromosome segregation (Ionov et al., 1993). Evidence that 
these may be early events in human cancer appears to be corroborated by NGS-based 
characterizations of pre-malignant lesions that harbor active repetitive elements (Ewing et 
al., 2015; Rodic et al., 2015).  
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Disruption of broad mechanisms that regulate chromatin structure likely underlie 
frequent resurrection of repetitive elements under conditions of genomic instability. 
While the effectors of these marks have been characterized to varying degrees, 
mechanisms of recruitment to repeats remain poorly understood. An unexplored link 
between the organization of heterochromatin at repetitive sequences and cancer-initiating 
mechanisms may be the RB tumor suppressor protein (pRB). Thorough review of known 
pRB activities illuminates multiple connections that position pRB as a likely candidate to 
mediate recruitment to repetitive elements for broad organizers of chromatin structure.  
1.5 Retinoblastoma onset reveals the existence of a 
tumor suppressor gene 
Loss of growth control through tumor suppressor inactivation is a universal 
‘hallmark’ of every human cancer (Hanahan and Weinberg, 2011). The concept of tumor 
suppressor inactivation in cancer originates from studies of fusions between normal and 
cancer cells, and analyses of retinoblastoma incidence (Harris and Miller, 1969; 
Knudson, 1971). By the early 1970s, multiple studies suggested that cancers likely arose 
through multistage accumulation of mutations (Ashley, 1969). However, in 1971, Dr. 
Alfred Knudsen’s statistical analysis suggested that retinoblastomas arose through a 
minimum of two ‘events’. This analysis noted that bilateral inherited cases of 
retinoblastoma occurred at a younger age than unilateral non-inherited retinoblastoma. 
David Comings proposed that differences in time of cancer onset and tumor frequency 
amongst the two groups must be caused by ‘loss-of-function’ mutations to both alleles of 
a single critical ‘tumor-suppressive’ gene (Comings, 1973).  
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Assuming a constant rate of mutation for this gene, individual differences in 
complete inactivation must be due to a difference in the number of functional copies 
inherited. Individuals who inherit a germline mutation in one allele simply require the 
acquisition of a single inactivating mutation in the remaining functional allele to 
completely inactivate the gene. This would decrease tumor latency and increase tumor 
burden relative to patients that must acquire two independent inactivating somatic 
mutations (Comings, 1973; Knudson, 1971). This conclusion would be coined the ‘two-
hit’ hypothesis. Subsequent genetic studies of retinoblastomas identified that loss of the 
q14 segment of chromosome 13 was associated with the appearance of retinoblastoma 
(Cavenee et al., 1984; Cavenee et al., 1983; Cavenee et al., 1985; Dryja et al., 1986; 
Godbout et al., 1983). In 1986, a single gene mapped from this segment of chromosome 
13 was cloned and confirmed to be deleted in retinoblastomas and sarcomas (Friend et 
al., 1986; Lee et al., 1987). This gene became known as the retinoblastoma susceptibility 
gene, abbreviated as RB1.  
Today, the RB1 gene product, pRB, is recognized as one of the most frequently 
inactivated tumor suppressors in human cancer, and has been the center of intense 
investigation within the field of cancer biology (Dyson, 1998; Weinberg, 1995). 
Homozygous deletion of murine Rb1 results in embryonic lethality, while Rb1
+/-
 mice 
succumb to pituitary tumors in concert with loss of the remaining wild-type allele (Clarke 
et al., 1992; Jacks et al., 1992; Lee et al., 1992). Therefore, early loss-of-function 
molecular investigations were predominantly limited to cell culture experiments with 
Rb1
-/-
 MEFs, or characterizations of patient-derived cancer cells with RB1 deficiency 
(DeCaprio et al., 1989; Ewen et al., 1991; Goodrich et al., 1991; Hannon et al., 1993; 
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Horowitz et al., 1989; Muncaster et al., 1992; Williams et al., 1994). These early 
investigations identified two more RB1-like genes, p107 and p130, and characterized 
numerous pRB functions that would prove advantageous if disabled in cancer (Dyson, 
1998; Ewen et al., 1991; Hannon et al., 1993; Weinberg, 1995). Notably, pRB was 
observed to impart negative growth control through restriction of G1 exit. However, 
identification of a single indispensible tumor suppressor activity remains an area of 
contention, and currently appears to be multifaceted (Dyson, 2016). The known functions 
of pRB have emerged in tandem with discovery of the pRB interactome. Therefore, 
understanding of pRB function requires understanding of the structural underpinnings 
that govern the pRB interactome.  
1.6 The pocket domain defines the pRB pocket protein 
family 
The structural feature that defines the pRB-family is the hydrophobic small 
pocket domain that consists of two cyclin-like folds, referred to as the A and B 
subdomains respectively, separated by an unstructured linker region (Chow and Dean, 
1996; Huang et al., 1993; Qin et al., 1992). For this reason, pRB and the pRB 
homologues p107 and p130 are collectively referred to as the ‘pocket protein’ family. 
The small pocket domain contains the minimal segment required to interact with viral 
oncoproteins that include adenovirus E1A, human papilloma virus E7, and Simian 
vacuolating virus 40 large T antigen (DeCaprio et al., 1988; Dyson et al., 1989; Huang et 
al., 1993; Whyte et al., 1988). This minimal segment harbors a shallow hydrophobic 
binding cleft found within the B subdomain referred to as the LxCxE binding cleft since 
oncoproteins found to bind this region possess a conserved LxCxE peptide motif (Kaelin 
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et al., 1990; Lee et al., 1998). Discovery that DNA tumor viruses targeted pocket proteins 
and that the interaction appeared necessary for transformation proved amongst the 
earliest evidence for a tumor suppressive role for pRB family proteins.  
Downstream of the small pocket domain of pocket proteins is the intrinsically 
unstructured carboxy-terminus (C-terminus). Within human pRB, the small pocket and 
C-terminus encompass a region from residues 379-928 and are referred to as the large 
pocket. This region was originally defined as the minimal region required to maintain 
negative growth control (Qin et al., 1992). Early mechanistic investigations attributed this 
restriction to an interaction with the differentiation-regulated transcription factor 1 
(DRTF1) that was determined to be the E2a-binding factor (E2F) (Bandara and La 
Thangue, 1991; Chellappan et al., 1991; Kovesdi et al., 1987). This transcription factor 
was found to bind DRTF1-polypeptide-1 (DP1) to form a functional heterodimeric 
transcription factor (Girling et al., 1993). Through the use of tumor-derived RB1 mutants, 
viral oncoprotein-induced inactivation, and E2F interaction studies, an emerging model 
of mammalian cell cycle control proposed that pRB-family proteins associated with 
E2F/DP transcription factors to silence genes involved in cell cycle progression. These 
genes were discovered to contain an E2F-consensus or recognition motif within their 
promoters that were responsive to E2F-dependent transcription in transfection-based 
reporter assays (Boeuf et al., 1990; Kovesdi et al., 1987; Yee et al., 1987). Temporal 
signals governed dissociation of pRB proteins from E2F/DP to permit the transcription of 
these genes in a controlled manner (DeCaprio et al., 1989; Hurford et al., 1997). DNA 
tumor virus proteins could bind the pRB-family small pocket to perturb this temporal 
control and prevent negative growth control in cancer.  
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1.7 E2F transcription factors recruit pocket proteins to 
DNA 
Since pocket proteins were discovered to lack intrinsic DNA binding activity, the 
discovery of E2F-mediated pocket protein recruitment to cell cycle promoters presented a 
starting point to investigate differential transcriptional properties of pocket proteins. In 
mammals, the pocket protein-E2F network expanded considerably to eventually consist 
of eight E2F genes that encode 9 protein products, as E2F3a and E2F3b are generated by 
the use of alternative promoters (Johnson and Degregori, 2006). E2Fs are defined by their 
ability to bind to a sequence element that was originally identified in the adenovirus E2 
promoter (Boeuf et al., 1990; Kovesdi et al., 1987; Yee et al., 1987).  
With respect to structure, all E2F family members possess a highly conserved 
DNA binding domain (Morgunova et al., 2015; Zheng et al., 1999). A highly conserved 
dimerization domain allows E2F1-6 to interact with DP family members to confer 
specificity of DNA binding. As with the E2Fs, the DP family has expanded to consist of 
four members that exhibit differential preference for endogenous association with E2Fs. 
In contrast, E2F7 and E2F8 do not dimerize with DP family members, but instead bind as 
homodimers or E2F7-E2F8 heterodimers (Morgunova et al., 2015). E2F1-5 possess a 
transactivation domain required for activation of respective gene targets. Embedded 
within the E2F transactivation domain is a highly conserved segment that mediates 
binding of E2F1-4 to the pRB small pocket. E2F4 and E2F5 interact with p107, and 
p130. E2F6, E2F7, and E2F8 do not interact with any pocket proteins (Dimova and 
Dyson, 2005; van den Heuvel and Dyson, 2008).  
 Historically, the E2F transcription factors have been classified into two distinct 
functional categories based upon their observed ability to either activate or repress 
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transcription of simple reporter constructs possessing multiple E2F-binding sites in cell 
culture-based assays. E2F1, E2F2, and E2F3a, comprise one subfamily referred to as 
‘activator E2Fs’, while the remaining E2F family members are classified as ‘repressor 
E2Fs’. This historical classification appears to be an oversimplification as large-scale 
expression studies demonstrate that ‘activator E2Fs’ repress almost as many targets as 
they activate (Henley and Dick, 2012).  
1.8 Cyclin Dependent Kinases govern cell cycle entry 
and progression 
As the rudimentary model of pRB-mediated E2F repression emerged, a family of 
serine/threonine kinases, called the cyclin-dependent kinases (CDKs), were identified as 
likely determinants of cell-cycle dependent pRB-E2F dissociation (Bremner et al., 1995; 
DeCaprio et al., 1992; DeCaprio et al., 1989). CDK-consensus sites were discovered 
throughout the pRB protein, and over expression of Cyclin E or Cyclin A was discovered 
to allow cells to escape pRB-mediated cell cycle arrest (Bandara et al., 1991). These 
observations appeared to complement early observations that pRB became heavily 
modified during the G1-to-S transition (DeCaprio et al., 1989). However, the nature of 
these modifications and their effects on proliferative control would emerge in tandem 
with elucidation of the cyclin-CDK signaling network. 
Cyclin dependent kinases comprise the core components of eukaryotic cell cycle 
regulatory machinery. In mammals, there are currently 20 members of the CDK family, 
each of which possess a conserved catalytic core comprised of an ATP-binding pocket, a 
PSTAIRE-like cyclin-binding domain, and an activating T-loop motif (Malumbres, 
2014). CDK activity depends on association with regulatory subunits called cyclins that 
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are defined by a conserved sequence involved in CDK-binding and activation. While 
endogenous CDK levels remain relatively consistent, cyclin protein levels fluctuate in 
accordance with cell cycle stage (Evans et al., 1983). Upon stabilization of a certain 
cyclin, association with the appropriate CDK forms a cyclin-CDK complex in which the 
cyclin enhances CDK activity, and directs the complex to the appropriate target protein. 
Activation of the kinase requires phosphorylation of a conserved threonine residue on the 
activating CDK T-loop. In metazoans, CDK7 binds cyclin H to initiate CDK T-loop 
activation (Tassan et al., 1994). 
Cell cycle entry begins with an increase in D-type cyclins (D1, D2, and D3) that 
bind CKD4 and CDK6 to initiate progression past the G1 ‘restriction point’, a crucial 
point at which the cell irreversibly commits to cell cycle entry (Hochegger et al., 2008). 
Different D-type cyclins are activated in response to extracellular signals that stimulate 
different surface receptors. For example, mitogenic growth factors activate receptor 
tyrosine kinases on the cell surface to induce signalling cascades that ultimately result in 
the AP-1 transcription factor binding to and activating the cyclin D1 promoter, resulting 
in rapid accumulation of cyclin D1 (Donjerkovic and Scott, 2000).  
After the restriction point in late G1, E-type cyclins (E1 and E2) associate with 
CDK2. Cyclin E-CDK2 complexes phosphorylate substrates to promote entry into S-
phase, upon which A-type cyclins (A1 and A2) replace E-type cyclins to form cyclin A-
CDK2 complexes. As S-phase progresses, CDK1 becomes the most abundant CDK 
associated with the A-type cyclins (Bertoli et al., 2013). In late G2 phase, B-type cyclins 
(B1 and B2) replace A-type cyclins to form Cyclin B-CDK1 complexes required for 
mitotic entry and progression. Rapid increase of one type of cyclin just prior to cyclin-
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CDK complex formation occurs in accordance with rapid degradation of the preceding 
prominent cyclin (Glotzer et al., 1991). Thus, beyond the G1 restriction point, cyclin-
CDK complex formation and activation occurs in an autonomous manner to ensure 
completion of the cell cycle. 
 Just as mitogenic signals positively regulate cyclin-CDK activity, antimitogenic 
signals exert antagonistic effects through endogenous CDK inhibitors (CKIs) (Sherr and 
Roberts, 1995). CDK inhibitors are generally classified within two families. The first is 
an abbreviation based on originally observed functions towards inhibiting CDK4. The 
inhibitors of CDK4, or INK4, family of CKIs target G1 cyclin-CDK4/CDK6 complexes. 
The four INK4 proteins, p16
INK4A
, p15
INK4B
, p18
INK4C
, and p19
INK4D
 bind and distort the 
cyclin-binding site and the ATP-binding site of CDK4/6 to compromise catalytic activity 
through allosteric inhibition of cyclin and ATP binding. The CDK interacting 
protein/Kinase inhibitory protein, or Cip/Kip, family of CKIs consists of p21
Cip1/Waf1
, 
p27
Kip1
, and p57
Kip2
. Like INK4 CKIs, Cip/Kip CKIs obstruct the ATP-binding site of 
their target CDKs to achieve allosteric inhibition. However, Cip/Kip CKIs typically 
target cyclin-CDK complexes active in late G1 and S-phase, specifically CDK4 and 
CDK2. As negative regulators of cell cycle entry and progression, both Ink4 and Cip/Kip 
CKIs are frequently inactivated in human cancers (Asghar et al., 2015).  
Despite the emergence of a complex cyclin-CDK regulatory network, viable CDK 
knock out mouse models suggest a high degree of redundancy amongst CDKs involved 
in mammalian cell cycle progression. In contrast to cell cycle regulation, CDK members 
involved in transcriptional control function non-redundantly as ablation results in 
embryonic lethality for knockouts of CDK7, CDK8, and CDK11. Likewise, viable CKI 
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knockout models reveal a high degree of functional redundancy, with overt phenotypes 
most apparent in compound mutant backgrounds. The exception to this is p57
Kip2
 
knockout that causes embryonic lethality (Malumbres, 2014). 
1.9 CDK-induced structural alterations govern pRB-
E2F association dynamics  
The elucidation of the cyclin-CDK network has proven crucial to understanding 
determinants of pRB-E2F association and function throughout the mammalian cell cycle. 
Prior to the G1-S transition, hypophosphorylated pRB binds E2Fs at E2F cell cycle 
promoters. Inhibition of E2F-dependent transactivation depends on a direct physical 
interaction between the A-B interface of the pRB large pocket (RBLP) domain (residues 
379-928) and the C-terminal transcriptional activation domain of E2Fs (Qin et al., 1992) 
(Chow and Dean, 1996; Dick et al., 2000; Huang et al., 1993). Co-crystalization studies 
of the pRB small pocket and the E2F2 transactivation domain identify molecular contact 
points which occur primarily through basic residues of the A region of RBLP, and acidic 
residues of the E2F transactivation domain (Lee et al., 2002). However, stable binding 
and full repression of E2F activity requires the pRB C-terminus as well (Burke et al., 
2013; Sengupta et al., 2015). This binding and physical masking of the E2F 
transactivation domain is thought to be one of the mechanisms by which pRB renders 
E2Fs transcriptionally inactive. 
 Alleviation of E2F transcriptional repression occurs in tandem with CDK-
mediated phosphorylation of pRB at the G1-S transition. This is initiated by cyclin D-
CDK4/6 followed by cyclin E-CDK2 complexes (Calbó et al., 2002). Consensus mapping 
identifies 16 potential CDK phosphorylation sites on human pRB, 13 of which have been 
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confirmed in vivo. The majority of these sites occur in pairs distributed primarily 
throughout the intrinsically disordered regions of the protein (Rubin, 2013). A minimal 
docking site mapped within pRB-C-terminus mediates competitive association with 
either CDKs or the PP1 phosphatase (Hirschi et al., 2010). The conformational effects of 
CDK-induced phosphorylation ultimately dissociates pRB from E2Fs (Burke et al., 
2012). The elucidation of a CDK phosphorylation code on pRB has evolved through 
structural and functional investigations.  
The current model of how particular CDK phosphorylation events displace E2Fs 
from the small pocket is based upon structural investigation that utilized pRB and E2F 
fragments with truncated or absent linker regions and phosphomimetic residue 
substitutions. These investigations conclude that phosphorylation at S608/S612 within the 
linker region between the cyclin-like folds of the small pocket causes a sequence within 
the linker to bind the pocket as a helix that competes with the E2F transactivation domain 
(Burke et al., 2010). Furthermore, phosphorylation at T356/T373 causes regions of the 
pRB N-terminus to dock against the pocket subdomains, widening the E2F-binding site 
between the cyclin-like folds to a degree that allosterically inhibits E2F transactivation 
domain binding to the pocket. This also occludes protein binding to the LxCxE binding 
cleft. This effect can be recapitulated to a lesser extent with phosphorylation of T373 
alone (Burke et al., 2012). Phosphorylation of S788/S795 induces an association between 
a region within the pRB-C-terminus, and the pocket domain to disrupt pocket contact 
points with the most upstream residues of the E2F transactivation domain (Burke et al., 
2013). Collectively, multiple CDK phosphorylations induce intramolecular interactions 
between both pRB termini into the pocket region to achieve an additive effect that 
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enhances disruption between the pRB pocket and E2F transactivation domain (Dick and 
Rubin, 2013). 
1.10 E2F1 binds the pRB C-terminus independent of 
small pocket interactions 
The model of CDK-induced conformational changes suffices to explain 
association and dissociation dynamics of most of the ‘activator’ E2Fs with pRB. 
However, synthetic pRB mutants designed to disrupt RBLP-E2F complexes led to the 
discovery of a second E2F1 binding site outside of the A-B interface within the C-
terminal region of pRB (Dick and Dyson, 2003). Subsequently, GST-tagged recombinant 
protein fragments were used in pulldown assays to map minimal interaction domains on 
both the pRB C-terminus and E2F1. Within the pRB C-terminus, residues 825-860 were 
found to be indispensible to this interaction (Julian et al., 2008). Within E2F1, a minimal 
fragment from residues 1-374 that encompasses a region termed the ‘marked box’ 
domain (MBD), but excludes the transactivation domain, was required for the pRB C-
terminus interaction (Dick and Dyson, 2003). Substitution of the E2F1 MBD into E2F3 
could confer pRB C-terminal binding, while the analogous domain swap into E2F1 
abrogated the pRB C-terminus interaction with E2F1 (Julian et al., 2008). Conversely, 
pulldowns with GST-tagged recombinant C-terminal fragments of the pocket proteins 
demonstrate that this interaction is exclusive to the pRB C-terminus (Cecchini and Dick, 
2011).  
Although highly conserved amongst the E2Fs, the marked box domains of other 
activator E2Fs fail to bind the pRB C-terminus due to a proline located at a critical 
binding interface between the E2F MBD and pRB. The MBD of E2F1 is distinguished by 
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a valine instead of a proline at residue 276 that suffices to allow for the unique interaction 
when substituted for the analogous proline in E2F3 (Cecchini and Dick, 2011). Since 
E2F1 can utilize two distinct binding sites on pRB, the two binding interfaces are named 
according to E2F-binding specificity. The A-B interface of the pRB large pocket is 
referred to as the ‘general’ E2F binding site because it shows no preference for binding 
between E2F1-4, while the C-terminal binding surface is referred to as the E2F1-
‘specific’ binding site (Dick and Dyson, 2003). 
Co-crystalization studies of a pRB C-terminal fragment and a fragment of the 
E2F1-DP1 heterodimer identified specific molecular contact points between pRB-C and 
the E2F1 marked box domain and the DP1 coiled-coil domain (Rubin et al., 2005). These 
crucial residues would be used to generate a panel of pRB C-terminus mutants to be 
utilized in interaction assays with E2F1 (Cecchini and Dick, 2011; Julian et al., 2008). 
Ultimately, this screen yielded several pRB mutants that could disrupt the E2F1-pRB C-
terminus interaction with considerably fewer substitutions as compared to the original 
pRB mutant used to discover the interaction that harbored 11 amino acid substitutions.  
1.11 Distinct biochemical properties underlie the 
alternate pRB-E2F1 interaction 
Initial biochemical characterizations yielded curious properties of this alternate 
pRB-E2F1 conformation. Electromobility shift assays demonstrate that within this 
conformation, pRB-E2F1 exhibit reduced affinity for a probe with the E2F consensus 
sequence (Dick and Dyson, 2003). Accordingly, luciferase reporters under the control of 
E2F promoters are not repressed by this alternate pRB-E2F1 conformation (Julian et al., 
2008). Consistent with these properties, pRB mutants that disrupt small pocket E2F 
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interactions but retain the C-terminal interaction with E2F1 fail to induce a complete G1 
cell cycle arrest upon overexpression in SaOS-2 cells (Dick and Dyson, 2003).  
Perhaps the most striking feature of this alternate pRB-E2F1 interaction is its 
resistance to classic pRB-E2F dissociation signals. The first of these signals to be 
investigated was competitive binding between pRB and adenoviral oncoprotein E1A. 
Viral oncoproteins that bind the pRB LxCxE binding cleft dissociate the E2F 
transactivation domain from the pRB small pocket. Through utilization of the pRB C-
terminal interaction, pRB-E2F1 complexes are resistant to this disruption by either the 
12S or 13S forms of E1A. In contrast, both forms of E1A competitively displace other 
E2Fs, such as E2F4, that rely predominantly on the pRB small pocket interaction 
(Seifried et al., 2008).  
However, the biochemical property that has provided the most insight into the 
potential endogenous functions of this alternate conformation has been its behavior in 
response to CDK phosphorylation. Overexpression of cyclin D-CDK4 and cyclin E-
CDK2 in T98G cells enriches for a hyperphosphorylated pRB species that no longer 
associates with E2Fs that primarily bind pRB through the small pocket. In contrast, pRB-
E2F1 complexes are resistant to CDK phosphorylation of pRB due to utilization of the C-
terminal pRB interaction (Figure 1.4). This phenomenon is recapitulated with 
endogenous IPs in which E2F1 co-immunoprecipitates with both hypo and 
hyperphosphorylated pRB (ppRB) enriched from synchronized extracts. In contrast, 
E2F3 only associates with hypophosphorylated pRB (Cecchini and Dick, 2011). This 
complements observations of endogenous ppRB-E2F1 complexes by multiple  
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Figure 1.4: pRB-E2F dissociation dynamics at the G1/S transition 
During the G1 phase of the cell cycle, pRB binds heterodimeric E2F/DP transcription 
factors and recruits co-repressor complexes to render the transcription factors 
transcriptionally inactive. This interaction forms in part through the pRB ‘small pocket’ 
domain that binds the E2F transactivation domain. Upon cell cycle entry, activated 
cyclin/CDK complexes phosphorylate pRB to dissociate interactions between the pRB 
small pocket and the E2F transactivation domain. Unbound E2Fs activate transcription of 
genes required for DNA synthesis. An alternate interaction between the pRB C-terminus 
and the E2F1 marked box domain exhibits resistance to CDK phosphorylation. The 
biological relevance of CDK-resistant pRB-E2F1 association remains largely unknown. 
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independent groups (Calbó et al., 2002; Cecchini and Dick, 2011; Ianari et al., 2009; 
Wells et al., 2003).  
1.12 Biochemical properties suggest cell cycle-
independent functions of pRB-E2F1 
The unique biochemical properties of this CDK-resistant pRB-E2F1 interaction 
dictated initial investigations of potential endogenous functions. Since this complex does 
not recognize or suppress classic E2F cell cycle promoters and is resistant to CDK 
phosphorylation, cell cycle-independent functions of pRB or E2F1 provided a logical 
starting point to initiate exploration. An extended repertoire of transcriptional regulatory 
functions distinguishes E2F1 from other E2Fs. For instance, DNA damage activates 
transcription of machinery involved in DNA repair or induction of pro-apoptotic caspase 
cascades (Wu et al., 2009). E2F1 loss-of-function models reveal that E2F1 functions 
extensively in cell cycle-independent transcriptional regulation of components involved 
in either process (Irwin et al., 2000; Lin et al., 2001). 
Overexpression of pRB mutants in pRB-null C33A cell cultures suggest that the 
pRB C-terminus binds the E2F1 MBD to negatively regulate E2F1-induced apoptosis 
(Dick and Dyson, 2003). This complements reports that the E2F1 MBD activates pro-
apoptotic effectors independent of the transactivation domain (Hallstrom and Nevins, 
2003). DNA damage investigations suggest that the post-translational modifications 
imposed on both pRB and E2F1 following etoposide treatment establish populations of 
E2F1 which are resistant to pRB-binding, and others that form an pRB-E2F1 complex 
with hyperphosphorylated pRB, presumably through the pRB C-terminus. Paradoxically, 
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both populations localize to and activate the same pro-apoptotic E2F1 targets following 
DNA damage (Carnevale et al., 2011). Nevertheless, this provides evidence that alternate 
pRB-E2F1 conformations bind promoters devoid of E2F consensus motifs to regulate 
transcription of non-cell cycle genes in a cell cycle-independent manner. Whether this 
complex imparts transcriptional control at other non-cell cycle targets remains unknown.  
Beyond transcriptional control at the G1-S interface, pRB maintains genome integrity 
through transcription-independent activities on chromatin post-G1. While a post-G1 pRB 
recruitment mechanism has remained elusive, the CDK-resistant pRB-E2F1 interaction 
provides a possible mechanism that may underlie these functions. For instance, the pRB 
N-terminus interacts with Mcm7, DNA polymerase α and Ctf4 to restrict initiation of 
DNA replication (Borysov et al., 2015). Upon S-phase entry, Orc1 bound to pRB is 
displaced by E2F1 (Mendoza-Maldonado et al., 2010). This event regulates firing of the 
Lamin B2 and GM-CSF replication origins (Avni et al., 2003). To halt progression of the 
replication fork, pRB displaces PCNA (Braden et al., 2006).  
pRB also associates with chromatin post-G1 to ensure proper mitotic entry and 
progression (Bourgo et al., 2011). Mitotic defects in pRB-deficient cells were originally 
attributed to misregulation of E2F target genes involved in mitotic control, such as MAD2 
(Srinivasan et al., 2007). However, the use of synthetic pRB mutants demonstrates that 
pRB mediates mitotic regulation through transcription-independent means as well. Cells 
from a gene-targeted mouse model encoding alanine substitutions at I746, N750, and 
M754 residues within the pRB LxCxE binding cleft exhibit discrete loss of pRB 
interactions that form through the LxCxE binding cleft. This mutant is referred to as the 
pRB
LXCXE
 or pRB
L
 mutant (Isaac et al., 2006). The majority of proteins that bind pRB 
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through this cleft exhibit enzymatic activities used to alter chromatin structure, and often 
lack the LxCxE motif present in the original viral oncoproteins found to bind the cleft 
(Talluri and Dick, 2012). In this regard, it appears surprising that all of these interactions 
are largely dispensable for certain aspects of proliferative control as Rb1
L/L
 mice are 
viable, and Rb1
L/L
 cells exhibit proper induction of quiescence, with anomalies most 
apparent within the context of senescence and mammary gland development (Francis et 
al., 2009; Isaac et al., 2006; Talluri et al., 2010). Amongst the repertoire of pRB-
interactors that bind this cleft, the mitotic defects in Rb1
L/L
 cells have largely been 
attributed to loss of pRB binding to the Condensin II complex (Coschi et al., 2014). 
pRB-Condensin interactions were first noted in D.melanogaster where chromatin 
loading of the dCAPD3 subunit of the Condensin complex appeared to be dependent on 
the D.melanogaster pRB homologue RBF1 (Longworth et al., 2008). In mammals, two 
multimeric Condensin complexes exist, both of which contain SMC2 and SMC4 subunits 
that bind to form a hinge that connects two protruding coiled-coil arms that form a ring 
(Uhlmann, 2016). In Condensin I, this ring is completed by the CAPH subunit bound to 
CAPD2 and CAPG, while the SMC ring of Condensin II is connected by CAPH2 bound 
to CAPD3 and CAPG2. Condensin II associates with interphase chromosomes, and 
facilitates chromosome condensation during prophase (Hirano, 2012). As mitosis 
progresses, nuclear envelope breakdown permits entry of cytoplasmic Condensin I 
complexes that bind and further condense mitotic chromosomes during prometaphase and 
metaphase (Hirano, 2016). 
The mitotic functions of Condensins appear to underlie the overt aberrations present 
in Rb1
L/L
 cells. These cells exhibit slightly increased G2/M content accompanied by 
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lagging chromosomes, centromere fusions, and aneuploidy (Isaac et al., 2006). Further 
inspection of mitotic progression reveals chromosome condensation and segregation 
errors characterized by a diffuse metaphase plate and prolonged anaphase. Upon 
inspection of Condensin loading onto chromatin as a possible underlying mechanism, 
chromatin fractions reveal reduced enrichment of Condensin II subunits, but not 
Condensin I (Coschi et al., 2010). Collectively, this suggests that pRB recruits Condensin 
II to ensure proper chromosome condensation and segregation. Condensin II subunits are 
particularly enriched at pericentric heterochromatin. However, the mechanism by which 
pRB recruits Condensin II to pericentric satellite repeats during mitosis remains 
unknown.  
Collectively, misregulation of pRB functions during replication and mitosis likely 
contribute to the pronounced endoreduplication, aneuploidy, replication stress, and 
segregation defects that characterize a state of genomic instability in pRB-deficient cells. 
A common feature that underlies these activities is the ability of pRB to function as an 
adapter that recruits a diverse spectrum of machinery to modulate local chromatin 
structure. Indeed, pRB deficient cells exhibit defective heterochromatinization of 
pericentric and telomeric repeats (Gonzalo et al., 2005; Isaac et al., 2006; Manning et al., 
2014). However, since the mechanism of post-G1 pRB chromatin recruitment remains 
poorly understood, it remains unknown whether defective heterochromatinization is 
directly due to perturbed pRB function, or simply a by product of perturbed replication 
and mitotic progression. The CDK-resistance coupled with altered DNA binding 
specificity merits investigation into whether the CDK-resistant pRB-E2F1 interaction 
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exists endogenously and whether it may underlie the aforementioned post-G1 functions 
of pRB.  
1.13 Rationale 
Next-generation sequencing approaches detect repetitive element activation in 
premalignant lesions (Lee et al., 2012). A mechanistic basis for why misregulation is an 
early event in the initiation of tumorigenesis remains elusive. Mechanisms of repetitive 
element silencing provide a starting point to identify cancer-susceptible aspects of 
silencing. Knockout models for epigenetic silencers of repeats demonstrate extensive 
compensatory effects exerted by facultative heterochromatin (Déjardin, 2015). This 
suggests that disruption of facultative heterochromatin is likely a rate-limiting event that 
underlies constitutive misregulation of repetitive elements in cancer.  
The retinoblastoma tumor suppressor protein provides a potential mechanistic link 
between repetitive element misregulation upon initiation of tumorigenesis. Epigenetic 
writers that silence repetitive elements in ESCs are recruited to particular genes in a pRB-
dependent manner. This includes DNMTs, H3K9me3 HMTs, H3K27me3 HMTs, and 
HDACs (Kotake et al., 2007; Robertson et al., 2000). Whether this recruitment occurs at 
repeats has remained largely unexplored. More direct evidence comes from investigation 
of triple-knockout (TKO) MEFs that lack expression of all three pocket proteins. Extracts 
from proliferating TKO MEFs exhibit pronounced expression of L1 ORF2p (Montoya-
Durango et al., 2009). Whether this misexpression can be attributed to a single pocket 
protein remains unexplored.  
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Since repetitive element expression remains suppressed throughout the cell cycle, a 
repeat-silencing mechanism must be resistant to fluctuations in cell cycle phase. An 
interaction between the pRB C-terminus and the E2F1 marked box domain exhibits 
resistance to CDK-mediated phosphorylation that dissociates other pRB-E2F interactions 
that form primarily through the pRB small pocket (Cecchini and Dick, 2011). Within this 
conformation, pRB and E2F1 demonstrate altered DNA binding sensitivity (Carnevale et 
al., 2011; Dick and Dyson, 2003; Julian et al., 2008). Whether this altered DNA binding 
sensitivity underlies recruitment to repetitive sequences remains unexplored. If this is the 
case, this justifies investigation into whether post-G1 pRB-Condensin II recruitment to 
pericentric satellite repeats occurs through this mechanism. Overall, this work focuses on 
whether a CDK-resistant pRB-E2F1 interaction underlies both known and yet-unknown 
post G1 functions of pRB that are required to maintain genome integrity through 
recruitment of chromatin remodelers to repetitive genomic regions.  
1.14 Objectives 
In chapter 2, a novel gene targeted mouse model encoding an F832A substitution 
in the Rb1 gene, called Rb1
S
, is generated to disrupt the CDK-resistant pRB-E2F1 
interaction in order to investigate its endogenous functions. I hypothesized that the CDK-
resistant pRB-E2F1 complex functions as a scaffold to mediate epigenetic silencing of 
repeats genome-wide. To test this hypothesis, I mapped pRB occupancy at repeats across 
the genome using chromatin-immunoprecipiration-sequencing (ChIP-seq) and ChIP-
qPCR. To determine whether occupancy was functional, I performed RNA-seq and 
microarray analysis using mutant cells. DNA methylation and histone tail modifications 
were also compared at repetitive elements in order to determine potential epigenetic 
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regulatory roles of pRB at repetitive sequences. Finally, homozygous mutant animals 
were aged until animal protocol endpoints to determine whether loss of this interaction 
resulted in any overt phenotypes.  
In both chapter 3 and the appended paper (Coschi, Ishak, et. al 2014), I used 
Rb1
S/S
 MEFs to investigate contributions of the CDK-resistant pRB-E2F1 interaction to 
the maintenance of genome integrity. I hypothesized that pRB-E2F1 were required to 
ensure proper replication and mitotic progression independent of transcriptional 
regulation of E2F cell cycle target genes. In order to test this hypothesis, γH2AX foci and 
>4N DNA content were compared as overt indicators of genome stability. Microarray 
analysis and western blots were conducted to assess expression of E2F targets involved in 
replication and mitosis. To assess whether certain post-G1 functions of pRB utilized this 
scaffold, ppRPA accumulation, chromosome congression, chromosome segregation, and 
micronuclei frequency were assessed. Finally, we investigated whether this pRB-E2F1 
scaffold recruits the Condensin II complex to particular repetitive sequences, and whether 
such sequences were enriched for γH2AX foci upon loss of this recruitment.  
In chapter 4, the pRB-EZH2 complex was assessed as a potential target for drug-
induced epigenetic modulation. Specifically, acute EZH2 inhibition was assessed as a 
means of activating repetitive elements silenced by pRB-EZH2 in cell culture and in vivo. 
To determine how constitutive alleviation of multiple tumor suppressor-based chromatin-
organizing mechanisms affects tumorigenesis, Rb1
S/S
 mice were crossed into a Trp53
-/-
 
background, and characterized upon animal protocol endpoints for evidence of altered 
cancer phenotypes.  
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Chapter 2  
2 An RB-EZH2 complex mediates cell cycle independent 
silencing of repetitive DNA sequences 
2.1 Abstract 
Repetitive genomic regions include tandem sequence repeats, and interspersed repeats 
such as endogenous retroviruses and LINE-1 elements. Repressive heterochromatin 
domains silence expression of these sequences through mechanisms that remain poorly 
understood. Here, we present evidence that the retinoblastoma protein (pRB) utilizes a 
cell cycle-independent interaction with E2F1 to recruit enhancer of zeste homologue 2 
(EZH2) to diverse repeat sequences. These include simple repeats, satellites, LINEs and 
endogenous retroviruses, as well as transposon fragments. We generate a mutant mouse 
strain carrying an F832A mutation in Rb1 that is defective for recruitment to repetitive 
sequences. Loss of pRB-EZH2 complexes from repeats disperses H3K27me3 from these 
genomic locations and permits repeat expression. Consistent with maintenance of 
H3K27me3 at the Hox clusters, these mice are developmentally normal. However, 
susceptibility to lymphoma suggests that pRB-EZH2-recruitment to repetitive elements 
may be cancer relevant. 
2.2 Introduction 
Repetitive genomic regions comprise approximately 50% of the human genome 
(Lander et al., 2001). These repetitive elements include tandem repeats, such as satellite 
sequences that underpin the heterochromatin at centromeres, in addition to interspersed 
repeats that are capable of transposition (Slotkin and Martienssen, 2007). Expression of 
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repetitive elements poses a mutagenic threat to the host through multiple possible 
aberrations (Mager and Stoye, 2015). For example, de-repression of satellite repeats 
disrupts organization of centromeric heterochromatin and coincides with defects in 
chromosome segregation and meiosis (Slotkin and Martienssen, 2007). At the 
transcriptional level, de-repressed repeat sequences can serve as alternate enhancers or 
promoters that permit ‘read-through’ transcription and cis-activation of proximal genes, 
including proto-oncogenes that have been established as initiating events in human 
lymphomas (Lamprecht et al., 2010). More recently, sequencing-based studies 
demonstrate that re-integration of activated mobile repetitive elements can generate 
cancer-relevant mutations in pre-malignant lesions that precede various human cancers 
(Helman et al., 2014; Iskow et al., 2010; Lamprecht et al., 2010; Lee et al., 2012; Lock et 
al., 2014). Likewise, re-integration of activated satellites expands centromere repeats and 
can fuel cancer cell growth (Bersani et al., 2015). The frequent co-occurrence of 
repetitive element reactivation with genome instability suggests that the antagonism of 
repeat silencing may be achieved through mechanisms commonly employed to initiate 
tumorigenesis. Recent evidence of p53-mediated transposon repression indicates that this 
may indeed be the case (Leonova et al., 2013; Wylie et al., 2016). Thus, any potential 
contribution of repetitive sequences to cancer initiation must ultimately be mitigated 
through transcriptional silencing. Understanding how silencing is achieved is 
fundamental to understanding how cancer-initiating mechanisms may circumvent this 
facet of genome regulation. 
Repetitive elements are transcriptionally repressed by DNA methylation and 
histone tail modifications (Schlesinger and Goff, 2015). Sustained repression of repetitive 
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elements during periods of genome-wide DNA hypomethylation in early embryogenesis 
has stimulated investigation of histone-dependent repression mechanisms in ES cells 
(Leung and Lorincz, 2012; Levin and Moran, 2011). Repetitive sequences in ES cells are 
enriched for H3K9me2/3, H4K20me3, and H3K27me3 (Day et al., 2010). Upon loss of 
DNA methylation, H3K27me3 expands to maintain silencing of interspersed and tandem 
repeat sequences (Walter et al., 2016). Following genetic ablation of H3K9 histone 
methyl transferases, H3K27me3 compensates for H3K9me3 loss at interspersed and 
pericentromeric repeats (Peters et al., 2003). However, additional deletion of the 
Polycomb repressor complex 2 (PRC2) subunit EED can de-regulate these repetitive 
sequences indicating redundancy of repressive mechanisms (Walter et al., 2016). 
Proteomic analysis of ES cells indicates that 60% of histone H3 proteins are comprised of 
H3K27me2/3 modifications (Peters et al., 2003). Collectively, these data suggest 
H3K27me3-based heterochromatinization provides a dynamic epigenetic mechanism that 
silences repeat sequence expression in response to alterations in other silencing 
mechanisms, and likely contributes extensively on its own (Bulut-Karslioglu et al., 2014; 
Karimi et al., 2011; Liu et al., 2014). Despite this fundamental contribution to genome-
wide repeat silencing, little is known about the mechanism of H3K27me3 deposition and 
expansion at repetitive sequences, as investigation of Polycomb at non-unique genomic 
regions primarily concerns the regulation of neighbouring genes (Bauer et al., 2015; Casa 
and Gabellini, 2012). Beyond ES cells, investigation of repetitive DNA silencing by 
PRC2 remains even less understood. 
Dynamic response to various genomic alterations positions Polycomb as a robust 
barrier to reactivation of repeat sequences. Thus, disruption of genome stability through 
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repeat sequence resurrection likely requires disruption of Polycomb-mediated 
heterochromatin. A surprising link between Polycomb, repetitive sequences, and cancer-
initiating mechanisms may be the RB tumor suppressor protein (pRB). While pRB is best 
known as a repressor of E2F transcription factors at cell cycle genes during the G1 phase 
of the cell cycle, pRB family proteins also direct H3K27me3 to repress transcription 
during differentiation and stress (Blais et al., 2007; Bracken et al., 2007; Kareta et al., 
2015; Kotake et al., 2007). In addition, RB cell cycle-independent interactions with 
chromatin (Avni et al., 2003; Wells et al., 2003) have been observed, but genome-wide 
analysis of pRB at repeat sequences is lacking (Coschi et al., 2014; Montoya-Durango et 
al., 2009). In addition, there is no evidence pRB-mediated regulation of H3K27me3 is 
sufficiently widespread to match the magnitude of H3K27me3 abundance and 
distribution at repeats. 
In this study we demonstrate that pRB and EZH2 form a complex that directs 
H3K27me3 deposition at most repeat element types from simple sequence repeats and 
satellites, to DNA transposons, LINEs, SINEs, and endogenous retroviruses. We report 
the generation of a new strain of mice carrying a targeted point mutation, F832A (called 
Rb1
S
), that is specifically defective for recruitment of EZH2 to repetitive sequences. In 
the absence of pRB recruitment, EZH2 no longer directs H3K27me3 to these elements, 
leading to dispersion or loss of heterochromatin. Rb1
S/S
 fibroblast cells and splenocytes 
express diverse repeat sequences, including tandem and interspersed elements, and aged 
Rb1
S/S
 mice develop spontaneous lymphomas. Collectively, these data suggest that 
silencing of repetitive elements contributes to pRB’s function as a tumor suppressor. 
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2.3 Experimental Procedures 
2.3.1 Cell Culture and Mice 
Mouse embryonic fibroblasts (MEFs) were generated from E13.5 embryos using standard 
procedures and cultured as previously described (Coschi et al., 2014). Cells were 
typically arrested by serum starvation for at least 3 days. 
2.3.2 Chromatin immunoprecipitation 
ChIP methods were based on previously published work (Cecchini et al., 2014). Briefly, 
cells were cross-linked with 2mM ethylene glycol bissuccinimidylsuccinate (EGS) and 
1% formaldehyde. Chromatin was sonicated to ≤ 400 bp in length and normalized 
between experimental groups. Samples were pre-cleared with protein G Dynabeads and 
ChIP antibodies were added to immunoprecipitate proteins. Samples had their cross-links 
reversed at 65°C and were treated with RNase and proteinase K. DNA was isolated for 
qPCR or library preparation followed by single-end sequencing using Illumina 
HiSeq2500. See supplemental tables for list of ChIP-qPCR primers. Further details of 
ChIP-reChIP and ChIP-seq are available in supplemental experimental procedures. 
2.3.3 RNA expression 
Total RNA was isolated using Trizol reagent, treated with DNaseI, and reverse-
transcribed to generate cDNA using random primers and Superscript III reverse 
transcriptase (Invitrogen). qRT-PCR was performed using iQ SYBR green Super Mix 
(Bio-Rad) using a CFX96 Real-Time PCR Detection System (Bio-Rad). Relative changes 
in gene expression were calculated by normalizing to β-actin. Primer sequences are 
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described in supplemental materials. Some expression microarray experiments have been 
reported previously (Cecchini et al., 2014), or can be found in GEO (GSE85640). 
2.3.4 Analysis of ChIP-seq and RNA-seq experiments 
Sequence reads from ChIP experiments were mapped to the mm9 genome assembly 
without allowing mismatches as previously reported (Bulut-Karslioglu et al., 2014). 
Reads with more than one exact match were randomly assigned amongst these locations. 
RNA-seq reads were mapped to a custom repeat index (Day et al., 2010), assigning reads 
to their best match allowing up to two sequence mismatches. Further details on 
computational analyses are available in supplemental materials. Sequence data is 
available in GEO (accession number GSE85640). 
2.3.5 Generation of gene targeted mice 
A targeting vector encoding a floxed PGK-Neomycin cassette and an F832A missense 
point mutation in exon 24 of the Rb1 gene was generated and electroporated into mouse 
R1 embryonic stem (ES) cells in the London Regional Transgenic and Gene-Targeting 
facility. After G418 selection, positive clones were identified by Southern blotting and 
microinjected into blastocysts to generate chimeric males that were intercrossed with 
EIIa-Cre transgenic females essentially as we have reported previously (Isaac et al., 
2006). Primers designed to flank the floxed Neomycin cassette amplified a product 
approximately 80 bp larger than the wild-type product, indicating presence of a residual 
LoxP site after successful Cre-mediated excision of the floxed marker in targeted F1 
offspring. DNA sequencing confirmed germline transmission of the targeted allele. 
Targeted F1 progeny were intercrossed to generate mice that did not express the Cre-
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recombinase. Heterozygous F2 crosses produced offspring genotypes according to 
expected Mendelian frequencies, with viable, fertile, homozygous mutant
 
mice that 
developed into adulthood without overt developmental defects. Animals were housed and 
handled as approved by the Canadian Council on Animal Care. 
2.3.6 Cell cycle analysis 
Asynchronous or serum-starved MEFs were pulse-labeled with bromodeoxyuridine 
(BrdU; Amersham Biosciences) for 2 hours, detached with 3 mM EDTA, and ethanol-
fixed. Cells were then permeabilized with 2 N HCl and 0.5% TritonX-100, neutralized 
with 0.1M NaB4O7 (pH 8.5), immunostained with anti-BrdU (BD Biosciences), followed 
by FITC-conjugated secondary (Vector laboratories), then stained with propidium iodide. 
Cells were treated with RNase, strained, and analyzed by flow cytometry on a Beckman-
Coulter EPICS XL-MCL (Cecchini et al., 2012).  
2.3.7 Cell extracts 
Nuclear extracts were generated according to methods described by Cecchini and Dick 
(Cecchini and Dick, 2011). Briefly, cells were washed twice and collected in 1 ml of 
PBS. Cells were then re-suspended in three times cell volume of hypotonic lysis buffer 
(20 mM Tris-HCl, pH 7.5, 10 mM KCl, 3 mM MgCl2, 1 mM EDTA) supplemented with 
protease inhibitors. After 5 minutes on ice, 0.05% Nonidet P40 was added, extracts were 
iced 5 minutes before nuclei were pelleted by centrifugation at 1700 g for 10 minutes at 
4°C and washed twice with hypotonic lysis buffer containing 0.05% Nonidet P40. Nuclei 
were re-suspended in Gel Shift Extract (GSE) buffer (20mM Tris pH 7.5, 420 mM NaCl, 
1.5mM MgCl2, 0.2mM EDTA, 25% glycerol) and frozen at −80°C. Extracts were 
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thawed, cellular debris was cleared by centrifugation, and extracts were quantified for 
interaction assays.  To generate whole-cell lysates, cells were washed twice with PBS, 
and scraped in ice-cold RIPA buffer (50 mM Tris-HCl [pH 8.0], 150 mM NaCl, 1% 
Triton X-100, 0.5% sodium deoxycholate, and 0.1% SDS) supplemented with protease 
inhibitors. After 20 minutes on ice, lysates were centrifuged at 20800 g for 20 min at 4°C. 
Supernatant was isolated, quantified, boiled 5 minutes in Laemmli sample buffer, and 
then resolved by SDS-PAGE (Yu et al., 2012). See appendix F for antibodies used. 
2.3.8 Chromatin Fractionation 
Chromatin isolation method was adapted from Mendez and Stillman (Méndez and 
Stillman, 2000). Briefly, cells were resuspended in buffer A (10 mM Tris [pH 8.0], 10 
mM KCl, 1.5 mM MgCl2, 0.34 M sucrose, 10% glycerol, 1 mM DTT) supplemented with 
protease inhibitors at 4x10
7
 cells/ml, and incubated on ice for 5 minutes. Equal volume of 
0.3mg/ml digitonin in buffer A was added, and the cells were further incubated for 10 
minutes on ice in the presence of detergent. Approximately 5-10% of this total volume 
was stored to preserve a whole-cell extract fraction. Centrifugation at 1300 xg for 5 
minutes at 4°C pelleted nuclei, and supernatant containing the cytoplasmic fraction was 
collected. Nuclei were washed in buffer A, then lysed 30 minutes on ice in buffer B (3 
mM EDTA, 0.2 mM EGTA, 1 mM DTT) supplemented with protease inhibitors using a 
volume ~2x that of the pellet. Insoluble chromatin was pelleted by centrifugation at 1,700 
xg for 5 minutes at 4°C, and supernatant containing the nucleoplasmic fraction was 
collected. The chromatin pellet was resuspended in DNaseI buffer (20mM Tris [pH 7.5], 
10 mM MgCl2) at a volume ~2x that of the pellet, supplemented with 200U of DNaseI 
(Sigma), and incubated 1 hour on ice. All fractions were quantified, boiled in Laemmli 
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buffer, resolved by SDS-PAGE, and coomassie stained to assess fraction purity and 
histone normalization. Fractions were then used for western blotting. See Appendix F for 
antibodies used. 
2.3.9 GST pulldowns 
GST-fusion proteins were expressed in and purified from 500 ml cultures of BL21-DE3-
Gold Escherichia coli (Stratagene) using glutathione–Sepharose beads according to 
standard protocols. Purified GST-fusion protein (4 μg) was incubated with 400μg of 
nuclear extract diluted with low salt GSE buffer (20 mM Tris-HCl pH 7.5, 200 mM 
NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 1 mM DTT and 0.1% Nonidet P40), and rocked 
1-2 hours at 4°C. GST–protein complexes were collected with glutathione–Sepharose, 
washed twice with low salt GSE buffer, and eluted with Laemmli sample buffer for 
western blot analysis (Dick et al., 2000). See table S1 for antibodies used. 
2.3.10 Immunoprecipitation 
For immunoprecipitations, nuclear extract was diluted 1:1 in IP wash buffer (20mM Tris 
pH 7.5, 200 mM NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 25 mM DTT and 0.1% NP-40). 
Protein complexes were immunoprecipitated overnight at 4°C with antibodies pre-bound 
to washed protein G Dynabeads. Antibody-protein complexes were washed twice with IP 
wash buffer, then eluted in Laemmli sample buffer for western blot analysis. See table S1 
for antibodies used (Cecchini and Dick, 2011).  
2.3.11 Splenocyte ChIP 
Splenocyte ChIP experiments were conducted following splenocyte isolation from 6-
week old adult mice. Briefly, spleens were isolated from freshly sacrificed mice, and 
mashed through a 40μm sterile cell strainer in a 10cm dish containing 3-4ml of media. 
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Cells were then isolated, pelleted at 4°C, and incubated 5 minutes in 1x RBC lysis buffer 
(0.15M NH4Cl, 10mM KHCO3, 0.1mM EDTA) to lyse erythrocytes. Splenocytes were 
washed twice in 1x PBS, rocked 1 hour at room temperature in 10ml of 2mM EGS-PBS, 
then supplemented with formaldehyde to a final concentration of 1% and rocked for 
another 15 minutes at room temperature before fixation was quenched with 2.5M glycine 
for 15 minutes. Fixed splenocytes were pelleted, and processed in ChIP buffers 1-3 as 
described in methods. Splenocytes were resuspended in a final volume of 200µL of ChIP 
lysis buffer and sonicated to ≤400 bp before ChIP experiments were conducted as per 
MEF ChIP experiments.  
2.3.12 ChIP-reChIP 
For ChIP-reChIP experiments, we adapted methods from Thillainadesan and colleagues 
(Thillainadesan et al., 2012). Protein-DNA complexes were eluted 30 minutes at 37°C in 
10 mM DTT with 5 mM β-mercaptoethanol. Eluted DNA was diluted 10x in reChIP 
buffer (1% Triton X-100, 2 mM EDTA, 20 mM Tris–HCl pH 8.1, 150 mM NaCl), and 
incubated with second antibody overnight at 4°C. Antibody-protein complexes were 
immunoprecipitated with washed protein G Dynabeads for 2 hours at 4°C, then washed 
with low salt buffer, high salt buffer, and TE. Reverse-crosslinking and purification were 
done as described in ChIP methods section. See table S1 for antibodies used. 
2.3.13 ChIP-seq and Read Alignment  
ChIP was conducted as described in methods according to protocols adapted from 
Cecchini et al. (Cecchini et al., 2014). DNA from multiple replicates per genotype were 
pooled to achieve DNA yield required for library preparation (Illumina TruSeq). For pRB 
ChIP-seq in proliferating MEFs, 6 IPs were pooled, while 11-18 IPs were pooled in 
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arrested MEFs. For H3K27me3 ChIP-seq in proliferating MEFs, 9 IPs were pooled, 
while 12 IPs were pooled for IPs in arrested MEFs. For EZH2 ChIP-seq in proliferating 
MEFs, 9 IPs were pooled. Libraries were sequenced using an Illumina HiSeq 2500. 
Resulting FASTQ reads were aligned to mouse genome build mm9 using Bowtie version 
2.2.3 (Langmead and Salzberg, 2012). Reads aligning to multiple locations of a particular 
repeat element were distributed randomly to these positions, while reads mapping to the 
same location were retained as previously described (Bulut-Karslioglu et al., 2014). The 
following command was used:  bowtie2 -t -p 24 -D 15 -R 2 -L 32 -i S,1,0.75 -x mm9 -U 
reads.fastq -S output.SAM. 
2.3.14 Peak Calling and annotation 
Peaks were identified using MACS1.4 or MACS2 version 2.0.10 according to parameters 
stated below, and the options to detect broad peak distributions for histone marks (Feng 
et al., 2012; Zhang et al., 2008). The results from this peak calling were stored as BED 
files. The following commands were used: 
macs14 -t ChIP.sam -c input.sam -n output -g mm -p 0.01 -m 5,50 --bw 180 --keep-dup 
all -B -S –w; MACS2 callpeak -t ChIP.sam -c input.sam -n ouput -g mm -q 0.05 --broad -
-keep-dup all -B (q 0.01 for histones). Peak enrichment per genomic region was 
determined using HOMER (Heinz et al., 2010). Peak intersection and enrichment at 
repetitive elements was determined using BEDintersect of MACS peaks against repeat 
indices derived from UCSC RepeatMasker (Quinlan and Hall, 2010).  
2.3.15 deepTools enrichment analysis 
bamCompare was used generate bigWig files of ChIP reads normalized to input (Ramirez 
et al., 2014). computeMatrix was used to calculate read enrichment scores at wild-type 
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repeat peak intersects or promoter regions. heatMapper was used to plot enrichment at 
each repElement per repFamily +/-1kb of wild-type repeat peak intersect locations 
(Ramirez et al., 2014). 
2.3.16 RNA-sequencing  
Total RNA from quiescent MEFs was isolated using TRIzol reagent protocol 
(Invitrogen). rRNA was depleted from total RNA using RiboMinus Euk System V2 (Life 
technologies). rRNA-depleted RNA samples were submitted for picoanalyzer analysis to 
determine concentration, purity, and rRNA content. Samples with <10% rRNA remaining 
were submitted for library construction at the Sick Kids/TCAG (Toronto) facility 
followed by paired end sequencing on an Illumina HiSeq 2500.  
2.3.17 Expression microarray analysis 
Total RNA was extracted according to Trizol manufacturer protocol, and quality control 
tested using an Agilent 2100 Bioanalyzer. Preparations that met quality control standards 
were used to prepare biotin end-labeled single strand cDNA. 5.5 ug of prepared cDNA 
was hybridized for 16 hours at 45°C on GeneChip Mouse Gene 1.0 ST Arrays that were 
subsequently washed, stained, and scanned using the Affymetrix GeneChip Scanner 3000 
7G. RMA expression values derived from CEL files were log-transformed prior to 
ANOVA analysis using Partek Genomics Suite. Log2 values of mutant/wild-type were 
plotted as heatmaps using matrix to PNG at chibi.ubc.ca/matrix. Annotations were 
derived from Affymetrix MoGene-1 0-st-v1 Transcript Cluster Annotations, CSV, 
Release 32. 
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2.3.18 RNA-seq read alignment and analysis 
Single end sequence reads were aligned using Bowtie v1.0.0 to indices of repeats derived 
from Repbase and Tandem Repeats Databases(Day et al., 2010). Bowtie parameters were 
established to report the single best alignment per read, with a default value of 2 for the 
maximum number of mismatches; the following Bowtie v1.0.0 parameters were used:  
bowtie –S –best –k 1 –chunckmbs 500 –p24 –t –un. Read enrichments were binned using 
the awk command according to functional categories, based on RepeatMasker’s 
annotation. Residual rRNA reads were subtracted from the total number aligned reads 
reported for each sample. The number of reads for each category were then normalized to 
the corrected number of total aligned reads per sample. Expression per biological 
replicate relative to the control average was compared between repFamily categories as a 
LOG2 ratio, and plotted as a heatmap using matrix to PNG at chibi.ubc.ca/matrix.  
2.3.19 Bisulfite sequencing 
Bisulfite sequencing was conducted as previously described (Denomme et al., 2012; 
White et al., 2015). Briefly, P4 MEFs were trypsinized, washed and re-suspended in 1 ml 
of 1X PBS. 1 μL of cell suspension was embedded into a 2:1 3% low melting point 
(LMP) agarose (Sigma) and lysis [100 mM Tris–HCl, pH 7.5 (Bioshop), 500 mM LiCl 
(Sigma), 10 mM EDTA, pH 8.0 (Sigma), 1% LiDS (Bioshop), and 5 mM DTT (Sigma), 
1 μL of 2 mg/ml proteinase K (Sigma), and 1 μL 10% Igepal (Sigma)] solution for 
bisulfite mutagenesis. This mixture was iced 10 minutes, then lysed 20 hours overnight in 
500 μL of SDS lysis buffer (450 μL TE pH 7.5, 50 μL 10% SDS, 1 μL proteinase K) at 
50°C. Lysis buffer was replaced with 300 μL of mineral oil, and samples were processed 
for bisulfite mutagenesis or stored at -20°C 1-5 days, then processed for bisulfite to 
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amplify IAP (Lane, 2003) and LINE1 sequences as previously described (Denomme et 
al., 2012; White et al., 2015). Briefly, proteinase K was inactivated at 90°C, then samples 
were iced 10 minutes, incubated 15 minutes at 37°C with 0.1 M NaOH solution to 
denature DNA, and covered with 300 μL of mineral oil. Following addition of 500 μL of 
2.5 M bisulfite solution, samples were incubated 3.5 hours at 50°C, then desulfonated 15 
minutes in 1 mL of 0.3 M NaOH at 37°C. Samples were washed twice in TE pH 7.5 then 
water. Negative controls were processed in parallel. For first round PCR, 10 μL of 
agarose bead with bisulfite converted DNA was added to Hot Start Ready-To-Go (RTG) 
(GE Healthcare) PCR beads hydrated with 0.5 μL of 10 μM IAP (Lane, 2003)_F1/R1 or 
L1_F/R1 external primers, 1 μL of 240 ng/mL transfer RNA and 13 μL water with a 
25 μL mineral oil overlay. 5 μL of amplicon was added to 20 μL of RTG beads mixed 
with 0.5 μL of each 10 μM IAP (Lane, 2003)_F2/R2 or L1_F/R2 internal primer and 
19 μL water for nested PCR. PCR amplification was performed as follows: 94°C for 3 
minutes, followed by 35 cycles of 94°C for 1 minute, 53°C (IAP)/56°C (L1) for 1 minute, 
72°C for 1 minute, and a final extension of 72°C for 5 minutes.  
2.3.20 qRT-PCR analysis of expression 
Tissues from 6-8 week-old mice were harvested and processed for RNA isolation using 
the SIGMA GenElute mammalian total RNA kit. RNA was DNaseI (SIGMA) treated and 
reverse transcribed to cDNA using the BIO-RAD iScript RT Supermix kit. Isolated 
cDNA was used in qRT-PCR reactions. Resulting target Cq values were normalized to β-
actin, then expressed as fold change relative to the global wild-type mean. Normalized 
fold change was plotted as a heatmap using matrix to PNG at chibi.ubc.ca/matrix. 
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2.4 Results  
2.4.1 The RB protein associates with repetitive genomic 
sequences  
To explore emerging chromatin regulatory functions beyond cell cycle control, 
we compared pRB association with chromatin in arrested and proliferating mouse 
embryonic fibroblasts (MEFs). While noticeably reduced, pRB retains some chromatin 
binding in proliferating cells (Figure 2.1A). We sought to further investigate genome 
wide distribution of pRB across growth conditions by chromatin immunoprecipitation-
sequence analysis (ChIP-seq). We used a stringent sequence alignment approach that 
prohibited mismatches. We also randomized read assignments where more than one exact 
match existed to enhance potential alignments to repetitive regions of the genome (see 
methods and (Bulut-Karslioglu et al., 2014)). Analysis of peak distribution across broad 
genomic regions reveals a dramatic abundance of peaks in introns and intergenic 
locations (Figure 2.1B). The proportion of peaks that localize to introns and intergenic 
regions remains unaltered by proliferative status, suggesting that even though pRB 
occupancy on chromatin may be reduced in proliferating cells, this distribution pattern 
displays cell cycle-independence for pRB at these regions. Comparison of enrichment at 
wild type peak locations within promoters to the same genomic locations in Rb1
-/-
 
controls confirms a high degree of stringency in peak assignment (Figure 2.1C). Since an 
abundance of peaks localize to non-coding regions, we next annotated peaks based on 
categories of repetitive sequences (Figure 2.1D). Analysis of peak distribution reveals 
pRB association with SINEs, long terminal repeat (LTR)- containing endogenous 
retroviruses (ERVs), LINEs, and simple repeat sequences among others. Importantly, 
these surprising findings are mirrored in a meta-analysis of a recently published human  
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Figure 2.1: pRB associates with genomic repeats in murine and human fibroblasts 
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Figure 2.1: pRB associates with genomic repeats in murine and human fibroblasts 
 
(A) pRB western blots of MEF chromatin fractions. Coomassie stained histones indicate 
relative chromatin quantities per lane. (B) Overall genomic distribution of pRB ChIP-seq 
peaks. Growth conditions are indicated above the pie charts; n=424588 peaks and 
n=77809 peaks for mouse pRB in arrested and proliferating MEFs respectively; n=71511 
peaks for human pRB in arrested IMR90 cells. (C) Heat maps display scaled pRB ChIP-
seq read build ups from the indicated genotypes at proximal promoter regions occupied 
by wild type pRB peaks. Each row contains ±1 kb of flanking sequence. The intensity 
scale indicates magnitude of read enrichment (D) Percent distribution of pRB ChIP-seq 
peaks amongst indicated repeat sequence classes; n=321892 peaks for mouse pRB 
arrested, n=49210 peaks for mouse pRB proliferating, and n=99186 peaks for human 
pRB arrested. RNA repeats include tRNA, snRNA and others. (E) Genome browser 
tracks display mouse pRB ChIP-seq reads at Ccne2. Genomic co-ordinates are indicated 
above the tracks. Repeat Masker and RefSeq tracks are shown below. Red bars denote 
regions of pRB enrichment (peaks) determined with MACS. (F) The analogous region of 
human CCNE2 is shown and labeled akin to panel D. (G) Example of mouse pRB 
occupancy at a LINE-1 element 3' of the Ccne2 gene. (H) Example of a human pRB peak 
5' of CCNE2 that simultaneously overlaps multiple repeat elements. 
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pRB ChIP-seq study, although promoter occupancy is noticeably greater in human data 
(Figure 2.1B and 2.1D)(Ferrari et al., 2014).   
The RB protein is best known for its regulation of E2F-responsive cell cycle 
genes, and our mapping of ChIP-seq reads detects these promoter occupancy events in 
mouse and human data sets (Figure 2.1E and 2.1F). Repeat occupying peaks are also 
found in neighboring regions of the same chromosomes (Figure 2.1 G and 2.1H). Our 
analysis of peak distribution in murine cells demonstrates that at least two thirds of pRB 
occupying peaks map to repetitive sequences (Figure 2.1B and 2.1D). It is difficult to 
draw a similar conclusion in human data because many pRB peaks contain multiple 
repetitive elements in the same peak (Figure 2.1H). Collectively these data indicate that 
pRB associates with diverse repetitive elements in mouse and human fibroblasts. We 
describe this pattern of pRB distribution as cell cycle independent because it is similar 
between growth states, but recognize that its magnitude is altered. 
2.4.2 Loss of a CDK-resistant pRB-E2F1 interaction disrupts 
repeat association 
We previously identified an interaction between pRB and E2F1 that confers 
reduced binding to consensus E2F sequence elements and resistance to disruption by 
CDK phosphorylation(Cecchini and Dick, 2011; Dick and Dyson, 2003). We sought to 
determine whether the properties of this interaction could underlie the cell-cycle 
independent pRB occupancy observed in our ChIP-seq. We generated a targeted mutant 
mouse strain bearing a single F832A substitution to disrupt the unique interaction 
between pRB and E2F1, and named this allele Rb1
S
 (Figure 2.2A-D). Rb1
S/S
 mice are 
indistinguishable from their littermates (Figure 2.2E&F), and cells isolated from these 
mice exhibit ostensibly normal pRB expression levels with no indication of  
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Figure 2.2: In vivo disruption of the CDK-resistant pRB-E2F1 interaction. 
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Figure 2.2: In vivo disruption of the CDK-resistant pRB-E2F1 interaction. 
 
(A) Schematic diagram showing the minimal interaction regions for the different pRB-
E2F interactions. E2F1-4 transactivation domains (TAD) bind the pRB large pocket 
domain, while the E2F1 coiled coil and marked-box domain (CM) binds a minimal 
interaction surface mapped to the pRB-C-terminus. (B) Diagram of the Rb1 locus along 
with the targeting vector encoding the F832A missense point mutation in exon 24. Gene 
structure of a correctly targeted locus is shown with the PGK-neo cassette and the 
structure of the Rb1
S
 gene following excision of the PGK-neo cassette. Locations of 
probes used in Southern blots are shown. (C) Southern blots of two correctly targeted ES 
clones are shown. The left most blot shows the banding pattern from the 5' probe, the neo 
probe shows a single band corresponding to recombination of the targeting vector, and 
the right most blot shows the expected fragment sizes from hybridization with the 3' 
probe. (D) DNA sequencing of Rb1 exon 24 codon from genomic DNA of the indicated 
genotypes of mice. (E) Photographs of 6-8 week old wild type and Rb1
S/S
 mice. (F) 
Genotype frequencies from heterozygous intercrosses.  
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compensatory expression of RB-related family members p107 and p130 (Figure 2.4A). 
Furthermore, analysis of the F832A substitution in pRB demonstrates a specific defect in 
binding the E2F1 coiled coil and marked box domain, without effects on E2F 
transcriptional activation domain binding to pRB (Figure 2.3A-D). Consistent with these 
biochemical properties, cell cycle regulation and E2F target gene expression are 
indistinguishable from wild type controls (Figure 2.3E and 2.3G). 
 
Western blots of chromatin fractions reveal diminished pRB
S
 association with 
chromatin under both proliferating and arrested conditions (Figure 2.4A). ChIP-qPCR 
was performed to assess pRB recruitment in arrested and proliferating growth conditions 
at the cell cycle responsive Mcm3 promoter. In addition to Rb1
S/S 
cells, we utilized the 
previously characterized Rb1
G
 mutant that disrupts canonical pRB-E2F transcriptional 
control through R461E and K542E substitutions for comparison (Cecchini et al., 
2014)(Figure 2.4B). Under arrested conditions, the pRB
S
 protein exhibits similar 
association with the Mcm3 transcriptional start site (TSS) as wild type pRB, while the 
pRB
G
 mutant exhibits reduced occupancy. Under proliferating conditions, wild type and 
pRB
S
 occupancy of the Mcm3 promoter diminishes, consistent with CDK-dependent 
regulation of pRB-E2F interactions at this genomic location.  
Given the retention of pRB
S
 at E2F cell cycle targets, but the clear loss of chromatin 
association revealed by fractionation, we conducted ChIP-seq for pRB in Rb1
S/S 
cells to 
discover genomic locations that require this pRB-E2F1 interaction. Since pRB
S
 
chromatin association was globally reduced in Figure 2.4A, we focused our analysis on 
wild type locations lost in Rb1
S/S 
cells. Under both growth conditions, ChIP- 
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Figure 2.3: The Rb1
S/S
 mutant maintains pRB cell cycle regulatory functions in 
primary mouse fibroblasts. 
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Figure 2.3: The Rb1
S/S
 mutant maintains pRB cell cycle regulatory functions in 
primary mouse fibroblasts. 
 
(A) Nuclear extracts were prepared from wild type and Rb1
S/S
 primary mouse embryonic 
fibroblasts (MEFs) and pRB was isolated using a GST-E7 pulldown. A western blot 
demonstrates pRB binding to E7 and a coomassie stained gel shows the loading levels of 
GST proteins. (B) Western blotting and commassie stained gels of GST-pulldowns using 
GST-E2F1
CM
 (aa 200-301) in complex with HIS-DP1
CM 
(aa 198-350) to isolate pRB 
from nuclear extracts using its unique interaction with E2F1. (C) GST-E2F1-TAD 
pulldowns were performed to assess binding at the canonical pRB-E2F interaction site. 
(D) IP-western blotting experiment using extracts from the indicated genotypes of MEFs. 
The left most blots show levels of pRB, E2F1, and E2F3 present in extracts and pRB 
associated levels of E2F1 and E2F3 are shown to the right. (E) Asynchronous or 72-hour 
serum-starved passage 4 MEFs were BrdU pulse-labeled for 2 hours, ethanol-fixed, 
immunostained, and PI-stained for signal quantification via flow cytometry. Graphs show 
the proportions of each cell cycle phase from this analysis. (F) qRT-PCR of cDNA from 
total RNA of 72-hour serum-starved P4 MEFs for indicated targets in pRB mutant MEFs.  
(G) Western blots of the indicated cell cycle and E2F regulated proteins from whole cell 
extracts of 72-hour serum-starved P4 MEFs of the indicated genotypes. For all graphs, 
error bars indicate +/- 1 standard deviation; an asterisk represents a significant difference 
from the wild type control P≤0.05 by t-test. 
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Figure 2.4: Cell cycle independent pRB-repeat association. 
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Figure 2.4: Cell cycle independent pRB-repeat association. 
(A) Western blots of whole cell extracts display expression levels of wild type and the 
F832A mutant (Rb1
S
) pRB, as well as related family members p107 and p130. Western 
blot detects pRB association with chromatin fractions from arrested and proliferating 
cells. Coomassie stained histones serve as a loading control. (B) pRB ChIP-qPCR at the 
Mcm3 transcriptional start site (TSS) and 2 kb 5' of Mcm3 for the indicated genotypes 
under arrested and proliferating conditions. (C) Heat maps of pRB ChIP-seq read 
enrichment per repClass for the indicated growth conditions and genotypes. Each row 
represents one scaled wild type peak location at an element within the repClass and 
includes ±1 kb of flanking sequence. The intensity scale indicates magnitude of read 
enrichment. (D) ChIP-qPCR for pRB at the indicated repetitive elements conducted in 
proliferating and arrested MEFs. (E) Two representative genomic regions depict wild 
type and mutant pRB repeat association at LINE-1 fragments across growth conditions. 
Red bars mark regions of pRB enrichment (peaks). For all graphs, error bars indicate one 
standard deviation from the mean and an asterisk represents a significant difference from 
wild type (P≤0.05 by t-test). 
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seq in Rb1
S/S 
fibroblasts uncovers a dramatic loss of pRB enrichment at repetitive 
elements occupied by wild type pRB that is equally evident by ChIP-qPCR (Figure 2.4C-
E). Comparison of read build-ups at wild type peak locations reveals that pRB 
localization is disrupted by the F832A substitution at the vast majority of elements in 
these repClass groups, and resembles Rb1
-/-
 controls at these locations (Figure 2.4C). 
Quantitatively, greater than 80% of wild type pRB peak intersections at repetitive 
elements are lost in Rb1
S/S 
chromatin under both growth conditions (Figure 2.5A).  
In contrast to repetitive elements, the pRB
S
 enrichment profile at E2F cell cycle 
genes parallels that of wild type pRB (Figure 2.5B). Interestingly, pRB localizes 
extensively to repeat-containing regions within 1kb of non-E2F target genes, and indeed, 
pRB
S
 exhibits a loss of enrichment at these regions under both growth conditions (Figure 
2.5C). ChIP-qPCR for pRB at major satellites, LTR-containing, and non-LTR 
retrotransposon repeat classes confirms diminished pRB
S
 occupancy at repetitive 
elements, while the pRB
G
 mutant parallels the cell cycle independent occupancy 
displayed by wild type pRB at these elements (Figure 2.4D). Genome browser tracks 
show two examples of pRB peak loss in Rb1
S/S
 cells at fragments of LINE-1 elements 
(Figure 2.4E). Lastly, ChIP-qPCR detects E2F1 at these repetitive sequences, consistent 
with a model of E2F1 contributing to pRB localization to repeats (Figure 2.5D). 
Collectively, these data indicate that disrupting pRB’s CDK-resistant binding site 
for E2F1 prevents its localization to repetitive regions of the genome. Analysis of mutant 
forms of pRB with distinct defects for E2F interaction type across different growth 
conditions further supports the conclusion that pRB possesses a cell cycle independent  
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Figure 2.5: Occupancy of repetitive sequences by pRB and E2F1.  
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Figure 2.5: Occupancy of repetitive sequences by pRB and E2F1.  
(A) Peak retention relative to wild type-repeat intersections was determined using 
BEDintersect. Bar graphs show peak location by repeat element class using the indicated 
color scheme. RNA repeats include tRNA, snRNA and others. The frequency of peak 
retention in Rb1
S/S 
mutant cells compared with wild-type at these repeat elements is 
shown for both growth conditions. N=321892 peaks for wild-type pRB in arrested cells, 
n=49210 peaks for mouse pRB in proliferating cells.  (B) Average pRB ChIP-seq 
enrichment profiles across the 1kb upstream region of pRB regulated E2F cell cycle 
target genes for the indicated genotypes visualized using deepTools profiler.  (C) Heat 
maps of pRB ChIP-seq read enrichment within 1kb regions that contain wild type pRB 
peaks upstream of RefSeq genes. The intensity scale indicates the magnitude of read 
enrichment. Pie charts indicate relative repeat content of such regions, followed by 
enrichment profiles at the repeat-void regions within this category.  (D) ChIP-qPCR 
assays were performed to detect E2F1 at the indicated repetitive sequences. Error bars 
indicated one standard deviation from the mean. An asterisk indicates a significant 
difference compared to wild type P≤0.05 by t-test. 
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mechanism for repeat occupancy that is distinct from its transcriptional regulatory role 
during the G1-S phase transition. 
2.4.3 pRB-repeat association is required for silencing of repetitive 
sequence expression. 
To investigate the functional role of repeat occupancy by pRB, we performed 
RNA-seq on arrested wild type and Rb1
S/S 
MEFs. Total RNA was depleted of rRNA prior 
to library construction, and reads were aligned to repeat indices and binned according to 
repeat classification and family. The number of reads in each category was normalized to 
the total number of aligned reads per sample. Columns display expression from three 
separate Rb1
S/S
 MEF preparations as a log2 ratio normalized to the average of three wild 
type samples (Figure 2.6A). Rb1
S/S
 MEFs exhibit increased expression of type I and type 
II transposable elements (e.g. Gypsy, Mariner/Tc2, LINE_other, RTE, and SINE/ID), 
satellites, and simple repeats in all three biological replicates. In two samples, many 
families of LTR containing repeats, DNA transposons, LINEs, and SINEs show 
widespread de-regulation in mutant MEFs. Collectively, this demonstrates transcriptional 
misregulation of repeats that matches the occupancy pattern of pRB among repetitive 
sequences. We note variability of expression in sample C5137_E3, however, broad 
differences between biological replicates are common to investigations of repeat 
sequence expression (Howard et al., 2008; Muotri et al., 2010; Wylie et al., 2016), and 
limited misregulation appears specific to this MEF preparation alone. 
Representative elements from highly deregulated repeat classes were selected to 
further explore pRB-repeat regulation. Mapping sequence reads to instances of LINE-1, 
IAP, and major satellite sequences confirms increased read abundance across these  
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Figure 2.6: pRB silences repetitive element expression. 
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Figure 2.6: pRB silences repetitive element expression. 
(A) Heat map of repeat expression from three Rb1
S/S
 MEF preparations relative to the 
average of three wild type replicates. RNA-seq reads were aligned to repeat indices, 
binned according to repClass and repFamily, and normalized to the total number of 
aligned reads in the sample. Expression was quantified as a log2 ratio relative to the 
average of three wild type replicates. (B) RNA-seq reads aligned to instances of LINE, 
IAP endogenous retrovirus, and major satellite repeats. (C) qRT-PCR of the indicated 
repetitive elements in proliferating MEFs plotted as log2 of the ratio with wild type, 
using actin as an internal control. Each MEF pair was cultured independently three times 
and expression levels for each replicate is shown to illustrate variability in expression 
between culture and genotypes. (D) Expression microarrays performed with RNA from 
arrested MEFs of the indicated genotypes. Log2 values of mutant/wild type are shown as 
a heat map to depict expression levels of endogenous retrovirus detecting probe sets on 
the arrays. 
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elements (Figure 2.6B). Furthermore, elevated transcript levels from major satellites, 
LINE-1 elements, and IAP endogenous retroviruses are readily detectable in arrested and 
proliferating cultures of Rb1
S/S
 MEFs by qRT-PCR (Figure 2.6C and 2.7A). Elevated 
LINE-1 5' UTR and IAP LTR-containing transcript levels are consistent with full length 
element expression (Figures 2.6B and 2.6C). Again, we note that MEFs from embryo 
C5137_E3 are refractory to expression in three separate analyses of these cells (Figure 
2.6C). Microarray analysis was performed to compare the specificity of endogenous 
retroviral expression in Rb1
S/S 
cells with other structure-function mutants of pRB that 
disrupt binding to the E2F transactivation domain (Rb1
G/G
) or to LXCXE motif 
containing proteins (Rb1
L/L
). This analysis reveals increased expression of repeats 
specifically in the Rb1
S/S 
mutant and not the other genotypes (Figure 2.6D). Importantly, 
expression of canonical E2F target genes appears increased only in Rb1
G/G 
and Rb1
L/L 
cells (Figure 2.7B), further emphasizing the unique alteration in gene expression found in 
Rb1
S/S 
mutants.  
These experiments demonstrate that pRB occupancy of repetitive sequences is 
functionally important for their silencing, as loss of binding correlates with increased 
expression of a wide array of repeats that are detectable using a number of expression 
profiling methods. Curiously, many examples of pRB occupancy in Figures 2.1 and 2.4 
are fragments of repetitive elements that may not be capable of autonomous expression. 
This suggests that this pRB-dependent silencing mechanism is broad and indiscriminate 
both in the elements that it silences and their potential for expression.  
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Figure 2.7: Distinct transcript expression patterns in Rb1
S/S 
cells. 
(A) Expression levels of the indicated repetitive elements was determined by qRT-PCR 
in serum starved wild type and Rb1
S/S
 MEFs. Error bars indicate +/- 1 standard deviation 
from the mean and an asterisk indicates a significant difference (t-test, P<0.05). (B) 
Expression microarrays were performed with RNA isolated from arrested MEFs of the 
indicated genotypes. Log2 values of mutant/wild type are shown as a heat map to depict 
expression levels of known pRB-E2F target genes. 
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2.4.4 H3K27me3 enrichment at repetitive sequences is pRB-
dependent 
DNA methylation and histone modifications contribute to both redundant and 
non-redundant silencing of repetitive elements. The contribution of each was assessed in 
fibroblasts from our mutant mice. ChIP was used to detect histone tail modifications 
regulated by pRB and present at repetitive elements in ES cells. While H4K20me3 and 
H3K9me3 enrichment remain unchanged between genotypes at major satellites, LINEs, 
and LTR-containing endogenous retroviruses (Figure 2.8A and 2.8B), a prominent 
reduction of H3K27me3 appears evident (Figure 2.9A). Beyond methylation, Rb1
S/S
 cells 
exhibit elevated H3K9Ac enrichment at these repetitive elements, and derepression by 
Trichostatin A further suggests that histone deacetylation functionally contributes to this 
regulation (Figure 2.8C). In contrast, H19 and Gapdh maintain equivalent enrichment of 
these histone tail modifications between genotypes.  
We performed ChIP-seq for H3K27me3 to expand upon the pRB-dependence 
observed at repetitive elements by ChIP-qPCR. Similar to pRB, the vast majority of wild 
type H3K27me3 peaks reside within intronic and intergenic regions, irrespective of 
proliferative status (Figure 2.9B). A number of distinct effects of the Rb1
S/S
 mutation on 
H3K27me3 distribution emerge from this data. H3K27me3 reductions are readily 
observed in sequence tracks over repeat-rich intergenic regions (Figure 2.9C). Many 
canonical genes regulated by H3K27me3, such as in Hox clusters, Cdkn2a, and Sox2, 
retain normal H3K27me3 enrichment in Rb1
S/S
 MEFs (Figure 2.9D and 2.8D). 
Comparison of H3K27me3 read build-up at wild type peak locations across repeat classes 
reveals diminished enrichment in Rb1
S/S
 cells, particularly under arrested growth  
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Figure 2.8: The Rb1
S/S
 mutant maintains normal H3K9 and H4K20 lysine 
methylation at repeats. 
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Figure 2.8: The Rb1
S/S
 mutant maintains normal H3K9 and H4K20 lysine 
methylation at repeats. 
(A) H3K9me3 ChIP-qPCR was performed using chromatin from wild type and Rb1
S/S
 
MEFs for the indicated repetitive families and unique location controls under arrested 
conditions. (B) H4K20me3 ChIP-qPCR of the same repetitive element families in 
arrested MEFs. (C) H3K9Ac ChIP-qPCR at the indicated repetitive sequences in arrested 
MEFs. For all graphs, error bars indicate +/- 1 standard deviation, an asterisk indicates a 
significant difference compared to wild type P≤0.05 by t-test. Wild-type MEFs were 
treated with 2.5 μM Trichostatin A for 24 hours and extracts were prepared for western 
blotting. Blots show expression of L1 Orf2p and H3K9Ac respectively. (D) Genome 
browser tracks display mouse H3K27me3 ChIP-seq reads at Cdkn2a and Sox2 loci. 
Genomic co-ordinates are indicated above the tracks. Repeat Masker and RefSeq tracks 
are shown below. Red bars denote regions of pRB enrichment (peaks) determined with 
MACS. (E) Overall genomic distribution of H3K27me3 ChIP-seq peaks at repetitive 
elements is shown for wild type MEFs, and peak retention frequency for Rb1
S/S
 is shown 
for both growth conditions. RNA repeats include tRNA, snRNA and others. N=622358 
peaks for H3K27me3 in arrested cells, n=539696 peaks for H3K27me3 in proliferating 
MEFs. 
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Figure 2.9: H3K27me3 enrichment at repetitive elements is pRB-dependent. 
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Figure 2.9: H3K27me3 enrichment at repetitive elements is pRB-dependent. 
(A) ChIP-qPCR for H3K27me3 at the indicated repetitive and unique targets in arrested 
MEFs. Error bars indicate one standard deviation from the mean and an asterisk 
represents a significant difference from wild type (P≤0.05 using a t-test). (B) Overall 
genomic distribution of H3K27me3 ChIP-seq peaks. Growth conditions are indicated 
above pie charts; n=656342 peaks in arrested cells, n=143252 peaks in proliferating cells. 
(C) Genome viewer tracks depict H3K27me3 read build up at L1 elements (highlighted 
by red boxes). Genomic co-ordinates and scale are indicated above peak tracks. (D) 
H3K27me3 distribution at a Hox gene cluster. (E) Heat maps of H3K27me3 read 
enrichment per repClass for the indicated growth conditions. Each row represents one 
scaled wild type peak location at an element within the repClass and includes ±1 kb of 
flanking region. The intensity scale indicates magnitude of read enrichment. 
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conditions (Figure 2.9E). However, some individual repeat elements disperse or broaden 
their H3K27me3 distribution, and this is more common in proliferating cells. Comparison 
of peak intersections at repetitive elements reveals that 75% of wild type H3K27me3 
peaks in repeat regions are lost in Rb1
S/S
 chromatin in both arrested and proliferating 
conditions (Figure 2.8E). The retention of reads at many repeats in proliferating Rb1
S/S
 
cells (Figure 2.9E) at magnitudes below the threshold of peak calling suggests that 
H3K27me3 becomes dispersed, but not altogether lost under proliferating conditions. 
This is important because elevated expression levels of repeats in proliferating Rb1
S/S 
cells (Figure 2.6C) suggests silencing by H3K27me3 is compromised.  
These data demonstrate an extremely broad mechanism of heterochromatin 
establishment among many distinct repeat element types. To our knowledge, DNA 
methylation is perhaps the only other mechanism that is as indiscriminate in its choice of 
sequences to silence. Therefore, we investigated the status of DNA methylation in Rb1
S/S
 
MEFs by bisulfite sequencing (Figure 2.10A and 2.10B), to determine if H3K27me3 and 
DNA methylation may be functionally related by pRB. Amplification of the same 
families of LINE-1 and IAP LTR viruses as in Figure 2.4D and 2.6C bears no obvious 
DNA methylation differences. We also cultured wild type and Rb1
S/S
 fibroblasts in the 
presence of 5-aza-cytidine to inhibit DNA methylation, and analyzed repeat expression 
by qPCR (Figure 2.10C). As expected, repeat sequence expression increases in Rb1
+/+
 
cells but not Rb1
S/S
 MEFs, suggesting that they are already derepressed.  
Our data reveals a dramatic loss of H3K27me3 organization at repetitive genomic 
sequences. The loss of H3K27me3 is similar in magnitude to loss of pRB recruitment to  
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Figure 2.10: Rb1
S/S
 mutant cells retain DNA methylation at repetitive elements. 
(A&B) Bisulfite sequencing of MEF DNA for IAP-LTR and LINE-1 families of repeats. 
Each row of circles represents a separate clone sequence. Lack of a circle in a particular 
row represents the absence of a CpG detected at that position in the clone. Black circles 
represent meCpG. (C) qRT-PCR of cDNA from total RNA of vehicle- or 5-aza-cytidine-
treated MEFs for the indicated repeat targets. Error bars indicate +/- 1 standard deviation, 
with t-test p-value indicated. 
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repeat sequences in Rb1
S/S
 fibroblasts. Our data further suggests that alterations to DNA 
methylation do not underlie widespread changes to heterochromatin in Rb1
S/S
 cells. For 
this reason, we interpret our experiments to be indicative of a mechanism for silencing 
repetitive DNA sequences that acts in parallel to DNA methylation in primary fibroblasts. 
2.4.5 pRB-chromatin association is required for EZH2 recruitment 
to repetitive sequences. 
The polycomb repressor 2 complex (PRC2) contains the enhancer of zeste 
homologue 2 (EZH2) histone methyltransferase that methylates H3K27 to establish the 
trimethylation mark. We explored whether pRB-dependent regulation of EZH2 might 
underlie epigenetic and transcriptional changes observed in Rb1
S/S
 cells. 
ChIP-seq was used to determine whether EZH2 association at repeat elements 
was affected in growth arrested Rb1
S/S
 cells. This analysis reveals that EZH2 also 
displays primarily intronic and intergenic distribution (Figure 2.11A). Across all repeat 
classes, wild type locations of EZH2 enrichment diminish in Rb1
S/S
 MEFs (Figure 
2.11B), with more than 80% of wild type peak intersections at repetitive elements lost in 
Rb1
S/S
 fibroblasts (Figure 2.12A). ChIP-qPCR confirms pRB-dependent EZH2 
association with chromatin at major satellites, LINEs, and endogenous retroviral 
sequences (Figure 2.11C). Since pRB and E2Fs control EZH2 expression (Bracken et al., 
2003; Jung et al., 2010), we confirm that EZH2 levels remain unchanged in Rb1
S/S
 MEFs, 
and therefore do not mislead our investigation of function or localization (Figure 2.12B). 
pRB-dependent EZH2 localization suggests regulation beyond transcriptional control of 
EZH2 at repetitive sequences. Indeed, ChIP-reChIP indicates that EZH2 and pRB co-
localize at LINE-1 and IAP LTRs, while chromatin association in Rb1
S/S
 MEFs is 
comparable to background (Figure 2.12D). Co-immunoprecipitation demonstrates that  
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Figure 2.11: pRB-chromatin association mediates EZH2 recruitment to repetitive 
DNA. 
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Figure 2.11: pRB-chromatin association mediates EZH2 recruitment to repetitive 
DNA. 
(A) Overall genomic distribution of EZH2 ChIP-seq peaks in arrested wild type MEFs; 
n= 840543 peaks. (B) Heat maps of EZH2 read enrichment per repClass. Each row 
represents one scaled wild type peak location at an element within the repClass that 
includes ±1 kb of flanking region. Intensity scale indicates magnitude of read enrichment. 
(C) ChIP-qPCR for EZH2 at the indicated repetitive elements. (D) ChIP-reChIP for 
EZH2 followed by pRB, quantified at the indicated repetitive elements with genetic 
knockouts as controls. (E) Two representative genomic regions depict ChIP-seq tracks 
for EZH2, pRB, and H3K27me3 in arrested MEFs. Genomic co-ordinates and scale are 
indicated above peak tracks. Red boxes highlight peak overlaps across datasets. For all 
graphs, error bars indicate one standard deviation from the mean and an asterisk 
represents a significant difference from wild type (P≤0.05 using a t-test). 
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Figure 2.12: pRB-E2F1 dependent and independent roles for EZH2. 
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Figure 2.12: pRB-E2F1 dependent and independent roles for EZH2. 
(A) Peak distribution of EZH2 ChIP-seq peaks at repetitive elements is shown for wild 
type MEFs, and peak retention frequency for Rb1
S/S
 is shown for both growth conditions. 
RNA repeats include tRNA, snRNA and others. N=465495 peaks analyzed. (B) Western 
blots of the indicated Polycomb proteins from whole cell extract of P4 MEFs of the 
indicated genotypes under the indicated growth conditions. (C) IP-western blot analysis 
to detect pRB associated with EZH2 in nuclear cell extracts from the indicated genotypes 
of MEFs. (D) ChIP-reChIP for EZH2 followed by pRB quantified at the indicated 
repetitive elements. Chromatin was derived from the indicated genotypes. Error bars 
indicate one standard deviation from the mean and an asterisk represents a significant 
difference from wild type (P≤0.05 using a t-test). (E) Heat maps of EZH2 read 
enrichment per repClass that intersect with pRB peaks. Each row represents one scaled 
wild-type peak location at an element within the repClass that includes ±1 kb of flanking 
region. Intensity scale indicates magnitude of read enrichment. (F) Graph depicting the 
percentage peak intersection between pRB and EZH2 as a proportion of total pRB peaks 
in wild type chromatin for the indicated repClass categories. (G) Graph showing log2 Δct 
values for qRT-PCR of repetitive sequence expression in tumor samples isolated from 
Rb1
S/S
 mice. 
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both wild type and pRB
S
 bind EZH2 (Figure 2.12C). In addition, ChIP-reChIP reveals 
that E2F1 deficiency prevents pRB and EZH2 co-localization to LINE-1, IAP, and major 
satellite repeats (Figure 2.12D). Collectively, this suggests a model whereby pRB
S
 can 
bind EZH2, but fails to localize to repetitive sequences because of its deficiency for 
binding E2F1, while wild type pRB is capable of both EZH2 and E2F1 interactions, 
leading to H3K27me3 deposition at repetitive locations (Figure 2.11E).  
Our data indicates that pRB, E2F1, and EZH2 are capable of forming a complex 
at repetitive genomic regions. However, while peak intersections between pRB and 
EZH2 at repetitive sequences in Rb1
S/S 
cells indicate a genetic requirement for pRB to 
recruit EZH2, they do not co-localize stoichiometrically (Figure 2.12E and 2.12F). This 
suggests that pRB and E2F1 may recruit EZH2 initially, but subsequent spreading of 
EZH2 and H3K27me3 may occur independent of pRB.  
2.4.6 Rb1S/S mice succumb to spontaneous lymphoma 
In order to determine where this repeat silencing mechanism is most relevant, we 
assessed repeat expression in tissues of adult mice using qRT-PCR (Figure 2.13A). For 
most tissues, expression varies between individuals with no consistent trend relative to 
wild type controls. However, four of eight Rb1
S/S
 mice display elevated levels of all 
repeats tested in the spleen (F241, F242, F248, and F307), while only one of eight wild 
type mice expresses repeats in this tissue (F233). This suggests that pRB dependent 
silencing may be most relevant in the spleen. However, a survey of major tissues in these 
mice, including the spleen, reveals no obvious histological differences. Given that 
expression of repetitive sequences stimulates an immune response to eliminate these 
cells, we searched for evidence of interferon activation. Figure 2.13B shows qRT-PCR  
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Figure 2.13: Altered chromatin and repeat expression in Rb1
S/S 
splenocytes. 
(A) Heat map of repeat element expression in tissues of 6-8 week old wild type and 
Rb1
S/S
 mutant mice quantified by qRT-PCR. Log2 ratio of expression is displayed 
relative to the average of all wild type measurements for a given element in each tissue. 
(B) Heat map of interferon gene expression in splenocytes from the same mice analyzed 
above. (C) H3K27me3 and H3 ChIP from freshly harvested splenocytes of 6 week-old 
wild type and Rb1
S/S 
mutant mice. Enrichment at the indicated repeat element families 
was determined by qPCR. Error bars indicate one standard deviation from the mean (n=3, 
an asterisk indicates P<0.05, t-test). 
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analysis of Ifn-α and Ifn-β expression in splenocytes. Again, expression varies between 
individuals, but we note that two Rb1
S/S 
mice display high level expression of both (F296 
and F307), further suggesting that Rb1
S/S 
mice are responding to abnormal repeat 
expression in their splenocytes. Conversely, this magnitude of interferon response is 
largely absent from wild type mice. Since normal mammalian immune function seeks to 
eliminate repeat misexpressing cells, we further sought evidence of altered repression by 
investigating H3K27me3 deposition at repetitive sequences in splenocytes. ChIP-qPCR 
assays demonstrate that H3K27me3 is reduced at IAP ERVs, LINE-1 elements, and 
major satellites, but H3 levels remain comparable between genotypes (Figure 2.13C). 
These experiments suggest that H3K27me3 is altered in chromatin from Rb1
S/S
 
splenocytes, and that repeats can be misexpressed, but these cells are likely unable to 
accumulate in young adult mice with a functional immune system. 
To determine the long-term consequences of the Rb1
S
 mutation, we generated 
cohorts of Rb1
S/S
 mutant mice and wild type siblings to monitor over the course of their 
lifetime for the manifestation of pathology. Mutant mice exhibit a significantly reduced 
tumor free survival with a median lifespan of 576 days (Figure 2.14A). Necropsy and 
histopathological analysis reveals that the majority of mice succumb to lymphomas, 
particularly in the spleen and mesenteric lymph node (Figure 2.14B). Examples of lesions 
evident upon necropsy are shown in Figure 7C as well as the normal abdominal cavity of 
an unaffected wild type mouse at 2 years of age. The corresponding histology for each 
example is shown (Figure 2.14D). In addition, qRT-PCR of RNA derived from these 
tumor samples indicates that diverse repetitive sequences are expressed in these 
malignancies (Figure 2.12G). This suggests that pRB’s ability to form complexes with  
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Figure 2.14: Aged Rb1
S/S
 mice are tumor-prone. 
(A) Kaplan-Meier plot of tumor free survival for mice of the indicated genotypes aged 
until animal protocol endpoints. Tick marks indicate animals necropsied at intermediate 
ages. Mutant mice are significantly more cancer prone than wild type (log rank test, 
P<0.05). (B) The table indicates anatomical location and cancer type listed by frequency 
of occurrence. (C) Images of the peritoneal cavity upon necropsy for the indicated 
animals. A white arrow indicates an abnormal mass in the spleen of mouse C6217. A 
dashed line highlights the mesenteric lymph node of mouse C6209. A white arrow 
indicates abnormal liver and a black arrow indicates a normal lobe in mouse C5360. (D) 
H&E staining of tissue sections from the abnormality indicated in the mutant animals 
above. A black arrow indicates the lymph node in mouse C6209. The scale bars indicate 
300µm.  
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E2F1 at repetitive sequences and establish H3K27me3 dependent silencing is highly 
relevant to its tumor suppressive functions.  
Collectively, our work suggests a model in which pRB recruits EZH2 to repeat 
sequences where it catalyzes H3K27me3 to silence expression, and a point mutation in 
pRB that blocks localization to these sequences prevents recruitment of EZH2 and causes 
dispersion of H3K27me3. Endogenously, this mechanism is important in splenocytes 
where deregulated expression of repeats is most detectable, and these cells eventually 
give rise to lymphomas in older Rb1
S/S
 mice.  
2.5 Discussion  
Our data reveals a mechanism in which pRB and EZH2 co-operate to establish 
H3K27me3 that silences expression of genomic repeat sequences. This mechanism is 
largely indiscriminate as it silences tandem repeats, such as simple sequence repeats and 
satellites, in addition to retrotransposons. These characteristics indicate that pRB-EZH2 
dependent silencing of repeats plays a broad but previously unappreciated role in genome 
organization. 
Investigation of Polycomb-based repeat regulation by H3K27me3 in mammals 
primarily concerns critical steps of early embryonic development (Leeb et al., 2010; 
Macfarlan et al., 2012). Misregulation typically manifests in defects that prevent 
embryonic development before implantation (Leeb et al., 2010; Macfarlan et al., 2012), 
or that have overt consequences in adult mice (Li et al., 2015). Lack of developmental 
impediments in Rb1
S/S
 mice, and retention of H3K27me3 at developmentally regulated 
loci, such as Hox genes and Sox2, suggests the pRB-EZH2 complex must be recruited to 
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repeats through a mechanism that is distinct from previous studies, or this pRB dependent 
mechanism is not functional in cells during early development.    
Comprehensive understanding of Polycomb function requires detailed elucidation 
of chromatin recruitment mechanisms (Bauer et al., 2015; Casa and Gabellini, 2012). 
Previous studies demonstrate that non-coding transcripts can target Polycomb repressor 
complexes to specific loci, as observed upon X-chromosome inactivation (Blackledge et 
al., 2015). Based on the co-immunoprecipitation of pRB and EZH2 and their co-
occupancy of repeats by ChIP-reChIP, it is likely that pRB directly recruits EZH2 to 
repeats. Diminished pRB binding to repeats in Rb1
S/S
 cells resulted in loss of EZH2 and 
H3K27me3 peaks, but our data also suggests that EZH2 may not stably associate with 
pRB at all of these locations and may spread H3K27me3 heterochromatin without it.  
Beyond non-coding RNAs, sequence specific transcription factors can recruit 
Polycomb to specific genomic locations to initiate such nucleation and spreading (Bauer 
et al., 2015; Casa and Gabellini, 2012). Our study indicates that E2F1 can fulfill this role, 
and while some repeats contain consensus E2F elements (Montoya-Durango et al., 2009), 
E2F1 site selection appears increasingly diverse in the post-genomic era. Early ChIP-chip 
experiments revealed considerable heterogeneity in binding sites (Bieda et al., 2006), and 
sequence-independent roles in DNA damage recognition and repair further suggest that 
E2F1 is not simply a sequence specific transcription factor (Biswas and Johnson, 2012). 
Our initial identification of pRB’s unique interaction with E2F1 was based on the 
inability of this complex to recognize a consensus E2F promoter element (Dick and 
Dyson, 2003). Major satellite repeats exemplify this in vivo where GC-rich consensus 
E2F elements are missing, but pRB and E2F1 bind cooperatively such that E2F1 binding 
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is greatly diminished without pRB (Coschi et al., 2014). Therefore, pRB-E2F1 
interactions underlie recruitment of Polycomb to repeats, however a recognition 
mechanism for E2F1 at the variety of repeat sequences identified remains unclear and is 
highly reminiscent of searches for Polycomb response elements in mammalian gene 
promoters (Bauer et al., 2015) 
The cancer susceptibility of Rb1
S/S
 mice suggests a role for pRB-EZH2 in genome 
maintenance and tumor suppression. This begs the question of how this mechanism 
functions endogenously, particularly since up regulation of repeat sequences in the spleen 
appeared quite variable. We note that elevated repetitive elements are detectable in 
splenocytes from cancer prone Tlr3, Tlr7, and Tlr9 triple deficient mice (Yu et al., 2012), 
even though chromatin dependent repression mechanisms are wild type. This implies that 
immune surveillance acts to eliminate wild type cells that sporadically express repetitive 
elements on an ongoing basis, even if their repressive mechanisms are normal. This may 
explain the high degree of variability in repeat expression found in cells deficient for 
DNA methylation or histone methylation dependent repressive mechanisms (Howard et 
al., 2008; Muotri et al., 2010; Wylie et al., 2016). In this way, splenocytes of Rb1
S/S
 mice 
may be poised to over express repeats, but are eliminated by immune detection 
mechanisms, preventing their accumulation and consistent detection of repeat expression.  
It is difficult to conclude that repeat expression alone causes cancer in Rb1
S/S
 
mice. However, there are a number of reasons to expect that a pRB-E2F1-EZH2 complex 
has cancer relevant properties. First, the preference for lymphomas and age of onset in 
Rb1
S/S
 mice phenotypically parallels E2f1
-/-
 mice (Yamasaki et al., 1996). Missense 
alleles in human RB1 are rare, so it is not surprising that the Rb1
S
 allele is absent from 
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cancer genome datasets. However, a low penetrance RB1 family has been reported to 
possess exon 24 and 25 deletions (Bremner et al., 1997) that eliminate pRB’s unique 
binding domain for E2F1(Cecchini and Dick, 2011; Julian et al., 2008). Similarly, 
multiple instances of D295 substitutions in DP1 (Munro et al., 2014) indicate that the 
unique contact point for E2F1/DP1 with pRB is directly targeted in human cancers. 
Lastly, other Rb1 targeted strains that compromise E2F transcriptional control at 
canonical cell cycle target genes, such as Rb1
G/G 
(Cecchini et al., 2014), or that are prone 
to unstable genomes related to defective chromatin condensation, as in Rb1
L/L
 and 
Rb1
NF/NF  
mice (Coschi et al., 2010; Vormer et al., 2014), are not spontaneously cancer 
prone. Since only Rb1
S/S
 cells misexpress repeat sequences among these genotypes, and 
repeat expression is most pronounced in the cancer prone tissue of Rb1
S/S
 mice, these data 
point to a very strong correlation between defective pRB-EZH2 repeat suppression and 
cancer incidence.   
 Likely the most significant implication for our work is the relationship between 
RB1 status and the effects of new EZH2 inhibitors. We anticipate that EZH2 inhibitors 
will cause widespread derepression of repetitive sequences in pRB positive cancers as 
reported for inhibitors of DNA methylation (Chiappinelli et al., 2015; Roulois et al., 
2015), and this may offer a new pathway to sensitize tumors to immunotherapy. 
Furthermore, our work suggests EZH2 inhibitors may have activity as anti-viral agents as 
they may awaken latent viral genomes. This manuscript reveals an exciting new 
connection between a canonical tumor suppressor and heterochromatin formation that 
further supports repetitive element silencing as a cancer relevant process. 
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Chapter 3  
3 Disruption of CDK-resistant chromatin association by 
pRB causes DNA damage, mitotic errors, and reduces 
Condensin II recruitment 
3.1 Abstract  
Organization of chromatin structure is indispensible to the maintenance of genome 
integrity. The retinoblastoma tumor suppressor protein (pRB) mediates both 
transcriptional repression and chromatin organization, but the independent contributions 
of these functions have been difficult to study. Here, we utilize a synthetic Rb1 mutant 
allele (F832A) that maintains pRB association at cell cycle gene promoters, but disrupts a 
cyclin-dependent kinase (CDK)-resistant interaction with E2F1 to reduce occupancy of 
pRB on intergenic chromatin. Reduced pRB chromatin association increases spontaneous 
γH2AX deposition and aneuploidy. Our data indicates that the CDK-resistant pRB-E2F1 
scaffold recruits Condensin II to major satellite repeats to stabilize chromatin structure in 
interphase and mitosis. In its absence, pericentromeric major satellite repeats are enriched 
with γH2AX, but LINE and ERV repeats remain free of this DNA damage marker. This 
suggests that DNA damage phenotypes in Rb1 F832A mutant cells are mechanistically 
distinct from silencing of repetitive sequence expression.  
3.2 Introduction 
Regulated alterations in chromatin structure during the cell cycle ensure coordination 
of transcription, DNA replication, and segregation of chromosomes in mitosis. 
Perturbations to broad mechanisms of chromatin organization that disrupt the careful 
coordination of these processes are often observed in concert with genome instability 
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(Papamichos-Chronakis and Peterson, 2013). This state of instability, characterized by 
persistent DNA damage, often precedes tumorigenesis (Jackson and Bartek, 2009). In this 
regard, it is not surprising that genes encoding broad organizers of chromatin structure 
are often classified as tumor suppressors. 
In human cancer, a frequent target for disruption or misregulation is the 
retinoblastoma protein (pRB) (Dyson, 2016). Primary fibroblasts deficient for pRB 
exhibit relaxed chromatin structure (Herrera et al., 1996), along with replication defects 
and reduced chromatin compaction in prophase and chromosome segregation errors 
(Coschi et al., 2014; Coschi et al., 2010; Longworth et al., 2008; Manning et al., 2010; 
Manning et al., 2014). These changes are often accompanied by manifestations of 
genome instability, such as aneuploidy and widespread DNA damage (Coschi et al., 
2014; Manning et al., 2014; van Harn et al., 2010). However, since pRB exerts 
transcriptional control over S- and M- phase cell cycle targets through E2Fs (Hernando et 
al., 2004; Schvartzman et al., 2011), genetic models of pRB deficiency may not 
distinguish the mechanistic contributions of pRB chromatin regulation from pRB-E2F 
transcriptional control in the maintenance of genome integrity. Thus, the ability to 
determine contributions of pRB chromatin organization to maintenance of genome 
stability requires specific loss-of-function models that maintain E2F transcriptional 
control and cell cycle regulation.  
To regulate chromatin structure, pRB serves as a scaffold for a number of regulatory 
complexes that methylate DNA, modify histone tails, or mediate topological remodeling 
of nucleosomes (Longworth and Dyson, 2010). DNA-binding proteins, such as 
transcription factors, mediate region-specific pRB-chromatin association (Talluri and 
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Dick, 2012). This recruitment is predominantly mediated by E2F transcription factors. 
However, pRB-E2F complexes dissociate at the G1-S transition in response to cyclin-
dependent kinase (CDK) phosphorylation. Recent evidence indicates that pRB uses an 
alternate CDK-resistant interaction with E2F1 to associate with repetitive elements 
(Calbo et al., 2002; Cecchini and Dick, 2011; Coschi et al., 2014; Ianari et al., 2009; 
Ishak et al., 2016). Germline disruption of this interaction abrogates EZH2-mediated 
facultative heterochromatinization at repetitive elements in concert with repeat 
misexpression and lymphomagenesis in mice (Ishak et al., 2016). The cancer 
susceptibility observed upon loss of CDK-resistant pRB-chromatin association merits 
investigation into whether this pRB-E2F1 interaction might underlie other pRB-
dependent activities that impact genome integrity. 
Here, we report that disruption of pRB’s unique interaction with E2F1 causes the 
accumulation of γH2AX foci, aneuploidy, increased RPA phosphorylation, and mitotic 
defects. Importantly, E2F target genes involved in DNA replication and mitosis remain at 
normal expression levels. We demonstrate that cells bearing an F832A mutation in Rb1 
(Rb1
S
) exhibit impaired chromatin recruitment of the Condensin II complex specifically 
at genomic locations where γH2AX accumulates. This mechanism further suggests that 
chromatin organization is an indispensible facet of pRB-mediated tumor suppression. 
3.3 Experimental Procedures 
3.3.1 Cell culture 
Gene targeted mouse strains bearing a null allele of Rb1 (Rb1
tm1Tyj
) and an F832A point 
mutation to disrupt pRB’s unique interaction with E2F1 (Rb1S, or Rb1tm3Fad) have been 
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previously described (Ishak et al., 2016; Jacks et al., 1992). Primary murine embryonic 
fibroblasts (MEFs) were isolated and cultured from E13.5 embryos of the desired 
genotypes according to established procedures (Thwaites et al., 2016).  All experiments 
were performed on passage 4 (P4) cells. 
3.3.2 Fluorescence microscopy 
Immunofluorescence was conducted as previously described (Coschi et al., 2014). 
Briefly, 2.5x10
5
 MEFs were seeded per confocal dish, incubated 24h, washed 3x for 5 
minutes in 1x PBS, fixed by incubation with 4% paraformaldehyde in 1x PBS for 10 
minutes at room temperature, then washed and stored at 4°C. To immunostain, cells were 
permeabilized for 10 minutes with 0.3% Triton X-1000 in 1xPBS (PBS-T), blocked for 1 
hour at room temperature with 5% goat serum in PBS-T, incubated one hour with mouse 
anti-Phospho histone H2A.X Ser139 (05-636, Millipore) diluted 1:400 in PBS-T, washed, 
and incubated one hour in goat anti-mouse Alexa Fluor 594 secondary antibody diluted 
1:800 in PBS-T. Cells were washed 3x for 5 minutes with PBS-T, then incubated 5 
minutes with DAPI in PBS-T. Stained MEFs were washed 3x with PBS-T, twice with 1x 
PBS, then mounted with a coverslip using SlowFade® Gold antifade reagent (S36937, 
Life Technologies). Fluorescence was visualized using an Olympus Fluoview FV1000 
confocal microscope system, with images compiled using Olympus Fluoview FV1000 
Viewer. γH2AX foci were quantified using the focinator program (Oeck et al., 2015) with 
fixed thresholds and parameters maintained across all groups in a given experiment.  
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3.3.3 Flow cytometry 
Asynchronous or serum starved MEFs were ethanol-fixed, stained with propidium iodide, 
treated with RNase, strained, and analyzed by flow cytometry on a Beckman-Coulter 
EPICS XL-MCL (Cecchini et al., 2012).  
3.3.4 Detection of RNA and protein levels 
RNA levels were determined by Affymetrix Mouse Gene 1.0 Array as previously 
described using rRNA-depleted total RNA from serum starved P4 MEFs (Cecchini et al., 
2014) (Ishak et al., 2016). Log2 values of mutant/wild-type expression determined with 
Partek Genomics Suite were plotted as heat maps using matrix to PNG at 
chibi.ubc.ca/matrix. Array CEL files are available at GSE85640 and GSE54924. To 
assess protein levels, whole-cell lysates and chromatin fractions were generated as 
previously described (Ishak et al., 2016), resolved by SDS-PAGE, and immunoblotted 
using the following antibodies: RPA32 (A300-244A, Bethyl labs), RPA32 pSer33 (A300-
246A, Bethyl labs), H3, (ab1791, Abcam), Actin (A2066, Sigma), PCNA (F-2 Santa 
Cruz), Mcm3 (4012S, Cell Signaling), Mcm7 (H-5, Santa Cruz), BubR1 (C-20, Santa 
Cruz), Cdk1 (ab7953 abcam), Mad2 (C-19, Santa Cruz), CAP-D3 (Coschi et al., 2010), 
SMC2 (Coschi et al., 2014). 
3.3.5 Chromatin immunoprecipitation and ChIP-seq analysis 
Chromatin immunoprecipitation experiments and analyses were conducted as previously 
described (Ishak et al., 2016). Briefly, cross-linked chromatin fragments were pre-cleared 
with protein G Dynabeads for immunoprecipitation with ChIP antibodies. Cross-links 
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were reversed at 65°C followed by DNA isolation. For ChIP-reChIP experiments, 
crosslinks were maintained following the first immunoprecipitation. Protein-DNA 
complexes were eluted, and subjected to a second immunoprecipitation with a different 
antibody. DNA was isolated as described for single-IP ChIP. deepTools was used to 
generate heat maps depicting ChIP-seq read enrichment at wild-type peak locations. 
bamCompare was used to normalize ChIP to input reads, then computeMatrix was used 
to determine read enrichment at wild-type repeat peak intersects with the mm9 
RepeatMasker index from UCSC Table Browser. heatMapper was used to plot 
enrichment per peak location (Ramirez et al., 2014). Reads are available at GSE85640. 
ChIP antibodies used were anti-phospho histone H2A.X Ser139 (07-164, Millipore), anti-
CAP-D3 (Coschi et al., 2010), and a previously described cocktail of pRB antibodies 
(Cecchini et al., 2014). ChIP-qPCR primer sources have been previously described 
(Cecchini 2014, Ishak 2016 references). Sequences 5- to 3' are as follows: PCNA_E2F_F 
CAGAGTAAGCTGTACCAAGGAGAC, PCNA_E2F_R 
CGTTCCTCTTAGAGTAGCTCTCATC, PCNA_-2kb_F 
CATCAGTGAATACGTCTCTGTTCCA, PCNA_-2kb_R 
CTGCTTCTCAGTTGTTTTAGGAAGG, Maj_F 
GACGACTTGAAAAATGACGAAATC, Maj_R 
CATATTCCAGGTCCTTCAGTGTGC, L1 5' UTR_F 
CTGCCTTGCAAGAAGAGAGC, L1 5' UTR_R AGTGCTGCGTTCTGATGATG, IAP 
LTR_F CTGACAGCTGTGTTCTAAGTGGTAAACAAA, IAP LTR_R 
AGAACACCACAGACCAGAATCTTCTGC 
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3.3.6 Video Microscopy 
Video microscopy was conducted as previously described (Coschi et al., 2010). Briefly, 
MEFs infected with ecotropic retroviruses carrying pBABE-H2B-GFP packaged in 
Bosc23 cells were plated into glass-bottom tissue culture dishes in phenol-free DMEM 
with 5% FBS, penicillin, streptomycin, and glutamine. Cells were maintained at 37°C 
with 5% CO2 as phase-contrast and fluorescent images were captured every 3 minutes for 
15 hours by a DMI 6000b Leica microscope. Images were assembled into movies and 
analyzed for mitotic errors. 
3.4 Results 
3.4.1 The Rb1S mutation causes defects in genome integrity  
To assess the contribution of pRB-E2F1 interactions in chromatin association and its 
effects on genome stability, we utilized a previously described mutation (F832A, called 
Rb1
S
) that disrupts pRB’s unique C-terminal interaction with the E2F1 marked box 
domain (Cecchini and Dick, 2011; Coschi et al., 2014; Ishak et al., 2016). ChIP-sequence 
of pRB from wild type and Rb1
S/S
 cells was analyzed. Alignment of pRB ChIP-seq reads 
reveals locations of pRB enrichment within repetitive elements throughout the genome 
and these are lost in ChIP-seq using pRB
S
 (Figure 3.1A). Strikingly, this pattern of repeat 
occupancy by pRB is relatively preserved under proliferating conditions. In contrast, pRB 
ChIP-qPCR demonstrates that pRB
S
 retains occupancy at cell cycle and E2F regulated 
promoters, such as Pcna, at levels comparable to that of wild-type pRB (Figure 3.1B) 
(Ishak et al., 2016). Therefore, in contrast to previous models of pRB-deficiency,  
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Figure 3.1: Disruption of pRB association with repetitive sequences. 
(A) Heat maps display scaled pRB ChIP-seq read build ups. Wild-type pRB read build 
ups are shown for mm9 RepeatMasker index locations. Each row contains ± 0.5 kb of 
flanking sequence surrounding the scaled reads. Intensity scales on right indicate the 
magnitude of read enrichment over input control. Heat maps of Rb1
S/S 
mutant ChIP-seq 
reads display occupancy at the analogous wild type positions under arrested and 
proliferating conditions. (B) pRB ChIP-qPCR analyzing amplicons at the Pcna 
transcriptional start site (TSS) and 2 kb 5' of Pcna. Error bars indicate one standard 
deviation from the mean, and an asterisk represents a significant difference from wild 
type (n = 3, P≤0.05 by t-test). 
  
128 
the Rb1
S
 mutation permits assessment of post-G1 pRB-chromatin regulatory activities 
independent of E2F cell cycle gene association and regulation.  
We investigated a number of broad measures of genome integrity in Rb1
S/S
 MEFs 
relative to controls. Since Rb1
-/-
 cells exhibit aneuploidy with increasing rounds of cell 
division (Srinivasan et al., 2007), we sought to determine whether loss of pRB-chromatin 
association at non-cell cycle genes could cause a similar effect. To assess cellular DNA 
content, proliferating and serum-starved MEFs were stained with propidium iodide and 
analyzed by flow cytometry. DNA content greater than the 4N peak was quantified to 
determine the proportion of aneuploid cells. In accordance with previous reports, Rb1
-/-
 
MEFs exhibit significantly elevated levels of >4N DNA. Intriguingly, Rb1
S/S
 MEFs also 
exhibit increased levels of >4N DNA relative to wild-type MEFs under arrested and 
proliferating growth conditions, albeit at levels less than those of Rb1
-/-
 MEFs (Figure 
3.2A).  
Another broad manifestation of genome instability observed upon pRB loss is the 
emergence of γH2AX foci in fluorescence microscopy experiments. Immunofluorescence 
revealed increased γH2AX foci in proliferating Rb1S/S MEF cultures comparable in 
magnitude to Rb1
-/-
 MEFs, with approximately 10% of nuclei displaying 5 or more foci 
(Figure 3.2B and 3.2C). Increased γH2AX foci together with elevated >4N DNA content 
in Rb1
S/S
 cells suggests pRB-E2F1 complexes might mediate post-G1 functions. Post-G1, 
pRB reduces DNA damage through mitigation of replication stress via mechanisms that 
remain poorly understood (Bester et al., 2011; Coschi et al., 2014; Manning et al., 2014). 
To explore the effects of reduced pRB chromatin association on replication, we assessed  
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Figure 3.2: Loss of genome integrity in Rb1
S/S 
mutant cells. 
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Figure 3.2: Loss of genome integrity in Rb1
S/S 
mutant cells. 
(A) Cells were stained with propidium iodide and analyzed by flow cytometry for DNA 
content. The histogram shows gates to demarcate cells with >4N DNA content. 4N DNA 
content was determined for the indicated genotypes of cells. Error bars indicate one 
standard deviation from the mean, and an asterisk represents a significant difference from 
wild type compared within the same growth condition (n = 3, P≤0.05 by t-test). (B) 
Immunofluorescence microscopy of proliferating MEFs stained for γH2AX (red) and 
DAPI (blue). White boxes indicate regions shown at increased magnification within the 
inset. Scale bars indicate relative magnification. (C) The number of γH2AX foci per 
nucleus was quantified and compared among three biological replicates per genotype 
using a χ2 test (Rb1+/+ n = 1054, Rb1S/S n = 744, Rb1-/- n = 602 total nuclei analyzed). (D) 
Western blots show RPA32 pSer33 levels for the indicated genotypes from arrested and 
proliferating MEFs. The Actin blot serves as a loading control. (E) RPA32 pSer33 and 
RPA32 western blots of chromatin fractions from proliferating MEFs. Histone H3 blot 
indicates loading. 
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relative phosphorylation levels of the single-strand DNA binding protein RPA. Western 
blots of whole cell extracts reveal increased levels of RPA32 pS33 under proliferating 
conditions relative to arrested wild-type MEFs. This proliferation-dependent RPA32 
pS33 increase appears further elevated in Rb1
S/S
 MEFs relative to control cells (Figure 
3.2D). Strikingly, western blots of chromatin fractions revealed that the elevated RPA32 
pS33 in mutant MEFs can be detected on chromatin at levels comparable to that of Rb1
-/-
 
MEFs (Figure 3.2E). 
In pRB deficient cells, misregulation of E2F transcriptional control of DNA 
replication components contributes to aneuploidy (Srinivasan et al., 2007). However, in 
accordance with pRB
S
 association with cell cycle promoters in ChIP experiments, 
microarray analysis revealed normal regulation of E2F targets involved in DNA 
replication in arrested Rb1
S/S
 MEFs (Figure 3.3A). In contrast, Rb1
-/-
 MEFs exhibited 
deregulation of DNA replication components under the same culture conditions (Figure 
3.3A). Beyond mRNA levels, western blots of whole cell extracts confirmed expression 
levels of DNA replication components in Rb1
S/S
 MEFs paralleled those in wild-type 
MEFs under both arrested and proliferating conditions, and contrasted with the 
pronounced misregulation evident upon complete loss of pRB expression (Figure 3.3B).  
Collectively, these observations suggest that reduced pRB-chromatin association 
under proliferating growth conditions increases the frequency of events that can 
compromise genome integrity. Expression analysis suggests that these effects in Rb1
S/S
 
MEFs are independent of E2F transcriptional control of DNA replication genes. 
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Figure 3.3: Normal expression of DNA replication targets of pRB-E2F. 
(A) Expression microarrays were performed with RNA from serum-starved MEFs of the 
indicated genotypes and wild type controls (n = 3). For each gene listed, corresponding 
log2 values of each mutant replicate vs. wild type is shown as a heat map. (B) Western 
blots indicate PCNA, Mcm3, and Mcm7 levels detected in whole-cell extracts from 
arrested and proliferating MEFs. The Actin blot serves as a loading control. 
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3.4.2 Rb1S mutant cells exhibit defects in mitosis. 
Beyond replication, pRB maintains proper chromosome segregation through 
coordination of multiple mitotic processes such as the regulation of E2F-activated spindle 
assembly checkpoint targets, and regulation of chromosome condensation (Manning and 
Dyson, 2012). We investigated whether the Rb1
S
 mutation affected mitosis. To visualize 
mitotic progression, wild-type and mutant MEFs were transduced with GFP-tagged H2B 
using viral delivery, and subjected them to live-cell video microscopy. Analysis of Rb1
S/S
 
cells revealed a marked defect in chromosome condensation apparent in prophase that 
frequently impeded chromosome congression at metaphase (Figure 3.4A and 3.4B). We 
next analyzed mitotic chromosome segregation. Figure 3.4C shows examples of normal 
mitotic stages and cell division observed by video microscopy in wild-type MEFs. These 
microscopy experiments revealed numerous mitotic aberrations present in Rb1
S/S
 MEFs 
such as chromosome bridges in anaphase, partial segregation of chromosomes, as well as 
missegregation of all chromosomes to one daughter, or failure of cytokinesis leading to 
binucleated cells (Figure 3.4D and 3.4E). Ultimately, the majority of mitotic Rb1
S/S
 MEFs 
fail to faithfully segregate duplicated chromosomes to their daughter cells, while over 
90% of wild-type MEFs displayed proper mitotic progression in this assay (Figure 3.4E). 
Mitotic errors such as lagging chromosomes and missegregation events contribute to 
the generation of micronuclei (Holland and Cleveland, 2012). To determine whether 
mitotic errors in Rb1
S/S
 cells were associated with the accumulation of micronuclei, MEFs 
were fixed and stained with DAPI for fluorescence-based visualization. Quantification of 
micronuclei revealed a significant increase in Rb1
S/S
 cells relative to wild type (Figure  
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Figure 3.4: Defective mitosis in Rb1
S/S 
mutant cells. 
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Figure 3.4: Defective mitosis in Rb1
S/S 
mutant cells. 
Mitosis was investigated by video microscopy experiments using MEFs transduced with 
H2B-GFP (Rb1
+/+
 n = 19, Rb1
S/S  
n = 15). (A) Merged images of phase-contrast and GFP 
channels display examples of chromosome condensation in prophase for indicated 
genotypes. (B) Quantitation of the frequency of condensation errors observed in wild 
type and Rb1
S/S
 MEFs. (C) Merged images of phase-contrast and GFP channels display 
examples of normal mitotic stages observed in wild type cells are shown. (D) Merged 
images of phase-contrast and GFP channels to demonstrate examples of defective 
anaphase and cytokinesis observed by video microscopy. (E) Quantitation of segregation 
events observed in wild type and Rb1
S/S
 MEFs. (F) Fluorescence microscopy of 
proliferating MEFs stained with DAPI (blue). White arrows demark examples of 
micronuclei while scale bars indicate relative magnification. (G) Quantitation of 
micronuclei frequency visualized by immunofluorescence microscopy. Error bars 
indicate one standard deviation from the mean, and an asterisk represents a significant 
difference from wild type (P≤0.05 by t-test, n = 3). 
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3.4F and 3.4G). However, the increase observed in mutant cells does not exceed the 
magnitude of micronuclei present in Rb1
-/-
 cells (Figure 3.4G). 
We next assessed whether misregulation of E2F mitotic target gene expression might 
underlie the mitotic errors observed upon reduction of pRB-chromatin association. Akin 
to DNA replication components, microarray analysis revealed normal expression of E2F 
mitotic checkpoint targets in Rb1
S/S
 MEFs that contrasted with the misexpression 
observed in Rb1
-/-
 MEFs (Figure 3.5A). Western blots of whole cell extracts confirmed 
that expression levels of mitotic checkpoint proteins in Rb1
S/S
 MEFs resembled 
expression levels observed in wild-type fibroblasts. Accordingly, Rb1
-/-
 cells exhibit 
misexpression of E2F mitotic checkpoint targets at the protein level (Figure 3.5B). 
Overall, lack of mitotic checkpoint misexpression in the presence of mitotic errors 
suggests that pRB-chromatin association facilitates mitotic progression independently of 
E2F transcriptional control.  
3.4.3 pRB-E2F1 recruits Condensin II to major satellites to 
mitigate DNA damage.  
In light of the post-G1 defects apparent upon diminished pRB
S
 chromatin 
association, we sought to identify a pRB-dependent mechanism that could link increased 
γH2AX, increased RPA32 pS33, and mitotic defects observed in Rb1S/S cells. Since pRB 
serves as a recruitment factor for numerous chromatin regulators including Condensin II 
(Coschi et al., 2014; Coschi et al., 2010; Longworth et al., 2008), we investigated its 
recruitment to sites of γH2AX deposition. First, to determine whether Condensin II 
exhibited sensitivity to diminished pRB-chromatin association, we assessed the 
expression of Condensin II subunits. Western blots of whole cell extracts from arrested  
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Figure 3.5: Normal expression of mitotic pRB-E2F target genes. 
(A) Expression microarrays were performed with RNA from serum-starved MEFs of the 
indicated genotypes and wild type controls (n = 3). For each gene listed, corresponding 
log2 values of each mutant replicate vs. wild type is shown as a heat map. (B) Western 
blots indicate BubR1, Mad2, and Cdk1 levels detected in whole-cell extracts from 
proliferating MEFs. The Actin blot serves as a loading control. 
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and proliferating MEFs revealed no differences in CAP-D3 and SMC2 expression in 
mutant cells relative to wild type controls (Figure 3.6A). We next assessed whether the 
Rb1
S
 mutation affected Condensin II recruitment to chromatin. Western blots of 
chromatin fractions revealed that relative to the arrested state, both CAP-D3 and SMC2 
exhibited increased chromatin loading in proliferating wild-type MEFs. Notably, this 
proliferation-dependent increase in Condensin II chromatin loading is diminished in 
Rb1
S/S
 cells (Figure 3.6B). We then used  ChIP-reChIP to determine whether reduced 
Condensin II loading on chromatin in mutant cells was due to a direct pRB-mediated 
recruitment mechanism. ChIP for CAP-D3 followed by ChIP for pRB confirms that 
CAP-D3 localizes with pRB to pericentric major satellite repeats in wild type MEFs. 
pRB-CAP-D3 co-recruitment is significantly reduced in Rb1
S/S
 MEFs, consistent with the 
global reduction of Condensin II loading observed in chromatin fractions (Figure 3.4C).  
Condensin II-mediated regulation of replication and chromosome condensation 
requires chromatin loading. We hypothesized that genomic locations of pRB-dependent 
Condensin II association, such as pericentric repeats, would be particularly sensitive to 
accumulation of γH2AX upon reduction of Condensin II recruitment. ChIP-qPCR 
demonstrates a relative increase in γH2AX at major satellite repeats in proliferating 
Rb1
S/S
 MEFs, while γH2AX levels in wild-type MEFs do not exceed background levels 
(Figures 3.6D). By comparison, γH2AX ChIP-qPCR experiments demonstrated that 
DNA damage is not increased at LINE1 or endogenous retroviral repeats in Rb1
S/S
 cells 
(Figure 3.6E and 3.6F). This indicates that only specific genomic locations accumulate 
γH2AX in response to the Rb1S mutation rather than all repeat locations occupied and  
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Figure 3.6: Recruitment of CAP-D3 by pRB mitigates DNA damage at 
pericentromeric major satellite repeats. 
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Figure 3.6: Recruitment of CAP-D3 by pRB mitigates DNA damage at 
pericentromeric major satellite repeats. 
(A) CAP-D3 and SMC2 levels were detected by western blotting whole-cell extracts 
from arrested and proliferating MEFs. The Actin blot serves as a loading control. (B) 
CAP-D3 and SMC2 western blots of chromatin fractions. Coomassie-stained histones are 
used as a loading control. (C) CAP-D3-pRB ChIP-reChIP was performed using 
chromatin from proliferating MEFs and occupancy was quantified at pericentromeric 
major satellite repeats by qPCR. Error bars indicate one standard deviation from the 
mean, and an asterisk represents a significant difference from wild type (n = 3, P≤0.05 by 
t-test). (D) γH2AX ChIP-qPCR was performed using chromatin from proliferating MEFs 
and quantified at pericentromeric major satellite repeats and normalized to IgG ChIP 
performed in parallel from same chromatin preparation. (E and F) γH2AX ChIP-qPCR as 
in D except occupancy was quantitated at L1 5' UTRs and IAP LTRs. 
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regulated by pRB. Overall, site-specific γH2AX accumulation at locations of pRB-
Condensin II loss in Rb1
S/S
 MEFs suggests that the CDK-resistant pRB-E2F1 complex 
mediates Condensin II recruitment to pericentromeric repeats to support genome 
integrity. Loss of this recruitment event is associated with the onset of DNA damage and 
mitotic errors that are prevalent in Rb1
S/S
 MEFs, and the contributions of this mechanism 
to cancer susceptibility in Rb1
S/S
 mice is likely significant.  
3.5 Discussion 
The original null alleles of Rb1 in mice revealed that it was indispensable to the 
maintenance of genome integrity (Zheng et al., 2002). However, deregulation of E2F cell 
cycle targets concurrent with loss of genome stability hindered the ability to assess 
whether pRB could maintain genome integrity independent of E2F transcriptional 
control. Here, we utilized a synthetic Rb1 mutant allele that maintains pRB association at 
E2F cell cycle targets, but reduces overall pRB-chromatin association at intergenic 
regions (Ishak et al., 2016). We demonstrate that cells from these mice possess inherently 
unstable genomes characterized by markers of DNA damage, replication abnormalities, 
and aneuploidy.  
Elevated RPA32 pS33 in Rb1
S/S 
chromatin is suggestive of DNA replication defects. 
pRB-E2F1-dependent Condensin II recruitment prevents many features that are 
characteristic of ‘under replication’ of pericentric repeats (Coschi et al., 2014; Harrigan et 
al., 2011; Lukas et al., 2011). It remains to be explored whether the pRB-E2F1 scaffold 
underlies other pRB interactions with replication components that may also contribute to 
spontaneous DNA damage. pRB restricts DNA replication initiation and progression 
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through its interaction with Mcm7 and its ability to suppress DNA polymerase α and Ctf4 
recruitment to replisomes (Borysov et al., 2015). It has also been shown that pRB 
associates with Orc1 at replication origins (Avni et al., 2003; Mendoza-Maldonado et al., 
2010). Finally, pRB can displace PCNA to halt progression of the replication fork 
(Braden et al., 2006). If the pRB-E2F1 scaffold mediates these interactions, it is possible 
that they also contribute to RPA32 pS33 and γH2AX at pericentric repeats.  
We note a significant failure of Rb1
S/S 
cells to condense chromosomes that precedes 
numerous chromosome segregation defects. These defects parallel mitotic errors 
observed in other models that are deficient for pRB-Condensin II recruitment to 
chromatin (Coschi et al., 2010; Longworth et al., 2008; Manning et al., 2010). 
Collectively, these data suggest that pRB-E2F1 forms a scaffold to permit Condensin II 
interaction with the pRB LxCxE binding cleft. Despite characterization of chromatin 
recruitment, mechanistic details of pRB-Condensin II association remain poorly 
understood. However, these phenotypes and the ensuing lymphoma in Rb1
S/S 
mice has 
intriguing similarities to recent studies examining a hypomorphic CAP-H2 mutant mouse 
strain (called Nessy) (Woodward et al., 2016), as well as lymphomas from E2f1
-/-
 mice 
(Yamasaki et al., 1996). E2f1
-/-
 mice frequently succumb to follicular B-lymphomas 
evident in the mesenteric lymph node and this is a common finding in Rb1
S/S 
mice (Ishak 
et al., 2016; Yamasaki et al., 1996). Nessy, or Caph2
I15N
 mutant mice, have lineage-
specific delayed anaphase entry that manifests as aneuploid CD4
+/lo
;CD8
+
;CD71
+
 thymic 
T-cells that develop into lymphomas in adult animals (Woodward et al., 2016). It will be 
interesting to understand the subtle differences in tissue tropism between the Rb1
S/S 
and 
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Nessy mice, although other pRB-E2F1 containing complexes recruited to chromatin 
likely underlie some of these differences. 
Our observations contribute to a growing body of literature that challenges 
classification of pRB as ‘inactive’ beyond entry into S-phase. In addition to Condensin II, 
the pRB-E2F1 scaffold also recruits EZH2 to repetitive elements in cycling cells (Ishak et 
al., 2016). We envision that disruption of both complexes likely contributes to the cancer 
phenotype in Rb1
S/S 
mice. First, loss of Condensin II recruitment and instability 
phenotypes are found in Rb1 mutant mice with defective LxCxE interactions (Rb1
L
), but 
this defect is insufficient to trigger cancer on its own (Coschi et al., 2014). In this study 
we show that instability phenotypes found in Rb1
S/S 
cells are most attributable to defects 
in Condensin II recruitment as γH2AX accumulates preferentially in pRB-E2F1-
Condensin II locations, yet Rb1
S/S
 mice are cancer prone. An important difference 
between Rb1
S/S
 and Rb1
L/L  
mutant mice is repeat misexpression that predominantly 
occurs in the spleens of Rb1
S/S 
mice where the majority of tumors arise. Based on this 
reasoning, we expect that loss of both pRB-E2F1-Condensin II and pRB-E2F1-EZH2 
complexes caused by the F832A mutation are both necessary to cause the cancer 
phenotype observed in Rb1
S/S
 mice. Collectively, this body of work further emphasizes 
the multifunctionality of pRB and how its disparate activities work together to underlie 
its tumor suppressor role.  
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Chapter 4  
4 Disruption of the CDK-resistant pRB-E2F1 scaffold up-
regulates L1 ORF2p, interferon response genes, and shifts 
tumor spectrum of Trp53
-/-
 mice 
4.1 Introduction 
Misexpression of endogenous repetitive elements threatens the stability of the host 
genome through numerous means. To prevent such deleterious effects, host genomes 
employ epigenetic silencing mechanisms to repress repetitive element activity(Slotkin 
and Martienssen, 2007). Perturbance of these mechanisms invokes an additional layer of 
defenses in which endosomal toll-like receptors (TLRs) and cytosolic RIG-I-like 
receptors (RLRs) detect nucleic acids of foreign origin to initiate an interferon (IFN) 
response that culls affected cell populations (Shen et al., 2015; Young et al., 2012; Yu et 
al., 2012). While this cascade is generally utilized upon ectopic viral detection, specific 
effectors distinguish an endogenous retrovirus (ERV)-specific TLR response. TLR7 
ensures production of ERV-specific antibodies, while TLR3 and TLR9 modulate ERV 
antibody response to propagate a type I IFN response. Mice deficient for these three 
TLRs succumb to T-cell acute lymphoblastic leukemia (T-ALL) that bear novel ERV re-
integrations (Yu et al., 2012).  
Studies using epigenetic modifiers have revealed the effect of redundancy on 
induction of the ERV-specific innate immune response. Observations of repetitive 
sequence resurrection following radiation or chemotherapy first suggested that genomic 
insults could suffice to disrupt repetitive sequence silencing (Vabret et al., 2016). 
Subsequent investigations with epigenetic inhibitors, such as inhibitors of histone de-
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acetylases (HDACs) or DNA methyltransferases (DNMTs), identified redundant and 
non-redundant effectors of repetitive sequence silencing. It became clear that targeted 
disruption of these effectors could activate the ERV-specific innate immune response in a 
dose-dependent manner (Chiappinelli et al., 2015; Roulois et al., 2015; Saito et al., 2016). 
More specifically, alleviation of non-redundant silencing mechanisms enhanced the 
interferon response (Desai et al., 2017; Leonova et al., 2013). While this IFN response 
initially serves as a negative selection pressure, constitutive IFN activation becomes 
antagonistic towards this end, sustaining cell populations that harbour nucleic acids of 
foreign origin (Vabret et al., 2016). Despite extensive characterization, the mechanisms 
by which epigenetic effectors target mutually exclusive repeats, and the biological 
contexts in which they are perturbed to activate the IFN response remain poorly 
understood. 
Recent evidence suggests that common inactivating events in cancer may disrupt 
chromatin organization at repetitive sequences (Levine et al., 2016). The p53 tumor 
suppressor protein suppresses retrotransposon expression and transposition through 
H3K9me3 deposition (Botcheva and McCorkle, 2014; Leonova et al., 2013; Wylie et al., 
2015). Recent discovery of pRB-EZH2-mediated H3K27me3 deposition at repetitive 
elements and specific pRB-Condensin II-mediated mitigation of γH2AX accumulation at 
major satellites merits investigation into the effects of alleviating multiple tumor-
suppressor based mechanisms of chromatin-organization at repetitive sequences (Ishak et 
al., 2016). Notably, it remains unknown whether pRB-mediated chromatin organization 
at repeats presents an opportunity to enhance the immune response through drug-induced 
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viral mimicry (Roulois et al., 2015). If so, pRB functional status may predict efficacy of 
clinically relevant epigenetic modulators. 
In this study, we investigate whether disruption of pRB-EZH2-mediated silencing 
through acute epigenetic modulation can suffice to de-repress repetitive elements. We 
investigate whether cells deficient for this silencing paradigm exhibit evidence of 
transposition, or evidence of ERV-specific innate immune responses. Finally, we explore 
the effects of disrupting the CDK-resistant pRB-E2F1 scaffold in a Trp53
-/-
 background. 
4.2 Experimental Procedures 
4.2.1 Cell culture and mouse colonies 
Mouse embryonic fibroblasts (MEFs) were generated from E13.5 embryos using standard 
procedures. Cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with L-glutamine (2mM), streptomycin (50μg/mL), penicillin (50U/mL), 
and 10% fetal bovine serum, incubated at 37°C with 5% CO2. Generation and 
characterization of Rb1
S/S 
mice has been described previously. To ablate p53 expression, 
Rb1
S/S 
mice were crossed into a Trp53
−/−
 background in which Trp53 exons 2-7 are 
substituted for a Neomycin cassette. The Trp53
−/−
 mice were obtained from The Jackson 
Laboratory. All animals were housed, handled, and analyzed as approved by the 
Canadian Council on Animal Care. 
4.2.2 Determination of protein and RNA expression 
Chromatin fractions whole cell extracts were prepared as previously described (Ishak et 
al., 2016). Antibodies used for Western blots are as follows: Ezh2 (D2C9; Cell 
Signaling), H3K27me3 (07-449; Millipore), H3K9Ac (06-942; Millipore), H3 (ab1791; 
  
150 
abcam), L1 ORF2p (M-300; Santa Cruz), tubulin (11H10; Cell Signaling), Actin (A2066; 
SIGMA). RNA was prepared in TRIzol as previously described. Primers used are as 
follows: Maj_F: GACGACTTGAAAAATGACGAAATC, Maj_R: 
CATATTCCAGGTCCTTCAGTGTGC, L1 5' UTR_F: 
CTGCCTTGCAAGAAGAGAGC, L1 5' UTR_R: AGTGCTGCGTTCTGATGATG, IAP 
LTR_F: CTGACAGCTGTGTTCTAAGTGGTAAACAAA, IAP LTR_R: 
AGAACACCACAGACCAGAATCTTCTGC. 
4.2.3 EZH2 inhibition 
In vivo based EZH2 inhibition was performed based upon methods modified from 
Beguelin et. al (2013). Briefly, mice received daily treatments of 150mg/kg/day of 
GSK343 or vehicle (Captisol) through 100μl intraperitoneal injections for 7 consecutive 
days. Splenocytes were harvested on day 8 for RNA extraction using TRIzol reagent. 
RNA was reverse transcribed and used for qRT-PCR. 
To inhibit EZH2 in MEFs, asynchronously growing P4 MEFs at 50% confluency were 
treated with GSK343 or vehicle (DMSO) with treatment volumes of 0.1% of total media 
volume. For the 96-hour treatment course, 10 μM were treatments were administered 
every 12 hours. H3K27me3 blots were performed from chromatin fractions of treated 
cells. For the 48-hour treatment course, treatments of 2.5μM or 5μM were administered 
once every 24 hours. L1 ORF2 blots were performed from whole cell extract of treated 
cells. GSK343 was stored at a stock concentration of 10mM in DMSO at -20°C protected 
from light.  
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4.2.4 Retrotransposition Assay 
P3 MEFs seeded at 2x10
5
 cells / well in a 6-well dish were co-transfected with 1μg of an 
eGFP-expressing L1 reporter plasmid along with 1μg of a Crimson-expressing plasmid. 
24h post-transfection, cells were split 1:3 into 6-well dishes. Three wells per 
experimental group were harvested 72h post transfection for live-cell flow cytometry to 
measure Crimson (+) cells as a measure of transfection efficiency. To test TSA sensitive 
de-repression, MEFs were treated with 2.5μM TSA or vehicle (DMSO) 6d post-
transfection. 7d post-transfection, live-cell flow cytometry was conducted to measure 
eGFP expression as a measure of retrotransposition using a FACSCalibur. Analysis was 
conducted using FlowJo software. Live cells were gated, and analyzed for Crimson (+) 
and eGFP (+) signal. Analysis of H2B-GFP-transduced MEFs were used to gate eGFP 
positive cells. Background signal from untransfected controls was subtracted from all 
samples, and eGFP signal was normalized to Crimson (+) signal. The following plasmids 
were used in this study: cep99-gfp-L1SM (gift from Boeke lab, NYU), cep99-gfp-TGF21 
(gift from Moran lab, U-M), pEF.myc.ER-E2-Crimson (Addgene), and pBABE-H2B-
GFP (Dick lab). See Appendix E for plasmid descriptions. 
4.2.5 Expression Microarray 
RNA levels were determined by Affymetrix Mouse Gene 1.0 Array as previously 
described (Ishak et al., 2016). Average RMA expression values of all three replicates per 
genotype were log2 transformed for an ANOVA analysis to determine significant 
expression changes of 1.5 fold or greater with a p value of 0.05 or less in mutant cells 
relative to wild-type cells. GeneOntology (GO) analysis on this list of genes yielded GO 
enrichment scores that were plotted for the top 5 enriched categories. Annotations were 
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derived from Affymetrix MoGene-1 0-st-v1 Transcript Cluster Annotations, CSV, 
Release 32. 
4.2.6 CD4 CD8 thymocyte quantification 
To determine distribution of immature and mature thymocyte populations, thymocytes 
from 4-6 week old mice were isolated from freshly sacrificed mice, and mashed through 
a 40μm sterile cell strainer in a 10cm dish containing 3-4ml of media. Cells were then 
isolated, pelleted at 4°C, and incubated 5 minutes in 1x RBC lysis buffer (0.15M NH4 Cl, 
10mM KHCO3 , 0.1mM  EDTA) to lyse erythrocytes. Thymocytes were washed twice in 
1x PBS, then labeled with fluorescein-conjugated α-CD8, R-phycoerythrin-conjugated α-
CD4, 7-AAD, and subjected to flow cytometry analysis to compare thymocyte 
maturation stage according to expression of CD4 and CD8 surface antigens. Percent 
viability was measured as proportion of total cells within the ‘live’ gate of count versus 
7-AAD plots. CD4 CD8 status was quantified as proportion of total viable cells per 
quadrant, and then plotted as an average of the same quantification for three animals per 
genotype. Error bars indicate +/- 1 standard deviation. 
4.3 Results  
4.3.1 Disruption of the CDK-resistant pRB-E2F1 interaction 
deregulates L1 ORF2p expression  
We sought to identify whether disruption of certain pRB interaction surfaces 
could permit expression of factors required for endogenous retrotransposition. Western 
blots of whole cell extracts from proliferating MEFs demonstrate L1 ORF2p 
misregulation is specific to the Rb1
S/S
 mutant, and not sensitive to disruption of pRB-E2F 
small pocket interactions in Rb1
G/G 
cells, or disruption pRB LxCxE binding cleft 
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interactions in Rb1
L/L
 cells (Figure 4.1A). This complements previous microarray-based 
analysis of repetitive element transcript levels across Rb1 synthetic mutant genotypes 
(Ishak et al., 2016). Importantly, since both the Rb1
S/S
 and Rb1
L/L
 mutants perturb 
Condensin II recruitment to pericentric satellites, this corroborates attribution of pRB-
mediated repeat silencing to EZH2 recruitment rather than interactions with Condensin II.  
4.3.2 GSK343 treatment de-represses repetitive elements in 
MEFs 
We sought to determine whether epigenetic modulation could perturb pRB-
mediated facultative heterochromatinization of repetitive sequences. Since pRB-mediated 
silencing is specific to EZH2 recruitment, chemical inhibitors of EZH2 function may 
recapitulate repetitive element deregulation observed in Rb1
S/S
 cells. Western blots of 
chromatin fractions reveal reduced H3K27me3 levels following GSK343 treatment of P4 
MEFs every 12 hours for 96 hours (Figure 4.2A). Upon confirmation of activity, GSK343 
treatments were modified to identify minimal doses that sufficed to de-repress repeats 
silenced by H3K27me3 in MEFs. Increasing doses of GSK343 produced modest 
increases in L1 ORF2p levels in proliferating MEFs, with no overt fluctuations in 
H3K27me3 levels as measured by western blots (Figures 4.2B and 4.2C). 
4.3.3 GSK343 treatment de-represses repetitive elements in 
splenocytes 
Ablation of epigenetic writers results in differential effects on repetitive element 
silencing based on cell type and developmental stage (Rowe and Trono, 2011). 
Disruption of pRB-EZH2-mediated silencing resulted in pronounced deregulation of 
repetitive elements in adult Rb1
S/S
 splenoctyes. To determine whether targeted EZH2  
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Figure 4.1: Disruption of the CDK-resistant pRB-E2F1 interaction de-represses L1 
ORF2p. 
(A) Western blots of whole cell extract from asynchronous P4 MEFs of the indicated 
genotypes demonstrate expression levels of L1 ORF2p, and tubulin as a loading control. 
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Figure 4.2: GSK343 inhibition of EZH2 de-represses repetitive elements in MEFs. 
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Figure 4.2: GSK343 inhibition of EZH2 de-represses repetitive elements in MEFs. 
(A) Western blot for H3K27me3 from chromatin fractions of asynchronous P4 MEFs 
treated every 12 hours with 10 μM of GSK343 or DMSO vehicle for 96 hours total. 
Coomassie-stained histones serve as a loading control, and chromatin from Ezh2
-/-
 MEFs 
serves as a control for antibody specificity. (B) Western blot for L1 ORF2p, EZH2, and 
Actin as a loading control from whole cell extracts of asynchronous P4 MEFs treated 
every 24 hours with with indicated concentrations of GSK343 or DMSO vehicle for 48 
hours total. (C) Extracts from (B) blotted for H3K27me3 and Actin along with extract 
from Ezh2
-/-
 MEFs to serve as a control for antibody specificity. 
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inhibition could recapitulate this effect, wild-type mice received daily treatments of 
150mg/kg/day of GSK343 or vehicle through intraperitoneal injections for 7 consecutive 
days. Splenocytes were harvested on day 8 for RNA extraction (Figure 4.3A). Strikingly, 
while overt tissue morphology remained unchanged, qRT-PCR revealed elevated levels 
of major satellites, 5' L1 UTR, and the IAP LTR in splenocytes from GSK343 treated 
mice only (Figures 4.3B and 4.3C). This demonstrates that acute EZH2 inhibition de-
represses repetitive elements in splenocytes.  
4.3.4 The CDK-resistant pRB-E2F1 complex suppresses 
retrotransposition of LINE1 reporters 
 
Amongst the repetitive element families silenced by pRB-EZH2 recruitment, a 
subset contain members that retain the potential to mobilize throughout the genome. 
Detection of L1 ORF2p suggests that the components required for endogenous 
retrotranspiosition are present in Rb1
S/S 
cells. To assess retrotransposition in cells 
deficient for pRB-EZH2 recruitment, we used a previously described assay in which a 
plasmid borne LINE1 element contains an eGFP reporter in the antisense orientation 
interrupted by an intron (Figure 4.4A) (Garcia-Perez et al., 2010). Only following 
expression, splicing, and retrotransposition can eGFP be expressed, thus serving as a read 
out for bona fide mobility of the reporter. Both a naturally occurring LINE1 (L1 Gf) and 
a synthetic version (L1 SM) exhibited elevated retrotransposition in Rb1
S/S
 MEFs relative 
to wild-type cells (Figure 4.4B). In addition to retrotransposition, we also used this assay 
to analyze silencing of retroelements. Treatment of cells with Trichostatin A (TSA)  
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Figure 4.3: GSK343 inhibition of EZH2 de-represses repetitive elements in 
splenocytes. 
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Figure 4.3: GSK343 inhibition of EZH2 de-represses repetitive elements in 
splenocytes. 
 
(A) Treatment scheme illustrates that 6-8 week-old wild-type mice received daily 
treatments of 150mg/kg/day of GSK343 or volume-matched vehicle for 7 consecutive 
days. Splenocytes were harvested on day 8. (B) Overt morphology of splenocytes upon 
necropsy. (C) Heat map of repeat element expression in spleens of treated mice 
quantified by qRT-PCR. Log2 ratio of expression is displayed relative to the average of 
all vehicle-treated mice. 
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Figure 4.4: pRB suppresses retrotransposition. 
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Figure 4.4: pRB suppresses retrotransposition. 
 
(A) Retrotransposition assay schematic. LINE1 reporters encode an anti-sense CMV-
eGFP marker in the 3'UTR interrupted by an intron in the sense direction. Upon genomic 
integration, expression, intron splicing, and re-integration, the sense CMV-eGFP is 
expressed. (B) Percent eGFP positive MEFs per genotype determined by flow cytometry 
normalized to co-transfected Crimson expression plasmid to provide an unconditionally 
expressed marker of transfection efficiency. Reporters used encoded endogenous L1 (L1 
Gf), and a synthetic L1 (L1 SM) with modified ORFs for optimized expression. Signal 
measured by live cell flow cytometry. (C) Whole cell extract WB of H3K9Ac, and H3 
from MEFs treated 24h with 2.5 μM TSA or DMSO vehicle. (D) Retrotransposition 
assay conducted with DMSO vehicle or 2.5 μM TSA treatment 24h prior to live cell flow 
cytometry. Percent eGFP positive cells were expressed as fold change relative to vehicle 
control for each genotype and reporter. Error bars indicate one standard deviation from 
the mean, an asterisk represents a significant difference from wild type or untreated 
control (P≤0.05 using a t-test). 
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inhibits HDAC activity to increase histone acetylation as detected by western blot of 
H3K9Ac (Figure 4.4C). TSA treatment of reporter-transduced wild type and Rb1
S/S
 
fibroblasts elevated the abundance of eGFP positive wild type cells, but not Rb1
S/S
 
mutants (Figure 4.4D). This suggests that retrotransposon expression is fully de-repressed 
in Rb1
S/S
 cells such that TSA dependent de-repression can no longer lead to higher levels 
of eGFP reporter transposition. Considered together with the elevated levels of 
retrotransposon reporter events that take place in Rb1
S/S
 MEFs, there is a strong 
likelihood that loss of pRB-EZH2 occupancy and repression of repetitive sequences may 
be associated with endogenous transposition of mobile repetitive elements. 
4.3.5 Disruption of the CDK-resistant pRB-E2F1 interaction 
activates innate immune components 
Cells with perturbed silencing of repetitive sequences exhibit activation of the 
innate immune response (Roers et al., 2016). To determine transcriptional responses 
associated with loss of pRB-mediated repetitive element silencing, expression 
microarrays of arrested Rb1
S/S 
MEFs were analyzed (Ishak et al., 2016). Average RMA 
expression values of all three replicates per genotype were log transformed for an 
ANOVA analysis to determine significant expression changes of 1.5 fold or greater with 
a p value of 0.05 or less in mutant cells relative to wild-type cells. GeneOntology (GO) 
analysis conducted on this list of genes revealed that 3 of the top 5 GO enrichment scores 
corresponded to categories that were specific to immune responses (Figure 4.5A).  
Up-regulated immune targets from this list were curated into tables based upon 
sensory or responsive roles in the immune response. Analysis of up-regulated sensory 
components revealed up-regulation of toll like receptors, C-type lectins, and Ig  
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Figure 4.5: Upregulation of innate immune components upon loss of the CDK-
resistant pRB-E2F1 interaction 
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Figure 4.5: Upregulation of innate immune components upon loss of the CDK-
resistant pRB-E2F1 interaction.  
(A) Average Affymetrix Mouse Gene 1.0 Array RMA expression values of all three 
replicates per genotype were log2 transformed for an ANOVA analysis to determine 
significant expression changes of 1.5 fold or greater with a p value of 0.05 or less in 
mutant cells relative to wild-type cells. GeneOntology (GO) analysis on this list of genes 
yielded GO enrichment scores that were plotted for the top 5 enriched categories. (B) 
Annotations of immune targets from this list were derived from Affymetrix MoGene-1 0-
st-v1 Transcript Cluster Annotations, CSV, Release 32 and plotted as tables according to 
‘sensory’ functions. (C) Same analysis as (B) with ‘response’ components listed. 
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components, in addition to surface markers associated with immune cells (Figure 4.5B). 
Amongst responsive components, Trim proteins exhibited the most pronounced up-
regulation, accompanied by other IFN and IL-stimulated cytokines (Figure 4.5C). 
Interestingly, components of the complement system downstream of antigen recognition 
were also enriched. Finally, components involved in immunogenic cytotoxicity were also 
up-regulated. Collectively, this suggests that nucleic acid sensory receptors and IFN 
stimulated cytokines are active in cells with disrupted pRB-EZH2-mediated repeat 
silencing.   
4.3.6 Disruption of the CDK-resistant pRB-E2F1 interaction does 
not alter thymocyte maturation 
Studies in embryonic stem cells demonstrate that p53, like pRB, mediates 
genome-wide chromatin organization. Specifically, p53 mediates H3K9me3-dependent 
silencing of repetitive sequences (Wylie et al., 2015). We sought to determine the effects 
of disrupting multiple tumor suppressor-based chromatin-organizing mechanisms. Trp53
-
/-
 mice predominantly succumb to thymic lymphomas (Jacks et al., 1994). However, the 
roles of E2F1 in thymocyte apoptosis may present a potential confounding variable to 
any alterations in tumor phenotypes.  
E2f1
-/-
 thymocytes exhibit attenuated apoptosis during negative selection as 
measured by CD4/CD8 surface markers (Field et al., 1996). As thymocytes mature, they 
progress sequentially from CD4/CD8 double negative, to double positive, and finally 
single positive status following selection. Elevated levels of single-positive E2f1
-/-
 
thymocytes underscore the role of E2F1 as a pro-apoptotic transcription factor, and 
complement their resistance to etoposide-induced apoptosis (Field et al., 1996; Lin et al., 
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2001). If pRB represses E2F1-induced apoptosis through the CDK-resistant interaction, 
then Rb1
S/S 
thymocytes may exhibit increased sensitivity to pro-apoptotic stimuli, and 
thus, delay or ablate onset of thymic lymphomas within a Trp53
-/-
 background. 
To assess potential alterations in thymocyte negative selection, freshly harvested 
thymocytes from 4-6 week old wild-type and Rb1
S/S
 mice were stained for CD4/CD8 to 
measure thymocyte proportions per maturation stage, and 7-AAD to measure thymocyte 
viability. No significant differences in total viability or thymocyte maturation were noted 
from this analysis, suggesting that any potential differences in thymic lymphoma 
development within a Trp53
-/-
 background could not be attributed to intrinsic 
developmental alterations (Figures 4.6A, 4.6B and 4.6C).  
4.3.7 Disruption of the CDK-resistant pRB-E2F1 complex 
decreases tumor-free survival of Trp53-/- mice. 
Since TP53 inactivating mutations often accompany RB1 inactivation in human 
cancers, Trp53
-/-
 mice were crossed with Rb1
S 
mice, and offspring were aged until animal 
protocol endpoints, upon which they were subjected to necropsies with portions of 
samples fixed for histological analysis, and the remaining sample portions frozen. Within 
a Trp53
-/-
 background, Rb1
S/S
 mice all succumb to tumors with decreased tumor latency 
relative to Rb1
+/+
 controls (p = 0.032) (Figure 4.7A). Consistent with previous studies, 
Rb1
+/+
; Trp53
-/-
 mice predominantly succumb to thymic lymphomas or sarcomas (Figure 
4.4B) (Jacks et al., 1994). A subset of Rb1
S/S
; Trp53
-/-
 mice presented with lymphomas in 
the spleen, or axial lymph nodes, or mesenteric lymph nodes (Figures 4.7B and 4.7C). 
Beyond lymphomas and sarcomas, a lung adenocarcinoma and a malignant papillary  
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Figure 4.6: Disruption of the CDK-resistant pRB-E2F1 interaction does not alter 
thymocyte maturation. 
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Figure 4.6: Disruption of the CDK-resistant pRB-E2F1 interaction does not alter 
thymocyte maturation. 
A) Freshly harvested thymocytes from 4-6 week-old mice were stained and subjected to 
live-cell flow cytometry analysis. Percent viability was measured as proportion of total 
thymocytes within the ‘live’ gate of count versus 7-AAD plots. (B) Representative CD4 
versus CD8 histograms demonstrate gating used to determine positive or negative signal 
by flow cytometry. (C) Proportion of total viable cells per quadrant plotted as an average 
of the same quantification for three animals per genotype. Error bars indicate +/- 1 
standard deviation. 
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Figure 4.7: Disruption of the CDK-resistant pRB-E2F1 interaction accelerates onset 
of tumorigenesis in a Trp53
−/−
 background. 
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Figure 4.7: Disruption of the CDK-resistant pRB-E2F1 interaction accelerates onset 
of tumorigenesis in a Trp53
−/−
 background.  
(A) Overall tumor-free survival plotted for Rb1
+/+
; Trp53
-/-
  (n = 18) and Rb1
S/S
; Trp53
-/-
 
mice (n = 13) as Kaplan-Meier curves with log rank test p-value indicated. (B) Table 
indicates occurrence per tumor type (C) H&E-stained sections exhibit histological 
characteristics specific to tumor type. Scale is indicated per image. For F132, a white box 
within an image at a lower magnification indicates the relative location of the adjacent 
image.  
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growth from the vas deferens were present amongst the Rb1
S/S
; Trp53
-/-
 cohort (Figures 
4.7B and 4.7C).  
Since different tumor types confer different latencies to animal protocol endpoints, 
latency was compared amongst control and mutant animals that succumbed to thymic 
lymphomas. Rb1
S/S
; Trp53
-/-
 mice that succumbed to thymic lymphomas exhibited a 
significantly reduced tumor latency relative to Rb1
+/+
; Trp53
-/-
 mice that developed 
thymic lymphomas (p = 0.023) (Figure 4.8A). No differences in overt morphology of 
thymic lymphomas were noted upon necropsy between cohorts. Mitotic cells were readily 
apparent upon histological analysis that revealed no pathological differences between 
thymic lymphomas of compound mutants versus single mutants (Figure 8B).  
4.4 Discussion 
This chapter explores a number of focused questions to initiate investigations of 
how the pRB-E2F1 scaffold may be exploited for therapeutic purposes, and how it may 
contribute to tumorigenesis in combination with p53 ablation. With respect to therapeutic 
exploitation, we explore whether a clinically relevant epigenetic modulator can alleviate 
H3K27me3-based repetitive element silencing. Intraperitoneal injections of the EZH2 
inhibitor GSK343 sufficed to de-repress repetitive sequences in splenocytes. De-
regulation was uniform for all drug treated animals at time of harvesting. In contrast, the 
response of aged-matched animals is less likely to be synchronized after 6-8 weeks of 
immune-induced negative selection (Ishak et al., 2016).  
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Figure 4.8: Disruption of the CDK-resistant pRB-E2F1 interaction accelerates onset 
of thymic lymphomas in a Trp53
−/−
 background. 
(A) Tumor-free survival of mice that succumbed to thymic lymphomas plotted for 
Rb1
+/+
; Trp53
-/-
  (n = 13) and Rb1
S/S
; Trp53
-/-
 mice (n = 8) as Kaplan-Meier curves with 
log rank test p-value indicated. (B) Representative images of thymic lymphomas upon 
necropsy accompanied by corresponding H&E stained sections. Scale bar indicates 100 
μm.  
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Disruption of repeat-silencing mechanisms may also permit retrotransposition of 
elements that retain the ability to transpose autonomously. Discovery of L1 ORF2p 
expression in Rb1
S/S 
MEFs suggests that the machinery required for endogenous 
retrotransposition is present in Rb1
S/S 
cells. Further exploration of L1 ORF2p expression 
in tissues of adult Rb1
S/S 
mice may reveal tissue-specific differences in any potential 
endogenous retrotransposition. Here, a transfection-based eGFP LINE reporter assay was 
used to assess whether pRB-EZH2-mediated silencing suppressed expression and 
retrotransposition in wild-type and Rb1
S/S
 MEFs. Reporter retroransposition is silenced in 
a pRB-dependent manner. Whole genome sequencing will be required to determine 
whether endogenous LINE retrotransposition can be observed upon alleviation of pRB-
repeat association in both experimental models, and human cancers. If so, LINE 
retrotransposition may be common to cancers with inactivated pRB.   
Constitutive disruption of repeat silencing induces an innate immune response that 
begins with stimulation of endosomal toll-like receptors (TLRs) or cytosolic RIG-I_like 
receptors that initiate an interferon (IFN) response. Expression microarray analysis of 
Rb1
S/S
 MEFs suggests that such a response may occur in upon disruption of pRB-EZH2-
mediated repeat silencing. Upon detection of repetitive transcripts, TLR7 ensures 
production of ERV-specific antibodies. Indeed TLR7 and immunoglobin components 
were amongst the most up-regulated sensory components in mutant MEFs. Downstream 
of receptor stimulation, TRIM proteins propagate the response to ensure that a host of 
IFN-stimulated cytokines can respond and induce cytotoxicity to cull the cells if required. 
Transcriptional targets associated with the immune response in Rb1
S/S
 MEFs suggest that 
this response may be active upon disruption of this silencing paradigm. Accordingly, we 
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previously report IFN activation in splenocytes of adult Rb1
S/S
 MEFs (Ishak et al., 2016). 
However, assessing such signatures in multiple tissues of GSK343-treated adult mice 
may reveal additional cell types that may invoke such a response upon disruption of pRB-
EZH2-mediated heterochromatinization.  
Investigation of p53-deficient cells first revealed that retrotransposition and innate 
immune responses were sensitive to tumor suppressor-mediated repeat silencing 
(Leonova et al., 2013; Wylie et al., 2015). Identification of pRB-mediated H3K27me3 
deposition at repeats suggested that combinatorial inactivation of both pRB and p53 may 
exacerbate overall heterochromatinization defects relative to those observed upon 
inactivation of either tumor suppressor in isolation. To assess whether this was the case, 
Rb1
S/S
 mice were crossed into a Trp53
-/-
 background and aged until animal protocol 
endpoints. Upon necropsy, Rb1
S/S
; Trp53
-/-
 mice presented with a slightly more varied 
tumor spectrum and an overall decreased tumor latency relative to Rb1
+/+
; Trp53
-/-
 mice. 
Trp53
-/-
 mice predominantly succumb to thymic lymphomas.  Compound mutants that 
developed thymic lymphomas exhibited a significantly reduced latency relative to 
Rb1
+/+
; Trp53
-/-
 mice. While Rb1
S/S
; Trp53
-/-
displayed an increase in lymphomas beyond 
the thymus, Rb1
L/L
; Trp53
-/-
 display an increase in sarcoma incidence. This further 
distinguishes additional factors that contribute to genome instability in Rb1
S/S
 mice 
beyond disruption of Condensin II-mediated mitotic instability observed in Rb1
L/L
 mice. 
Mechanistic underpinnings of reduced latency may provide insight into yet-unidentified 
factors that govern tumor evolution in human cancers that lack both pRB and p53. 
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Chapter 5  
5 Discussion 
5.1 Summary of findings 
My thesis investigates mechanistic links between genome integrity and pRB-
mediated recruitment of chromatin organizing proteins to repetitive DNA sequences. The 
work here suggests that the CDK-resistant interaction between the pRB C-terminus and 
the E2F1 marked box domain establishes a scaffold that facilitates recruitment of 
multiple chromatin-organizing proteins to repetitive sequences across the genome 
throughout the cell cycle. The onset of lymphomagenesis evident upon disruption of this 
pRB-E2F1 interaction suggests that the activities of this complex constitute a previously 
unappreciated facet of pRB-mediated tumor suppression. 
My work in chapter two identifies the enhancer-of-zeste-homoglogue 2 (EZH2) 
histone methyl transferase as one such chromatin-modifying protein recruited through 
this pRB-E2F1 complex. pRB-E2F1 recruit EZH2 to deposit H3K27me3 and silence 
repetitive elements. Germline disruption of this interaction results in pronounced 
misexpression of repetitive elements in splenocytes, and lymphomas that arise in the 
spleen, mesenteric and axial lymph nodes.  
In chapter 3, the CDK-resistant scaffold is investigated as a biochemical 
mechanism that underlies previous observations of pRB-mediated Condensin II 
recruitment to pericentric heterochromatin. A portion of my investigation into this 
question was published in Cancer Discovery and it is appended to this thesis.  I will 
consider its implications while discussing findings from chapter 3. Chapter 3 
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demonstrates that disruption of the CDK-resistant pRB-E2F1 interaction coincides with 
increased γH2AX, aneuploidy, ppRPA32, and mitotic errors. While these functions are 
known to be associated with perturbed Condensin II recruitment, chromatin 
immunoprecipitation experiments demonstrate that γH2AX appears to be limited to 
regions co-occupied by pRB-Condensin II and not regions exclusively occupied by pRB-
EZH2. 
In chapter 4, I explore whether functions of the pRB-E2F1 scaffold provide an 
opportunity for therapeutic exploitation, and whether these properties direct disease 
outcomes in combination with other cancer-relevant events that deregulate repetitive 
elements. My work demonstrates that the EZH2 inhibitor GSK343 derepresses repetitive 
elements in MEFs and in splenocytes. While acute derepression may be therapeutic, 
constitutive derepression may permit retrotransposition as determined using LINE 
reporter assays. Furthermore, disruption of this silencing paradigm through the Rb1
S
 
mutation in concert with ablation of p53 expression decreases latency of thymic 
lymphomas, and increases diversity of tumor spectrum.  
Collectively, my work provides a mechanistic link between tumor suppressor 
inactivation and repetitive element misregulation in cancer. Specifically, cell cycle 
independent pRB-chromatin association at repetitive regions maintains genome stability 
through facultative heterochromatinization of repetitive sequences, and recruitment of 
chromatin-condensing proteins required for fidelity of DNA replication and mitosis. 
Discovery of this recruitment mechanism suggests a previously unidentified means of 
therapeutic exploitation of pRB-positive cancers through the use of EZH2 inhibitors. 
Upon review of the implications of this work, it is apparent that the investigation into the  
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Figure 5.1: The CDK-resistant pRB-E2F1 scaffold recruits chromatin-organizing 
complexes to repetitive sequences. 
The above model of post-G1 pRB-chromatin association depicts CDK-phosphorylated 
pRB, however whether CDK-phosphorylated pRB associates with repetitive elements 
endogenously remains to be investigated. The top half of the panel portrays pRB-E2F1-
Condensin II complexes at major satellites (MaSat). Loss of this recruitment in Rb1
S/S 
mutant cells coincides with increased γH2AX depicted specifically at major satellites, but 
not at other repetitive elements that are insensitive to loss of pRB-Condensin II 
interactions alone. Whether these regions account for increases in ppRPA32 remains to 
be explored. In addition, pRB-E2F1-EZH2 complexes are illustrated at both a major 
satellite and a LINE1 element to emphasize the increased repertoire of repetitive 
sequences occupied by this complex. Loss of pRB-dependent EZH2 recruitment 
coincides with loss of repressive H3K27me3 and transcriptional activation of both 
interspersed and tandem repetitive elements that include major satellites, IAP endogenous 
retroviruses, and LINE1 elements. Post-G1, pRB-E2F1 occupy repetitive sequences 
while pRB dissociates from E2Fs at cell cycle genes such as Mcm3 illustrated above.  
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properties of the pRB-E2F1 scaffold may illuminate answers to long-standing questions 
in the repetitive element field regarding recruitment of epigenetic effectors to repetitive 
sequences, host-directed alleviation of repetitive element silencing, and misregulation of 
silencing associated with mitotic defects and the onset of tumorigenesis.  
5.2 The CDK-resistant pRB-E2F1 scaffold recruits 
multiple complexes to repetitive sequences.  
The use of discrete pRB synthetic mutants has permitted elucidation of two 
distinct pRB-E2F1 complexes. The CDK-resistant pRB-E2F1 scaffold mediates EZH2 
recruitment and H3K27me3 deposition at repetitive sequences throughout the genome. In 
contrast, pRB-E2F1-Condensin II complexes occupy and act upon major satellite 
sequences, but are not functionally relevant at the L1 5'UTR or IAP LTR. Curiously, 
disruption of the pRB-E2F1 scaffold resulted in γH2AX accumulation at repeats 
regulated by pRB-Condensin II, but not pRB-EZH2 exclusively. The attribution of 
repetitive element silencing to EZH2 recruitment appears consistent with another 
synthetic pRB mutant model that is defective for Condensin II recruitment, but does not 
exhibit deregulation of repetitive sequences. Proliferating Rb1
L/L
 MEFs exhibit reduced 
H4K20me3 at pericentric repeats, and reduced H3K9me3 at cell cycle promoters upon 
senescence induction, consistent with defective recruitment of HMTs that establish 
constitutive heterochromatin marks (Isaac et al., 2006; Talluri et al., 2010). In contrast, 
H3K27me3 levels remain unperturbed at these sites and at Hox genes, consistent with 
proper H3K27me3 levels maintained at Hox genes in Rb1
S/S 
cells (Talluri et al., 2010). 
This suggests that H3K27me3 deposition at these regions is likely pRB-independent. 
Curiously, the D.melanogaster CAP-D3 subunit that interacts with the D.melanogaster 
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pRB orthologue Rbf restricts transposon activity (Schuster et al., 2013). This suggests 
that Condensin II may participate in transposon silencing in mammals, however the 
means by which this may occur remains unknown, but is likely independent of pRB.   
These observations give rise to questions regarding the biochemical properties 
that distinguish either complex. With respect to assembly, functional expression and 
epigenetic outputs suggest that pRB-dependent EZH2 recruitment must be independent of 
the LxCxE binding cleft. Since nuclear extract pulldowns with recombinant GST-RBLP
L
 
exhibit reduced binding to the PRC2 subunit RbAp46, this suggests RbAp46 may not 
participate in recruitment of EZH2 by pRB (Isaac et al., 2006). Alternatively, RbAp46 
may be required for non-PcG HDAC complex recruitment by pRB through the LxCxE 
binding cleft. Endogenous immunoprecipitations in previous data chapters assess protein-
protein interactions or genome occupancy but cannot distinguish whether pRB-mediated 
EZH2 recruitment is direct or indirect. Furthermore, a minimal region required for this 
recruitment has yet to be mapped on pRB.  
While Condensin II association with pRB has been characterized as LxCxE-
dependent, many of the same questions that exist for EZH2 recruitment exist for 
Condensin II recruitment. Despite extensive characterization, it remains unknown 
whether interactions between pRB and certain Condensin II subunits are direct or 
indirect, and which subunits are essential for this interaction. Evidence of a higher-
migrating CAP-D3 band that associates with pRB suggests modifications to Condensin II 
subunits, such as CAP-D3 phosphorylation, may facilitate interaction with pRB. Finally, 
properties that determine whether pRB-E2F1 will recruit Condensin II or EZH2 remain 
unknown. Biochemical experiments are required to determine whether this recruitment is 
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competitive, and whether additional co-factors or post-translational modifications are 
required to mediate this interaction. Development of pRB synthetic mutants that disrupt 
EZH2 recruitment and preserve LxCxE interactions will facilitate this endeavor.  
5.3 Do E2F-consensus motifs underlie pRB-E2F1 
recruitment to repetitive elements? 
Occupancy of the CDK-resistant pRB-E2F1 scaffold at a diverse repertoire of 
repetitive elements begs the question of the molecular basis that underlies repetitive 
sequence recruitment. Repetitive elements must be recognized by chromatin modifying 
complexes in order to be silenced, or by transcription factors to serve as alternative 
promoters or enhancers throughout the host genome. However, mechanisms of repetitive 
sequence recognition remain poorly understood. Classic mechanisms of promoter-
transcription factor dynamics predominantly involve the recognition of a conserved DNA 
motif or element within the promoter. There is some evidence to suggest that recognition 
of DNA sequences serves as the recruitment mechanism for a subset of proteins that bind 
repeats. 
For example, retrotransposition assays that utilize fragments of IAPs demonstrate that 
the presence of the 5'UTR or a 160bp region from the gag-encoding ORF suffice to 
silence the reporter (Sadic et al., 2015). Certain members of the Krüppel-associated box 
zinc-finger proteins (KRAB-ZFPs) recognize these sequences within the 5'UTR and gag 
regions (Wolf and Goff, 2009). KRAB-ZFPs harbor varying numbers of zinc finger 
motifs to confer DNA binding specificity. Divergence amongst these motifs are believed 
to underlie extensive occupancy of a diverse repertoire of repeats by Cys2-His2 zinc 
finger (C2H2-ZF) transcription factors that include the KRAB-ZFP members (Najafabadi 
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et al., 2015). These associations are often found within heterochromatinized repeats, and 
corroborate mechanistic investigations that conclude KRAB-ZFPs bind TRIM28 and 
SETDB1 to mediate H3K9me3 of certain repetitive elements (Schmitges et al., 2016).  
It appears that other DNA-binding motifs commonly found within transcription 
factors suffice to mediate sequence-based recognition of repetitive sequences. For 
example, a partial consensus motif within major satellite subrepeat 2 recognized by the 
homeodomain of Pax3 is required for Pax3 recruitment and deposition of H3K9me3 and 
H4K20me3 at pericentric satellites (Bulut-Karslioglu et al., 2012). The p53 transcription 
factor also associates with repetitive sequences. p53 recognizes DNA as a tetramer in 
which a DNA binding domain within its ‘core’ region associates with p53 recognition 
elements (Demir et al., 2017). p53 recognition elements in human ERV LTRs and L1 
5'UTRs appear to be mediate p53 recognition (Harris et al., 2009). Paradoxically, in vitro 
reporter assays suggest p53 association with these elements activates transcription, while 
in vivo NGS profiles suggest p53 association establishes repressive heterochromatin at 
these elements (Wylie et al., 2016).   
Investigation of E2F-based mechanisms of DNA recognition provide insights into 
how an E2F might recruit pocket proteins to repetitive sequences. E2F/DP heterodimers 
were discovered to recognize and bind the canonical E2F motif 5'TTTC[CG]CGC-3' 
(Boeuf et al., 1990; Kovesdi et al., 1987; Yee et al., 1987). More recent work suggests 
that these heterodimers along with atypical E2Fs bind the core sequence 5'-GGCGGG-3' 
(Jolma et al., 2013). Crystal structures of E2F4/DP2 fragments bound to DNA suggest 
that a winged-helix fold adopted by the DNA-binding domains of both transcription 
factors mediates this recognition (Zheng et al., 1999). Subsequent investigations of 
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atypical E2Fs reveal that the two DNA binding domains of E2F8 adopt an analogous 
structure upon DNA binding (Morgunova et al., 2015).  
Identification of L1 ORF2p expression in MEFs deficient for all three pocket proteins 
first prompted investigation of E2F recognition of mammalian LINE elements. 
Investigation of the human L1RP 5'UTR and the murine L1Md-A2 5'UTR identified a 
stretch of GGCG and CGCG respectively within either 5'UTR. These sequences were 
considered homologous to the E2F core recognition sequence 5'-GGCGGG-3', and were 
attributed as the basis of E2F recruitment to these UTRs. ChIP for E2F1 yielded 
occupancy above IgG background levels when quantified using primers that produced an 
amplicon >100bp that encompassed this sequence in the L1 5'UTR (Montoya-Durango et 
al., 2009). However, loss-of-function approaches, such as mutagenesis of this site, were 
never performed. Thus, the requirement of either sequence for E2F1 occupancy of the L1 
5'UTR remains unknown.   
In contrast to mammalian studies, investigations in plants conclude that the pRB-E2F 
network is extensively governed by E2F consensus motifs that are enriched within 
repetitive elements. Motif enrichment analysis of the Arabidopsis thaliana genome 
indicates that 73% of all E2F recognition sequences (TTssCGssAA) intersect with 
transposable elements, while overlap is 85% in Arabidopsis lyrata. This appears to 
suggest extensive amplification of E2F recognition sequences through transposable 
element activity. Notably, analysis of ChIP-seq profiles for histone tail marks reveal that 
these E2F binding sites within transposable elements exhibit significant enrichment of 
H3K27me1 (Henaff et al., 2014).  
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Despite the parallels between these studies and our model of H3K27me3 deposition at 
repeats through the pRB-E2F1 scaffold, the absence of E2F consensus sequences within 
pericentric repeats suggests that pRB-E2F1 recognition must be more complex in 
mammalian systems. Furthermore, the inability of E2F1 to associate with major satellites 
independent of pRB binding strongly suggests that this association is likely conferred 
through a structural motif, a post-translational modification, or an interaction with an 
additional binding partner formed upon E2F1 binding to pRB (See appendix C) (Coschi 
et al., 2014). This supports electrophoretic mobility shift assay experiments that 
demonstrate E2F1 bound through the pRB-C-terminus exhibits reduced affinity for a 
DNA probe that contains the E2F consensus motif (Dick and Dyson, 2003).    
Finally, sequence-dependent pRB-repeat recruitment may be mediated through E2F-
independent means. Recent studies in murine osteoblasts demonstrate that CDK-
phosphorylated pRB occupies the promoter regions of subtelomeric TERRA repeats. 
Occupancy appears to be dependent on the presence of Retinoblastoma Control Elements 
(RCEs) that facilitate pRB recruitment through the Sp1 transcription factor. Interestingly, 
reporter assays demonstrate that pRB positively regulates TERRA expression. Since 
TERRA forms DNA-RNA hybrids to maintain telomere length, this may be another 
means by which pRB maintains genome stability (Gonzalez-Vasconcellos et al., 2017). 
Direct roles of Sp1 in pRB-telomere requirement were not explored in this study (Kim et 
al., 1992). Beyond E2F1 and Sp1, it remains unknown whether other transcription factors 
may recruit pRB to repetitive sequences.  
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5.4 pRB-E2F1 repeat-recruitment independent of E2F 
consensus motifs? 
Recruitment to sites of DNA damage suggests that pRB and E2F1 can be 
recruited through sequence-independent means throughout the genome (Cook et al., 
2015; Vélez-Cruz et al., 2016). Recruitment to sites of DNA damage occurs through step-
wise deposition of post-translational modifications that recruit additional epigenetic 
‘writers’ that deposit new marks for recruitment of new effectors (Munro et al., 2012). 
Likewise, heterochromatinization also follows a hierarchical modification and 
recruitment scheme. At constitutively heterochromatinized regions, H3K9me3 is 
recognized and bound by HP1. Following this event, SUV4-20H1/2 histone methyl 
transferases catalyze H4K20me2/3 deposition at these regions (Saksouk et al., 2015). The 
participation of EZH2 in pRB-mediated silencing of repetitive sequences suggests that 
the pRB-E2F1 scaffold may adhere to the step-wise mechanisms of facultative 
heterochromatinization that underlie target site recruitment. 
Facultative heterochromatin is established through the activity of Polycomb group 
(PcG) proteins. These proteins were first discovered in Drosophila melanogaster as 
regulators of Hox gene expression, and thus, normal development. PcG recruitment in 
D.melanogaster is mediated through sequence recognition of Polycomb response 
elements (PREs) at target sites (Bauer et al., 2015). However, the lack of PREs that 
predict polycomb binding in vertebrates suggests that vertebrate PcG recruitment is more 
complex, and may involve targeting by different co-factors, adaptors, or transcription 
factors that recognize histone or DNA modifications. PcG-mediated heterochromatin is 
established through two multi-subunit complexes. Polycomb Repressor Complex 2 
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methylates lysine 27 of histone H3, while Polycomb Repressor Complex 1 ubiquitylates 
lysine 119 of histone H2A. The interplay between these two activities has provided a 
foundation to explore PcG recruitment mechanisms (Margueron and Reinberg, 2011).  
Early models of PcG activity suggested that H3K27me3 deposition by EZH2 or 
EZH1 of the PRC2 complex is recognized and bound by the PRC1 complex. Following 
recruitment, the RING1A or RING1B ubiquitin E3 ligases of the PRC1 complex 
ubiquitylate H2AK119 (Margueron et al., 2008). However, this model is challenged by 
recent discoveries of PRC1-mediated H2AK119Ub1 that precedes and recruits PRC2 to 
permit H3K27me3 deposition (Cooper et al., 2014). Following deposition, H3K27me3 
recognition by EED permits PRC2-mediated H3K27me3 spreading independent of 
nucleation mechanisms (van der Vlag and Otte, 1999). The interplay with PRC1 remains 
unexplored in our model of pRB-mediated PRC2 recruitment to repetitive sequences. 
PRC1-mediated ubiquitylation at repetitive sequences remains relatively unexplored. 
However, if H2AK119Ub1 levels remain unperturbed at repetitive elements in Rb1
S/S
 
MEFs, then E2F1-pRB-EZH2 recruitment may be mediated through recognition of 
H2AK119Ub1. Conversely, reduced H2AK119Ub1 at repetitive elements in Rb1
S/S
 MEFs 
would suggest a model of PRC2-based recruitment of PRC1 to repetitive sequences.  
PcG proteins also recognize modifications that neither PRC complex deposits. For 
instance, the tudor domains of the substoichiometric PRC2 subunits PCL1, PCL2, and 
PCL3 recognize and bind H3K36me3. In addition to histone methylation, enrichment of 
CpG islands at regions of PcG occupancy suggests DNA methylation may recruit PcGs 
as well (Entrevan et al., 2016). This presents another means by which pRB-E2Fs may 
alter facultative heterochromatinization at repeats.  Multiple E2Fs along with DP1 and 
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pRB have been discovered in certain PRC1 complexes within human polycomb 
interactome datasets (Hauri et al., 2016). If the GC-rich sequences at PcG-occupied CpG 
islands are recognized as E2F ‘core’ sequences, then disruption of the CDK-resistant 
pRB-E2F1 interaction may disrupt PRC1 recruitment in addition to PRC2 recruitment.  
PcG recruitment dynamics may explain pRB-E2F1 recruitment to repetitive 
sequences, but exclusion of pRB-Condensin II from the L1 5'UTR and IAP LTR suggest 
that differential recruitment mechanisms act on different pRB-E2F1 complexes. 
Comparison of genome wide occupancy patterns for PcG and Condensin components 
will reveal the extent of this apparent mutually exclusive occupancy. If PcG components 
direct E2F1-pRB-EZH2 recruitment, Condensin subunits may direct E2F1-pRB-
Condensin II recruitment. ESC ChIP-seq profiles for non-SMC subunits of Condensin II 
suggest that Condensin II localizes to promoters and enhancers in addition to pericentric 
repeats (Dowen et al., 2013). Analysis of occupancy profiles has yet to yield a cis-
regulatory motif that predicts Condensin association. Thus, in vivo recruitment of E2F1-
pRB-Condensin localization is likely mediated through additional mechanisms beyond 
sequence recognition.  
5.5 pRB-E2F1 functions may underlie phenotypes 
associated with both regulated and unregulated 
repetitive element reactivation 
 Repetitive elements are repressed through mechanisms that function cooperatively 
to maintain silencing throughout fluctuations in developmental or cell cycle stage. 
However, host genomes alleviate these mechanisms to permit repetitive element 
activation under certain conditions. For example, under conditions of environmental 
  
189 
stress, bursts of transposon activity serve as a means to increase genetic diversity within a 
gene pool of individuals with low genetic diversity (Rowe and Trono, 2011). The means 
by which stress signals propagate to epigenetic effectors that silence repeats remains 
unknown. In this regard, effectors of the stress response should be surveyed as possible 
candidates to dissociate the CDK-resistant pRB-E2F1 scaffold. Residues within the 
minimal interaction C-terminal interaction domain on pRB or the marked-box domain of 
E2F1 should be investigated for potential modifications imposed by stress response 
effectors. The identified dissociation mechanism should then be investigated as a means 
of pRB misregulation and repetitive element activation in human cancers.   
 Identification of how pRB-E2F1 recognizes repetitive sequences may also reveal 
whether pRB functions may underlie chromosome segregation defects that recur 
regardless of how repeat silencing is perturbed. Currently, the mechanisms that underlie 
these errors remain unknown. However, if DNA or histone modifications mediate pRB-
Condensin II recruitment to pericentric heterochromatin, then cells with defective 
constitutive heterochromatinization of repeats may exhibit reduced pRB-Condensin II 
recruitment. Thus, pRB-Condensin II recruitment and mitotic regulation should be 
investigated in cells that lack mutations in RB1 or Condensin subunits, but exhibit 
repetitive element mis-expression along with mitotic defects.  
5.6 Exploitation of pRB functions at repetitive 
elements 
Beyond epigenetic repression, the innate immune system serves as a form of 
‘responsive’ repeat silencing (Vabret et al., 2016). This response is predominantly 
characterized within the context of ectopic viral infection, in which nucleic acids of 
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foreign origin are detected by endosomal toll-like receptors (TLRs) and cytosolic RIG-I-
like receptors that initiate an interferon (IFN) response (Shen et al., 2015; Young et al., 
2012; Yu et al., 2012). 
Amongst endosomal pattern recognition receptors, TLR3, TLR7, TLR8, TLR9, 
and TLR13 sense different nucleic acids that have been endocytosed or phagocytosed 
(Vabret et al., 2016). TLR3 recognizes dsRNA, TLR7 and TLR8 generally recognize 
ssRNA, while TLR9 recognizes bacterial and viral ssDNA with unmethylated CpG 
regions(Jiménez-Dalmaroni et al., 2016). Specific endosomal receptors mediate the 
endogenous retrovirus (ERV)-specific response. TLR7 ensures production of ERV-
specific antibodies, while TLR3 and TLR9 modulate ERV antibody response to 
propagate a type I IFN response. Mice deficient for TLR3, TLR7, and TLR9 succumb to 
T-cell acute lymphoblastic leukemias (T-ALL) that bear novel ERV re-integrations (Yu 
et al., 2012). Stimulation of these TLRs activates a type I IFN response that may result in 
immunogenic cell death.  
The cytosolic RIG-I-like receptors (RLRs) RIG-I, MDA5, and LGP2 also contribute 
to nucleic acid sensory pathways that activate the innate immune response (Schlee and 
Hartmann, 2016). Upon detection of dsRNA, these pattern recognition receptors activate 
mitochondrial antiviral-signalling protein (MAVS) that induces nuclear localization of 
IFN regulatory factor 7 (IRF7) to initiate a type III IFN response. This response acts upon 
both ectopic and endogenous retroviruses. Following alleviation of DNA methylation at 
repetitive elements, transcripts from de-repressed endogenous retroviruses stimulate RIG-
I and MDA5 that then signal through MAVS and IRF7 to a type III IFN response. 
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Analogous to TLR-induced IFN responses, RLR-induced IFN responses may cause 
immunogenic cell death (Roers et al., 2016).  
The ability to induce immunogenic cell death upon activation of endogenous 
retroviruses presents an emerging strategy that uses epigenetic modulation as an immune 
enhancing therapy (Minn, 2015). This strategy, coined as ‘viral mimicry’, has been most 
extensively characterized within the context of DNMT inhibition. In human and murine 
cells, the FDA-approved DNMT inhibitor 5-aza-cytidine suffices to de-repress repetitive 
elements which are detected by cytosolic RIG-I-like receptors that induce an interferon 
response (Leonova et al., 2013). This response has been observed in human cells derived 
from colorectal cancers, ovarian cancers, promyelocytic leukemia, hepatocellular 
carcinomas, breast cancer, and in human intestinal tumor organoid models (Chiappinelli 
et al., 2015; Desai et al., 2017; Liu et al., 2016; Roulois et al., 2015; Saito et al., 2016).  
Characterization of viral mimicry has revealed that induction of the IFN response is 
sensitive to a threshold of repetitive element misregulation. Cells that exhibit some 
degree of repetitive element expression succumb to immunogenic cell death with 
relatively lower doses of 5-aza-cytidine compared to cells with proper repression of 
repetitive sequences. For example, p53-deficient cells and cancers exhibit increased 
expression of repetitive elements, and increased sensitivity to lower doses of 5-aza-
cytidine relative to p53-positive cells (Desai et al., 2017; Leonova et al., 2013). This is of 
particular clinical significance upon consideration of emerging mechanisms of tumor-
suppressor based silencing of repetitive elements that include ATRX-mediated H3.3 
deposition in addition to p53-mediated H3K9me3 deposition (Sadic et al., 2015; Wylie et 
al., 2015). 
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Identification of pRB-EZH2-dependent facultative heterochromatinization suggests 
that EZH2 inhibitors may be a yet-unidentified means of inducing viral mimicry. Indeed, 
my work in chapter 4 demonstrates that EZH2 inhibition through GSK343 treatment 
suffices to deregulate repetitive elements in wild-type MEFs and splenocytes. The next 
steps may be to characterize whether an IFN response is induced, and if so, whether 
induction is more efficient in cells with perturbed silencing of repetitive elements as a 
result of combinatorial treatments with chemotherapy, radiation therapy, or DNMT 
inhibitors. The observations from this work will determine whether tumor suppressor 
status may predict efficacy of viral mimicry induced from epigenetic modulators. 
Specifically, RB1-positive cancers may serve as ideal candidates for EZH2 inhibition.  
In contrast to viral mimicry induced upon acute ablation of silencing, sustained 
deregulation of repetitive elements promotes genome instability and proves advantageous 
towards tumorigenesis. Independent of the mutagenic effects of endogenous 
retrotransposition, constitutive IFN activation gradually becomes immunosuppressive, 
and is associated with cancer cell resistance to chemotherapy and radiation therapy 
(Kassiotis and Stoye, 2016). If tumor suppressor inactivation misregulates repetitive 
elements, then the potentially mutagenic and immunosuppressive consequences may be 
underappreciated drivers of clonal evolution and overall disease outcomes. To assess 
whether this was the effect, Rb1
S
 mice were crossed into a Trp53
-/-
 background. 
Decreased tumor latency and a modest increase in tumor spectrum in Rb1
S/S
;Trp53
-/-
 
relative to Rb1
+/+
;Trp53
-/-
 mice merit further investigation into whether a net increase in 
repetitive element misregulation underlies potentially increased genome instability in 
relevant cell-of-origin populations. The results of this work may suggest further 
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investigations into whether transcriptional signatures of active repetitive elements and the 
associated IFN response are a general property of all pRB-deficient human cancers.  
5.7 Summary of pRB-E2F1 functions at repetitive 
elements 
 In summary, the work presented in this thesis represents a significant contribution 
towards the elucidation of pRB functions at repetitive regions of the genome. My 
characterization of altered pRB-E2F1 recognition dynamics at major satellites presented 
in appendix C initiated investigation into whether this altered recognition conferred 
recruitment of the CDK-resistant pRB-E2F1 complex to other repetitive elements. This 
investigation revealed that the pRB-E2F1 scaffold mediates recruitment of multiple 
chromatin regulatory proteins to repetitive sequences throughout the genome. pRB 
recruits EZH2 to deposit H3K27me3 to silence repetitive elements genome wide. In 
addition to EZH2, pRB recruits Condensin II to major satellites to facilitate proper 
replication and mitotic progression. Loss of the CDK-resistant pRB-E2F1 scaffold 
precedes the onset of genome instability and lymphomagenesis.  
This work also reveals new questions stated throughout this discussion that concern 
distinguishing the biochemical properties of multiple complexes that utilize the CDK-
resistant pRB-E2F1 scaffold, and the recognition mechanism that underlies recruitment to 
repetitive sequences. In addition to these questions, future work should continue from the 
initial investigations presented in Chapter 4 that explore how loss of this regulatory 
paradigm affects tumor outcomes in a Trp53
-/-
 background, and whether the functions of 
pRB at repetitive elements prove relevant towards predicting efficacy of EZH2 inhibition 
in human cancers.  
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Appendix C: Haploinsufficiency of an RB-E2F1-Condensin II 
complex leads to aberrant replication and aneuploidy 
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Appendix D: List of primers used 
Primer  Primer Sequence (5'-3') Primer Use Source 
Maj_F1 
GACGACTTGAAAAATGACG
AAATC 
qRT-PCR, 
qPCR 
(Martens et al., 
2005) 
Maj_R1 
CATATTCCAGGTCCTTCAGT
GTGC 
qRT-PCR, 
qPCR 
(Martens et al., 
2005) 
IAP LTR_F 
TTGATAGTTGTGTTTTAAGT
GGTAAATAAA 
qRT-PCR, 
qPCR 
(Martens et al., 
2005) 
IAP LTR_R 
AAAACACCACAAACCAAAA
TCTTCTAC 
qRT-PCR, 
qPCR 
(Martens et al., 
2005) 
L1 5' UTR_F 
CTGCCTTGCAAGAAGAGAGC 
qRT-PCR, 
qPCR 
(Montoya-Durango 
et al., 2009) 
L1 5' UTR_R 
AGTGCTGCGTTCTGATGATG 
qRT-PCR, 
qPCR 
(Montoya-Durango 
et al., 2009) 
L1 ORF1_F 
AGATCTGGAACCATAGATG qRT-PCR 
(De Cecco et al., 
2013) 
L1 ORF1_R 
TTCTCATTGTGTCCTGGATT qRT-PCR 
(De Cecco et al., 
2013) 
L1 ORF2_F 
ACTTCCCAAATCTTAAA qRT-PCR 
(Puszyk et al., 
2013) 
L1 ORF2_R 
AAAAGTCTGGTGTAATT qRT-PCR 
(Puszyk et al., 
2013) 
IFNα_F TGCAATGACCTCCATCAGCA 
qRT-PCR (Schneider et al., 
2008) 
IFNα_R 
TTCCTGGGTCAGAGGAGGTT
C 
qRT-PCR (Schneider et al., 
2008) 
IFN-β1_F 
CTGGAGCAGCTGAATGGAA
AG 
qRT-PCR (Schneider et al., 
2008) 
IFN-β1_R 
CTCCGTCATCTCCATAGGGA
TCT 
qRT-PCR (Schneider et al., 
2008) 
β-act_9F 
CTGGCTCCTAGCACCATGAA
GATC qRT-PCR 
(Matsui et al., 
2010) 
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β-act_5R TGCTGATCCACATCTGCTGG qRT-PCR 
(Matsui et al., 
2010) 
Ccne1_F1 
AGCGAGGATAGCAGTCAGC
C qRT-PCR 
(Pandit et al., 
2012) 
Ccne1_R1 
GGTGGTCTGATTTTCCGAGG qRT-PCR 
(Pandit et al., 
2012) 
Ccna2_F1 
CTTCTTCCTTTTCCCTTGGC qRT-PCR 
(Pandit et al., 
2012) 
Ccna2_R1 
TTTCAGAGTCCCAGTGACCC qRT-PCR 
(Pandit et al., 
2012) 
Rbl1_F 
TTCCTGTGAAGAAGTTATAT
TCCCT qRT-PCR 
(Pandit et al., 
2012) 
Rbl1_R 
CTGTAGCGCTCATGGACAGA qRT-PCR 
(Pandit et al., 
2012) 
Cdt1_F1 
ACAGCCGGGCAAGATCCCCT qRT-PCR 
(Pandit et al., 
2012) 
Cdt1_R1 
GGCTCCCAACTTCCGTGCCC qRT-PCR 
(Pandit et al., 
2012) 
Mcm6_F1 
CCTGTGAATAGGTTCAACGG
C qRT-PCR 
(Pandit et al., 
2012) 
Mcm6_R1 
CATTTTCCTGAGGTGGAGCA
C qRT-PCR 
(Pandit et al., 
2012) 
Mcm3_TSS_F  
ATCCAGGAAGTCCAAGTAGT
CTCTC qPCR 
(Cecchini et al., 
2014) 
Mcm3_TSS_R  
TTGAAGTGGTTAGCCAATCA
TAACG 
qPCR (Cecchini et al., 
2014) 
Mcm3_-2kb_F 
GCCAAGGCAAAACAACAAT
TTCTAC 
qPCR (Cecchini et al., 
2014) 
Mcm3_-2kb_R 
CTATCTCTTTGATTTTGGGTG
GCTG 
qPCR (Cecchini et al., 
2014) 
Gapdh_F GAGCCAGGGACTCTCCTTTT 
qPCR (Cecchini et al., 
2014) 
Gapdh_R CTGCACCTGCTACAGTGCTC qPCR (Cecchini et al., 
  
217 
2014) 
H19_ICR_d_F 
CTGCAAACAATTCTGAAACT
GC 
qPCR (Kernohan et al., 
2010) 
H19_ICR_d_R 
TCTGCTTTTAACAAGGCTCT
CC 
qPCR (Kernohan et al., 
2010) 
IAP_F1 
TTGATAGTTGTGTTTTAAGT
GGTAAATAAA Bisulfite  
(Lane et al., 2003)  
IAP_R1 
AAAACACCACAAACCAAAA
TCTTCTAC Bisulfite  
(Lane et al., 2003)  
IAP_F2 
TTGTGTTTTAAGTGGTAAAT
AAATAATTTG Bisulfite  
(Lane et al., 2003)  
IAP_R2 
CAAAAAAAACACACAAACC
AAAAT Bisulfite  
(Lane et al., 2003)  
L1_F1 
AGAAGAGAGTTTGTTTGTAG
AGA Bisulfite  
this study 
L1_R1 
ACACCTAAAATTCTCTCTTC
CA Bisulfite 
this study 
L1_F2  
AGAAGAGAGTTTGTTTGTAG
AGA Bisulfite  
this study 
L1_R2 
TCATTTCCATCACCTATTTAA
CT Bisulfite  
this study 
PCNA_E2F_F 
CAGAGTAAGCTGTACCAAG
GAGAC qRT-PCR (Cecchini et al., 
2014) 
PCNA_E2F_R 
CGTTCCTCTTAGAGTAGCTC
TCATC qRT-PCR (Cecchini et al., 
2014) 
PCNA_-2kb_F 
CATCAGTGAATACGTCTCTG
TTCCA qRT-PCR (Cecchini et al., 
2014) 
PCNA_-2kb_R 
CTGCTTCTCAGTTGTTTTAGG
AAGG qRT-PCR (Cecchini et al., 
2014) 
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Appendix E: List of plasmids used 
Plasmid Name Source Description 
cep99-gfp-L1SM Jef Boeke full-length synthetic mouse LINE element (SM L1) 
cep99-gfp-TGF21  John Moran full-length endogenous L1 
pEF.myc.ER-E2-
Crimson 
Addgene Crimson reporter 
pBABE-H2B-GFP Fred Dick H2B-GFP Mammalian Expression vector, 
Retroviral 
pBSK-Rb25 Fred Dick Rb1
S
 targeting vector encoding an F832A 
substitution in Rb1 exon 24, and a floxed PGK-
neomycin cassette. 
 
Appendix F: List of antibodies used 
Antibody Target Source ChIP 
(Ab:Chr) 
WB IP 
(Ab:extract) 
C-15 pRb Santa Cruz 5 μg : 80 μg   
M-153 pRb Santa Cruz 5 μg : 80 μg 1:1000  
M-136 pRb 
(Cecchini et al., 
2014) 
5 μg : 80 μg  5 μg : 1 mg 
S855 pRb 
(Cecchini et al., 
2014)(Cecchini et 
al., 2014) 
5 μg : 80 μg 1:1000  
Hyb4.1 pRb Developmental 
Studies Hybridoma 
Bank 
500 μl : 80 
μg 
  
D2C9 Ezh2 Cell Signaling 5 μg : 80 μg 1:1000 4 μg : 1.5 mg 
D39F6 Suz12 Cell Signaling  1:1000  
C-19 Hdac1 Santa Cruz  1:1000  
06-942 H3K9Ac Millipore 4 μg : 30 μg 1:1000  
07-449 H3K27me3 Millipore 4 μg : 30 μg   
07-442 H3K9me3 Millipore 4 μg : 30 μg   
  
219 
07-463 H4K20me3 Millipore 4 μg : 30 μg   
ab1791 H3 abcam  1:2000  
M-300 L1_ORF2p Santa Cruz  1:1000  
C-20 p130 Santa Cruz  1:1000  
C-18 p107 Santa Cruz  1:1000  
4012S Mcm3 Cell Signaling  1:1000  
H432 Cyclin A Santa Cruz  1:1000  
A2066 Actin SIGMA  1:3000  
11H10 Tubulin Cell Signaling  1:2000  
05-636 H2A.X 
pSer139 
Millipore     
A300-
244A 
RPA32 Bethyl labs  1:1000  
A300-
246A 
RPA32 
pSer33 
Bethyl labs  1:1000  
F-2 PCNA Santa Cruz  1:1000  
C-20 BubR1 Santa Cruz  1:1000  
ab7953 Cdk1 abcam  1:1000  
C-19 Mad2 Santa Cruz  1:1000  
 CAP-D3 Dick lab 5 μg : 80 μg 1:1000  
 SMC2 Dick lab  1:1000  
  
220 
Appendix G: PCR Conditions 
PCR Conditions p53 
 
Master Mix per reaction 
- 1 L MgCl2 (50mM) 
- 2.5 L dNTPs (2mM) 
- 2.5 L 10X PCR Buffer (200mM Tris 
pH8, 500mM KCl) 
- 0.62L 20M AM3 primer 
- 0.62L 20M AM4 primer 
- 0.27L 20M neo-sense primer 
- 0.27L 20M neo-antisense primer 
- 11 L Water 
- 0.5L Taq (5units/µL) 
Total   18L 
 + 2L DNA sample 
 
Reaction Conditions 
Program – P53 New 
1. 94C 2:30 
2. 94C 0:30 
3. 58C 0:30 
4. 72C 1:10 
5. Go  to Step #2, 29 times 
6. 72C 10:00 
7. 12C hold 
 
Expected Results:  
 
Mutant (Null) = 424 bp 
Wild type = 548 bp 
 
 
Primers 
AM3: ATAGGTCGGCGGTTCAT 
AM4: CCCGAGTATCTGGAAGACAG  
Neo-sense: 
GGAAGGGACTGGCTGCTATTG 
Neo-antisense: 
CAATATCACGGGTAGCCAACG 
 
 
PCR Conditions Rb1
S
 
 
Master Mix per reaction 
- 0.5 L MgCl2 (50mM) 
- 2 L dNTPs (2mM) 
- 2 L 10X PCR Buffer (200mM Tris 
pH8, 500mM KCl) 
- 1L 20M Rb1S_F 
- 1L 20M Rb1S_R 
- 11 L Water 
- 0.5L Taq (5units/µL) 
Total   18L 
 + 2L DNA sample 
 
 
 
Reaction Conditions 
Program – Rb1S_GENO 
1. 94C 2:00 
2. 94C 0:45 
3. 57C 0:45 
4. 72C 0:45 
5. Go  to Step #2, 39 times 
6. 72C 5:00 
7. 12C hold 
 
Expected Results:  
 
Mutant = 254 bp 
Wild type = 153 bp 
 
 
Primers 
Rb1S_F: 
ATGCATAGCTGCTGTCATCC 
Rb1S_R: 
GACTGTTGGCCAGTTTGGTT 
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